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Figure 1, page 93
(A) Camera lucida drawing of the ventral aspect of the lumbosacral region of an ElO 
chick embryo after evisceration showing the location of the dorsal root ganglia (DRG).
(B) Schematic illustration of an ElO chick embryo showing the locations of tlie cranial 
sensory ganglia.
Figure 2, page 104
Reliability of the RT-PCR technique. Autoradiographs showing the products of RT- 
PCRs amplified with either p75- or L27-specific primers.
Figure 3, page 106
Bar charts showing p75 mRNA expression relative to L27 mRNA in purified 
preparations of chicken sensory, sympathetic, and parasympathetic neurons at ElO, 
E12, E14, and E16.
Figure 4, page
Phase contrast photomicrograph of E7 chicken sympathetic neurons suiwiving without 
neurotiophic factors on a polyomithine-laminin substratum.
Figure 5, pages 109-110
Regulation of in vitro p75 mRNA levels in E7 chicken sympathetic neurons. Graphs 
show (A) effect of NGF, CNTF, and SCF; (B) effect of RA; (C) effect of TGF-pl, 
-p2, and -p3; and (D) effect of depolarization by KCl and of depolarization in the 
presence of CNTF.
Figure 6, page 112
Regulation of in vitro p75 mRNA levels in (A) E14 chicken sympathetic and (B) E14 
DRG neurons. Graphs show the effects of NGF, CNTF, and KCl alone and in various
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combinations.
Figure 7, page 124
Autoradiographs showing the products of RT-PCRs amplified with BDNF-specific 
primers.
Figure 8, page 125
Bar charts showing BDNF mRNA levels relative to L27 mRNA in purified DMTG, 
jugular, TMN, and VLTG neurons from ElO, E12, and E14 chicken embiyos.
Figure 9, page 127
Bar chart showing percent survival of ElO DMTG, jugulai*, TMN, and VLTG neurons 
after 48 hours in control cultures and cultures supplemented with 5 ng/ml NGF and 5 
ng/ml BDNF.
Figure 10, page 128
Photomicrographs of co-cultures of TMN and DMTG neurons. (A) Phase contrast 
view showing all neurons and their processes. (B) The same field as in (A) viewed by 
rhodamine epifluorescence showing Dil-labelled TMN neuron.
Figure 11, page 130
Bar chai't showing percent survival of ElO TMN neurons cultured alone or co-cultured 
with a ten-fold greater number of ElO DMTG neurons.
Figure 12, page 138
Autoradiograph showing the products of RT-PCRs amplified with primers specific for 
full-length chicken trkB.
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Figure 13, page 139
Graph of the level of full-length trkB mRNA relative to L27 mRNA (fg mRNA 
per pg L27 mRNA) in the vestibular and nodose ganglia of chicken embryos at stages 
17 to 24.
Figure 14, page 141
Graph of the level of p75 mRNA relative to L27 mRNA (fg p75 mRNA per pg L27 
mRNA) in the vestibulai* and nodose ganglia of chicken embryos at stages 17 to 24 
(stage 20 was the earliest stage at which nodose ganglia were studied).
Figure 15, page 142
Graph of the level of BDNF mRNA relative to L27 mRNA (fg BDNF mRNA per ng 
L27 mRNA) in the heart, hindbrain, and otic vesicle of chicken embiyos at stages 16 to 
24.
Figure 16, page 144
Graph of the level of full-length trkB mRNA (fg per neuron) at 12 hourly inteiwals in 
low-density cultures of stage 19 chicken nodose neurons grown without or with BDNF 
in the culture medium for 72 hours.
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Abbreviations 
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BDNF Brain-derived neurotrophic factor 
ChAT Choline acetyl transferase 
CIAP Calf intestinal alkaline phosphatase
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ddNTP Dideoxynucleotide triphosphate 
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DG Diacylglycerol
DMSO Dimethyl sulphoxide
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DNase 1 Deoxyribonuclease 1
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Erk 1,2 Extracellular signal-regulated kinase 1,2
FGF(-S) Fibroblast growth factor(-5)
G ABA y-aminobutyric acid
GAP Ras GTP-ase activating protein
GDNF Glial cell line-derived neurotrophic factor
HIFCS Heat-inactivated foetal calf serum
HIHS Heat-inactivated horse serum





L broth/agar Luiia broth/agar 
LIF Leukaemia inhibitoiy factor 
MAPK Mitogen-activated protein Idnase 
MAPKK Mitogen-activated protein kinase kinase 
MOPS 4-Moipholinepropanesuifonic acid 
NGF Nerve growth factor 
NPY Neuropeptide Y
NT-3, -4/5, -6 Neurotrophic factor-3, -4/5, -6
OD Optical density
PEG Polyethylene glycol





RT-PCR Reverse transcription-polymerase chain reaction
SCF Stem cell factor
SDS Sodium dodecyl sulphate
SH2 Src homology 2
SNT 5MC-associated neurotrophic-factor-induced tyrosinephosphorylated target
SOS Son of sevenless
SCG Superior cervical sympathetic ganglion
TAE buffer Tris-acetate-EDTA buffer
TBE buffer Tris-boric acid-EDTA buffer
TG F-p (1, 2, 3) Transforming growth factor-p(l, 2, 3)
TEMED N, N, N', N'-Tetramethylethylenediamine
TH Tyrosine hydroxylase






BDNF binds to two ti’ansmembrane receptors: trkB, which is a tyrosine kinase 
essential for signalling, and p75, which is a common nenrotiophin receptor whose role 
is contoversial. To determine the relationship between BDNF synthesis, BDNF 
receptor expression, and neuronal responsiveness, the expression of BDNF, trkB, and 
p75 mRNAs were studied for different populations of sensory neurons whose axons 
reach their targets and become dependent on BDNF for suiwival at different times. 
BDNF mRNA was expressed in the peripheral and central tai'gets of these neurons 
prior to the arrival of sensory axons. The onset of BDNF responsiveness was preceded 
by the expression of first p75 mRNA then trkB mRNA, and neurons that start 
responding to BDNF early were the first to express trkB mRNA. BDNF upregulated 
trkB mRNA expression just shortly before the onset of BDNF dependence.
BDNF is expressed not only in sensory neuron targets but in some of these 
neurons themselves. To determine whether BDNF is synthesized in NGF-dependent or 
BDNF-dependent neurons, BDNF mRNA expression was studied in purified 
populations of cranial sensory neurons that depend on either NGF or BDNF for 
survival. During the period of neuronal death, BDNF mRNA expression was highest in 
NGF-dependent cutaneous sensory neurons, lower in BDNF-dependent cutaneous 
sensory neurons, and undetectable in BDNF-dependent proprioceptive neurons. In co­
culture, NGF-dependent neurons promoted the survival of BDNF-dependent neurons 
by the production and release of BDNF, implying a paracrine role for BDNF duimg the 
period of naturally occurring neuronal death.
To deteimine if the level of p75 expression in sensory neurons is related to the 
particular neurotrophin they require for survival, p75 mRNA levels were measured in 
puiified populations of cranial sensory neurons. No clear relationship between the level 
of p75 mRNA expression and neuron type was observed. Studies of the regulation of 
p75 mRNA expression in sympathetic neuroblasts revealed that retinoic acid increased 





The following is a brief account of the events occurring in early neural 
development. These are described more fully in a review by Schoenwolf and Smith
(1990). The onset of neural development is marked by the formation of a dorsally- 
positioned groove along the ectodermal surface of the gastrula. The neural groove then 
widens, accompanied by the thickening of the ectoderm lateral to it which forms the 
neural plate on the dorsal side of the embryo. The margin of the neural plate bears 
ridges called neural folds which start fusing near the anterior end to foim the neural 
tube. Most of the cells from which the brain and spinal cord are formed come from the 
neural tube. The beginning of brain development is maiked by a slight anterior swelling 
of the neural tube.
During neural tube closure, a group of cells, the neural crest, detach from the 
margin of the neural ectoderm and foim the peripheral nervous system. They come to 
lie in a band along the length of the neural plate and finally position themselves dorsally 
and laterally to the closing neural tube. The cells then undergo a period of migration 
into the periphery followed by differentiation into spinal and autonomic ganglia, glial 
cells of the autonomic and sensory neivous system, and other non-neuronal tissues 
such as melanocytes, chromaffin cells of the adrenal medulla, cartilage, blood-foiming 
cells, connective tissue covering the brain and spinal cord, and pai'ts of the facial bones.
Neural tissues are also foimed from ectodermal placodes which appear* as 
thickenings of the ectoderm in the head region. Structures such as the anterior pituitary 
gland, the olfactory sensory epithelium, and the lens are derived from placodes. The 
more caudally postioned 'neurogenic' placodes give rise to epithelial cells that migrate 
to form the neurons of certain cranial sensory ganglia.
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The Neurotrophic Theory
During development, neurons extend axons towards their target fields to 
establish contacts with tai'get cells and make appropriate synaptic connections. Since 
more neurons aie generated than required, a mechanism must exist for controlling the 
number that finally malce successful synaptic connections in the target field. This 
process is marked by a distinct period of neuronal cell death, which commences shortly 
after the first neurons innervate their targets (Cowan et a l, 1984). It has been assumed 
that the target field itself controls the size of neuronal populations that innervate it by 
synthesizing a limiting supply of a neurotrophic factor on which the neurons are 
dependent for survival. This has been embodied in the neurotrophic theory (Davies, 
1988a; Barde, 1989; Oppenheim, 1991; Thoenen, 1991).
Most of the studies supporting the theory have been on neiwe growth factor 
(NGF), the first neurotrophic molecule to be identified and completely chai'acterized. It 
was shown that NGF is produced by cells in the target field of neurons that require it 
and that its availability regulates neuronal survival. NGF is bound by the neuron and 
the NGF-receptor complex internalized and transported to the cell soma (Levi- 
Montalcini, 1987). It has also been demonstrated that NGF is produced in the target 
field in proportion to the density of innervating neurons (Heumann et a l, 1994; Shelton 
and Reichai'dt, 1984), especially duiing development (Harper and Davies, 1990).
An alternative proposal to limited production of neurotrophic factor is one of 
limited access to it. Enough neurotrophic factor would be produced to support all the 
developing neurons and whether or not a neuron survives would be governed by its 
ability to form sufficient neuronal branches and synaptic sites through which to obtain 
the factor (Oppenheim, 1989). Studies in support of this theory make use of hyper- 
innervated embryonic chicken muscle produced by phannacological paralysis. It has 
been demonstrated that extract from this muscle promotes motoneuron survival with a 
similar efficiency to that from noimal embryos both in vitro (Tanaka, 1987) and in vivo 
(Houenou et a l,  1989), which suggests that neurotrophic factor is synthesized at 
similar levels in normal and hyper-innei*vated muscle.
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However, further studies on the nervous system and other NGF-related 
neurotrophic molecules have shown that the control of target inneiwation is not so 
simplistic. The members of the NGF family of neurotrophic factors (or neurotrophins) 
are brain-derived neurotrophic factor (BDNF), neurotrophin-3, -4/5, and -6 (NT-3, 
-4/5, and -6). Both NGF, its related neurotrophic molecules, and their receptors will be 
discussed in more detail in later sections of this Chapter.
Recent studies have exposed the limitations of the neurotrophic theory. Apart 
from obtaining neurotrophic support from innervated target cells (the classical 
retrograde mechanism) (Levi-Montalcini, 1987; Thoenen et a i, 1987), neurons might 
also obtain it from other neurons which are afferent (an anterograde mechanism). 
Oppenheim (1991) has described how a number of neuronal types degenerate when 
afferent input is lesioned, providing strong evidence for an anterograde mechanism. 
Neurotransmitter molecules, which are transported anterogradely, may also influence 
neuronal survival. Lipton and Kater (1989) have documented the effects on neuronal 
survival and differentiation of a variety of neurotransmitters.
A further source of neurotrophic support may come from cells ensheathing 
neiwes. Heumann e ta l  (1987), have demonstrated that a high rate of NGF synthesis is 
maintained by peripheral nerve-ensheathing cells duiing development which decreases 
in adulthood. It also increases briefly when the nerve is lesioned. This suggests that the 
nerve cells receive a local supply of NGF prior to target innervation during 
development or before re-contacting target organs during regeneration.
Some types of neuron have been found to synthesize both neurotrophic factors 
and their respective receptors and so respond to their own neurotrophic factors in an 
autocrine mechanism. Dorsal root ganglion (DRG) neurons, sympathetic neurons, and 
hippocampal pyramidal neurons synthesize both BDNF and its receptor, trkB (Ernfors 
et al.y 1990a; Klein etal., 1990b; Wetmore, etal., 1991; Schecterson and Bothwell, 
1992; Wright et al., 1992). Direct evidence for autocrine support by BDNF has come 
from studies using both early (Wright et al., 1992) and adult (Acheson et al., 1995) 
DRG neurons. Neurotrophic factor secreted by one neuron may also be available to
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other neurons within a population, possibly via a paracrine mechanism of neuronal 
support. Autocrine or paracrine support mechanisms would obviously provide a 
function distinct from that of neuron-target interaction. They may play a role in 
maintaining neurons prior to tai'get field innervation (Korsching, 1993).
The Structurally-Related Family of Neurotrophic Factors
The work of Hamburger and his colleagues provided evidence that neurons 
require more than nutrients in order to survive. Theii* experiments involved the removal 
of a wing or limb bud in the chick embryo prior to innervation, with resultant death of 
the innervating sensory, autonomic, and motor neurons. These results suggested that 
the peripheral tissues might produce certain substances essential for the maintenance of 
neurons (review by Levi-Montalcini, 1987). Experiments directed at understanding the 
nature of this peripheral influence led to the discoveiy of the first neurotrophic factor, 
NGF, in the early 1950's, Levi-Montalcini and Hamburger (1951,1953) obseiwed that 
transplantation of a mouse sarcoma into chick embryos after limb bud removal resulted 
in the enlargement of sympathetic and dorsal root ganglia and hyper-innervation of the 
tumour. Studies of the substance released by the sarcoma were initially earned out 
using neuiite outgrowth assay techniques for chick sympathetic and dorsal root ganglia 
(Levi-Montalcini etal., 1954) and ultimately led to the purification of NGF.
Other members of the family of structurally-related polypeptide neurotrophic 
factors (i.e., BDNF, NT-3, NT-4/5, and NT-6) have been identified more recently. 
Elucidation of the primary structures of these molecules has revealed that their basic 
conformations are determined by strictly conserved cysteine-rich domains. Distinct 
regions of vaiiation between the molecules are responsible for their binding to specific 
high-affinity receptors, located on a variety of neuronal types, through which their 
biological actions are mediated. The neurotrophic factor-receptor interaction also 
involves a low-affinity receptor component which is common to all the factors. The 
spatial and temporal expression of the neurotrophic factors and their receptors during 
development plays an essential role in regulating the foimation of the nervous system.
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Nerve Growth Factor (NGF)
As the first neurotrophic factor to be isolated, NGF remains the best 
characterized with respect to structure and function. It promotes the survival of 
sympathetic neurons (Chun and Patterson, 1977; Greene, 1977), certain types of 
sensoiy neurons (Davies and Lindsay, 1985), and basal forebrain cholinergic neurons 
(Hatanakaefa/., 1988).
The NGF protein was purified from the submandibular gland of the male mouse 
(Angeletti and Bradshaw, 1971; Angeletti et a l, 1973), where it is found in great 
quantities. Why NGF is located here in such quantity (approximately 0.1% of total 
protein; Cohen et a l, 1960) is uncertain. Aloe e ta l  (1986) suggest that it might be 
important in the aggressive behaviour of male mice as the salivary glands release large 
quantities of NGF into the bloodstream during fighting. This, however, is not found in 
other aggressive animals.
Significant levels of NGF are also found in other exocrine tissues and their 
secretions. These include snake venom (Bailey et a l 1975), guinea pig prostate 
(Chapman et a l, 1981), bull semen and seminal vesicles (Hoffman and Unsicker, 
1982), and the submandibular gland of the African rat Mastomys natalensis (Aloe et 
a l,  1981). No explanation has been found for the presence of NGF in these regions; 
there appeal's to be no influence on the developing or mature nervous system (Thoenen 
and Barde, 1980; Haiper and Thoenen, 1981). Most studies have been carried out 
using mouse NGF because the submandibular gland of male mice is such a rich source 
of the factor.
Protein Structure
NGF isolated from the submandibulai' gland of the male mouse has a molecular 
weight of 130,000 Da. It is synthesized as a complex of three subunits, a  , p, and y. 
Only the p subunit has an effect on neurons. Hence, the active form of NGF is often 
refened to as p-NGF. It is generated from a 305 amino acid prepro-NGF by proteolytic 
cleavage and comprises a 26,000 Da dimer of two identical 118-amino acid monomers.
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each containing three intrachain disulphide bonds (Bradshaw et a l, 1993). Loss of 
these bonds results in loss of biological activity (Greene and Shooter, 1980; Thoenen 
and Barde, 1980).
X-ray diffraction studies have recently been used to determine the three- 
dimensional structure of the mature molecule (McDonald et a l, 1991). Dimer foimation 
occurs through hydrophobic contacts between the flat surfaces of each monomer. The 
hydrophobic core of each monomer bears the majority of amino acids common to aU the 
neurotrophic factors, including the disulphide bonds. Several amino acids that are 
conserved in the neurotiophic factors contiibute to NGF structure by forming hydiogen 
bonds (review by Ebendal, 1992). A group of positively-chaiged amino acids has been 
shown to be important in the interaction of NGF with the low-affinity receptor (Ibdnez 
et a l, 1992). Of the regions that differ between the neurotrophic factors, one forms 
three closely-associated p-hairpin loops in the NGF protein. It is possible that these 
regions are responsible for the different spécificités each factor has for its high-affinity 
receptor (review by Ebendal, 1992).
Gene Structure
The mouse NGF gene is 45 kb in length and consists of five exons separated by 
four introns. The mature protein is translated from the transcript of a single 3' exon. 
The remaining 5' exons are smaller and undergo alternative splicing to produce at least 
four transcripts that encode precursor proteins that differ in their amino termini (Selby 
et a l, 1987), The two major transcripts give rise to precursor proteins of molecular 
weights 34,000 Da and 27,000 Da. The 34,000 Da precursor has a hydrophobic signal 
peptide 70 residues downstream from the initiation methionine, while the 27,000 Da 
precursor has a hydrophobic signal peptide at the amino tenninus. Both are further 
processed thiough cleavage and glycosylation to give matuie, biologically active protein 
(Edwards e ta l ,  1988). The reason why several different transcripts are produced is 
uncertain. Of the two major transcripts, the one encoding the larger precursor is the 
most abundant in mouse submandibular gland and in placenta from several species.
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while the other transcript is predominant in all other tissues.
Brain-Derived Neurotrophic Factor (BDNF)
BDNF was the next neurotrophic factor to be characterized. It promotes the 
survival of sensory neurons that are unresponsive to NGF (Davies et a l, 1986a; 
Lindsay e ta l,  1985), the dopaminergic neurons of the substantia nigra (Hyman et a l, 
1991), and developing motoneurons under certain expeiimental conditions (Oppenheim 
e ta l ,  1992).
M olecular Structure
BDNF was first isolated from pig brain (Baide et a l, 1982). It was found to be 
a 12.3-kDa basic protein. Molecular cloning (Leibrock et a l, 1989) has shown that the 
BDNF protein has approximately 50% amino acid identity with NGF.
BDNF gene sequence information has been determined for a number of other 
species, including human and rat (Maisonpiene eta l, 1991) and chicken (Maisonpierre 
et a l, 1992). The rat BDNF gene has been shown to span over 40 kb of genomic DNA 
and consists of four short 5' exons and one 3' exon encoding the mature BDNF protein 
(Timmusk et a l, 1993). Eight different BDNF mRNAs with four 5' ends and two 
alternative polyadenylation sites are transcribed from this gene. BDNF mRNAs 
containing the first three 5’ exons are expressed predominantly in the brain, whereas 
transcripts containing the fourth exon aie found predominantly in the lung and heart
N eurotrophin-3 (NT-3)
NT-3 was the third member of the NGF gene family to be identified and, in 
contrast to NGF and BDNF, this did not require prior purification of the NT-3 protein. 
Primaiily, the research groups involved made use of the polymerase chain reaction 
(PCR) technique and the nucleotide sequence homology between NGF and BDNF 
(Hohn et a l, 1990; Maisonpierre era/.,1990; Rosenthal et a l, 1990).
NT-3 supports proprioceptive sensory neurons that project to skeletal muscle.
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enteroceptive sensory neurons (Hohn et a i, 1990), and embiyonic motoneurons in 
vitro (Henderson etaLy 1993).
N eurotrophiiî-4/S (NT-4/5)
Hallbdok et al. (1991) took advantage of the regions of conservation between 
NGF, BDNF, and NT-3 in a PCR-based search for further members of the NGF gene 
family. As a msult, NT-4 was identified and sequenced for the clawed toad Xenopus. 
Mammalian versions of NT-4 have since been isolated from the rat and human genomes 
(Ip et a l y  1992). Ip et a l (1992) have also isolated a pseudo-NT-4 gene containing 
several frame shifts, an internal stop codon, only four of the six essential cysteine 
residues, and no cleavage site to process the mature neuroti'ophic factor. The biological 
activity of recombinant Xenopus NT-4 is similar to that of BDNF in that it promotes the 
in vitro survival of sensory neurons (Hallbook et a l y 1991). NT-4 has also been 
shown to support the survival of embryonic rat motoneurons in vitt'o (Henderson et a l y 
1993).
Berkemeier et a l (1991) also used a PCR strategy to isolate DNA fragments 
encoding a protein they refeired to as neurotiophin-5 (NT-5). This protein has the same 
sequence as that described for human NT-4 by Ip et a l (1992). Berkemeier et a l
(1991) claim that NT-5 is a distinct neurotrophic factor from NT-4 as it is expressed at 
low levels in a few peripheral organs and can stimulate sympathetic neurons when in 
the form of a recombinant protein; properties not exhibited by Xenopus NT-4. 
However, because the sequences of NT-5 and human NT-4 are the same, mammalian 
NT-4 is referred to as NT-4/5.
N euFotrophm -6 (NT-6)
NT-6 was cloned from a genomic libraiy of the teleost fish Xiphorus maculatis 
(Gotz et a l y 1994) and remains the most recently identified member of the NGF family 
of neui'otrophic factors. It bears the structural features characteristic of this gene family, 
including the six conserved cysteine residues and has been found to promote the
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survival of a similar range of neurons to NGF.
N eurotrophic Factor Expression
in the Central Nervous System
NGF, BDNF, and NT-3 appear to be synthesized primarily in specific neurons 
in the brain and, therefore, target-derived influences are achieved through interactions 
between neurons (Ayer-LeLievre et al.y 1988; Gall and Isackson, 1989; Ernfors et al.y 
1990a,b; Philips et al. y 1990; Isackson et al.y 1991). Several studies have demonstrated 
the changes in NGF mRNA and protein levels in valions regions of the rat brain during 
embryonic and early postnatal development (Laige et a l y  1986; Lu et a l y  1989; Mobley 
et a l y  1989). NGF mRNA and protein levels aie initially low and uniform throughout 
the brain and do not reach a maximum until postnatal day 21 in the neocortex and 
hippocampus. During development, BDNF is expressed initially at low levels but 
increases to become the most widespread neurotrophic factor in different areas of the 
brain. It reaches its peak level of expression two weeks after birth. NT-3 mRNA is 
weakly expressed in the hippocampus and cerebellum and reaches its maximum level of 
expression shortly after birth. NGF, BDNF, NT-3, and NT-4 are expressed in the 
adult brain (Persson and Ernfors, 1992). NT-6 expression has been detected in a small 
region of teleost cerebellum beneath the midbrain tectum during organogenesis, in 8- 
day old fish, and in the adult (Gotz et al.y 1994).
in Peripheral Tissues
NGF expression has been studied extensively in the peripheral whisker pad 
target field of the mouse trigeminal system. Davies et al. (1987) have demonstrated that 
NGF mRNA and protein are synthesized in the non-neuronal epithelial and 
mesenchyme cells of the target field at the time of anival of the fiist nerve fibres. NGF, 
BDNF, and especially NT-3 are expressed in many peripheral taiget tissues such as 
skeletal muscle, liver, and gut. NT-3 is expressed predominantly in these peripheral 
tissues, being only wealdy expressed in the brain, and is known to support the
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proprioceptive neurons projecting to skeletal muscle and the somatosensory fibres of 
the nodose ganglion (Thoenen, 1991). NT-6 expression has been detected in adult 
teleost gill, liver, and eye with weak expression in skin, spleen, heait, and skeletal 
muscle (Gotz et aly 1994).
Neurotrophic Factor Receptors
The use of highly purified 125% NGF in binding and cross-linking studies has 
facilitated the characterization of NGF receptors in the late 1970's (Sutter e t  a l y  1979; 
Schechter and Both well, 1981). It is now well established that members of the NGF 
family of neurotrophic factors recognize two types of receptor, distinguishable by their 
pharmacological properties (review by Meakin and Shooter, 1992). One type of 
receptor binds all the factors with low affinity and has a dissociation constant of lO'^M. 
It is a ceU surface protein with a moleculai* weight of 75 kDa in the human, although the 
rat protein is slightly larger, and is refened to as p75 for all species. The p75- 
neurotrophic factor moiety is not internalized. The precise role of p75 in mediating the 
biological effects of neurotrophic factors is not certain but it may form part of a 
complex or interact in some other way with the second class of receptors. These are 
products of the trk oncogenes, a family of related tyrosine kinase-bearing receptors. 
They show specific high affinity binding for the neurotrophic factors (the dissociation 
constants being in the low picomolar range for NGF and NT-3 but undeteimined for 
BDNF) and aie capable of internalizing bound factor. Neurotrophic factor binding 
induces autophosphorylation of an intracellular tt'k tyrosine Idnase residue.
The Low-Affinity p7S Receptor
Chao and co-workers (1986) isolated the gene encoding human p75 using gene 
transfer assays with subsequent immunological detection of the transfected NGF 
receptor-expressing cells. The rat p75 gene was cloned by Radeke and co-workers 
(1987) using cDNA probes obtained from NGF-expressing cells by subtraction with 
excess mRNA from untransfected cells. Chicken p75 has been cloned by Lai*ge and co­
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workers (1989). p75 mRNA size in chicken is 4.5 kb; in human, 3.8 kb; and in rat, 3.6 
kb. The molecules differ at their 3' noncoding regions which accounts for the size 
differences.
The human p75 gene encodes a glycoprotein consisting of a single 
transmembrane polypeptide of 427 amino acid residues, 399 of which make up the 
mature protein. Rat p75 cDNA codes for a protein of 425 amino acids, including a 29 
amino acid signal peptide. The extracellular domain comprises 222 amino acids, the 
transmembrane domain 22 amino acids, and the intracellular domain 152 amino acids. 
The amino acid sequences for human and rat p75 are almost identical but the chicken 
sequence has more variation. In all three species, the extracellular domain bears four 
conserved cysteine repeats. It has been demonstrated that these are responsible for 
ligand recognition since a secreted 168 amino acid receptor without all residues carboxy 
terminal to this domain still binds NGF (Welcher e ta l, 1991; Yan e ta l, 1991). There 
is also considerable homology between the three species within the transmembrane 
domain and in the C-terminus of the intracellular domain. The role of the intracellular 
domain remains to be fully elucidated. However, it has been shown that deletions in 
this region interfere with the ability of p75 to form functional high affinity NGF 
receptors (Hempstead et aly 1989).
A soluble, truncated form of p75 has been isolated from conditioned media of 
p75-producing cells and in various biological fluids (Distefano and Johnson, 1988). 
This comprises the extracellular domain only and is thought to be produced by post- 
translational processing as opposed to differential splicing. The biological significance 
of the truncated receptor remains unclear, but it binds NGF, BDNF, and NT-3 with 
equal affinity to the full-length transmembrane receptor. Truncated p75 may limit the 
activity of neurotrophic factors by competing for factors with the full-length receptor or 
act as a neurotrophic factor transporter (review by Barker and Murphy, 1992).
trk  Tyrosine Kinase Receptors
The human trk proto-oncogene locus was first identified when it became
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malignantly active in a colon carcinoma patient (review by Barbacid et a l y  1991). 
Martin-Zanca et al (1989) showed that this proto-oncogene encodes a 140 kD tyrosine 
kinase (designated p i40^^^^) which exhibits the structural characteristics of a growth 
factor receptor (review by Chao, 1992). In situ hybridization studies using mouse 
embryos showed that the trkA  gene is highly expressed in NGF-dependent neurons, 
for example, sensory neurons of spinal ganglia and a proportion of neurons from 
neural crest-derived cranial sensory ganglia (Martin-Zanca et al, 1990). Further studies 
established that pMO '^"^  ^ is a component of the high affinity NGF receptor. NGF 
stimulates tyrosine autophosphorylation of p i40^^^  ^in PC 12 cells, in spinal ganglia 
sensory neurons, and in NIH 3T3 cells transfected with trkA cDNA (Kaplan et al, 
1991a,b).
The observation that genes encoding trk tyrosine kinase receptors for BDNF 
and NT-3 should be structurally similar to that for pl40^^^^ led to the isolation of 
cDNA clones for trkB and trkC by low stringency hybridization with trkA probes. The 
intracellular tyrosine kinase domains of trkA, trkB, and trkC share 85% sequence 
homology. trkB and trkC encode the tyrosine kinase receptors pl45^^^^ and pl45^^^ 
respectively, both of molecular weight 145 kD. pl45^''^® has been shown to be the 
signalling receptor for BDNF (Klein et a l, 1991a; Glass et a l, 1991; Soppet et a l, 
1991; Squinto e ta l, 1991) and NT-4 (Berkemeier a/., 1991; Ip e ta l, 1992; Klein et 
aly 1992). pl45^^*^ has been shown to be the receptor for NT-3 (Lamballe et a l, 
1991). There appears to be some cross-talk between NT-3 and pl40^^^^ and pl45^^^®. 
NT-3 induces in vitro tyrosine phosphorylation of these receptors with similar 
efficiency to their cognate ligands NGF and BDNF (or NT-4) respectively (Klein et al, 
1991b; Soppet et a l, 1991; Squinto et a l, 1991). Glass et a l (1991) have 
demonstrated that NT-3 induces tyrosine phoshorylation of these receptors much less 
efficiently in NIH 3T3 cells. Ip et a l  (1993b) have shown that NT-3 exerts its 
neurotrophic effects on PC 12 cells and cultured neuronal cells bearing p l45^^ *C 
receptors.
Two isoforms of the trkA gene have been cloned. One was first identified in the
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rat (Meakin et a l, 1992) and the other in the human (Martin-Zanca et a l, 1989). The 
isoforms differ in that the rat molecule codes for an additional 6 amino acids in the 
extracellular domain. They are produced by alternative splicing and both appear to 
generate functional receptors. However, the one coding for the additional 6 amino acids 
is expressed predominantly in neuronal tissues while the other is expressed mainly in 
non-neuronal tissues (Barker et a l, 1993). The pl40^^*^ receptor comprises a 
glycosylated peptide chain with a single transmembrane domain (review by Meakin and 
Shooter, 1992). It is larger than p75, containing approximately 790 amino acid 
residues,
Middlemas and co-workers (1991) have shown that the rat trkB gene expresses 
multiple transcripts. Two of these are predicted to encode the full-length receptor and 
are 9.0 and 4.8 kb in size. There are a number of C-terminally truncated transcripts of 
7.5, 7.0, 2.4, 0.9, and 0.7 kb in length. These possess the extracellular domain but 
lack the tyrosine kinase domain. A 1.6 kb mRNA was also isolated that comprises the 
tyrosine kinase domain only. These forms are possibly generated through alternative 
splicing. Northern blot analysis has shown that at least 5 rr^B transcripts are present in 
the chick (Déchant et al, 1993a). These are estimated to be 9.0, 8.1, 6.3, 5.0, and 1.6 
kb in length. The 9.0 kb transcript is the only one possessing a tyrosine kinase domain 
and has only been detected in neuronal structures. The shorter transcripts lacking the 
tyrosine kinase domain are expressed predominantly in non-neuronal tissues.
Lamballe and co-workers (1991) first described cDNA clones encoding porcine 
p l45frA:C More recently, Valenzuela and co-workers (1993) have identified a number 
of rat trkC cDNA clones encoding novel forms of pl45^^^^. These include clones 
encoding both a full-length receptor similar to that identified in pig and 4 truncated 
forms lacking the tyrosine kinase domain. In addition, cDNAs encoding forms of 
p l45frK^  with either 14 or 39 amino acid inserts in their tyrosine kinase domains have 
been identified. All forms appear to have been generated by alternative splicing. The 
major transcript encoding the full-length receptor is 14 kb in size (as shown by 
Northern blotting). Although all forms are expressed throughout the nervous system.
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only the ti'uncated ones are detected in astrocytes, peripheral nerves, and non-neuronal 
tissues. Those containing the amino acid inserts are still capable of autophosphorylation 
in response to NT-3 but cannot mediate proliferation in fibroblasts or neuronal 
differentiation in PC 12 cells.
Developmental Expression of trk Receptors 
trkA
In mouse, trkA is initially expressed during early neurogenesis at embryonic 
day (E) 9.5 (Martin-Zanca et al., 1990; Wyatt and Davies, 1993). By E13.5, its 
expression is confined to certain structures of the nervous system. These include the 
DRG and cranial sensory ganglia (for example, the trigeminal, superior, and jugular 
ganglia). In older embryos (E17.5), trkA expression is also detectable in sympathetic 
ganglia (Maitin-Zanca et al., 1990) and in defined structures of the central nervous 
system, for example, the cholinergic neurons of the basal forebrain and the striatum 
(Steininger 1993).
trkB
Mouse trkB expression is first detected in both the central and peripheral 
nervous system at E8.5. It is expressed in many structures, for example, the forebrain, 
caudal midbrain, hindbrain, spinal cord, trigeminal ganglion, and differentiating neural 
crest cells which form the dorsal root ganglia (Klein et al., 1990b). trkB expression is 
found to be widespread in the nervous system thioughout embryonic development.
In adult mouse, the highest expression levels are found in the brain and spinal 
cord (Klein et al., 1990b). Expression is also detected in most structures of the 
cerebrum including the cortical layers, thalamus, and hippocampus. Non-neuronal 
tissues express trkB, for example, tongue, whisker pad mesenchyme, and outer dermal 
papilla (Klein e ta l, 1990a).
There are highly specific patterns of expression for the full-length catalytic 
receptor and the truncated foims without a tyrosine Idnase domain (Klein et a l, 1990a).
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In situ hybridization studies have shown that the truncated transcripts are located 
predominantly in the choroid plexus and ventricles. In general, the full-length receptor 
is more abundant in non-neuronal cells, for example, astrocytes, oligodendrocytes, and 
Schwann cells (Frisen et at., 1993).
In chicken, trkB transcripts encoding the full-length receptor have been detected 
during early embryonic development in most sensory ganglia. No expression is 
detected at any stage in BDNF non-responsive sympathetic and ciliary neurons 
(Déchant et al, 1993a). Expression is first detected in the trigeminal ganglion at E3.5. 
At E5, expression is restricted to the ventral region of the ganglion; expression in the 
dorsal region is poor at early stages of development but increases at later stages. In the 
nodose ganglion, transcripts are first detected at E4. Expression in the vestibular 
ganglion is high throughout development. In the DRG, expression is first detected at 
the mid-thoracic level at E3.5, predominantly in the ventral and lateral regions of the 
ganglion. Expression is also detected at lower levels in the ventral horn of the spinal 
cord, particularly in areas with motoneurons. Transcripts encoding truncated receptors 
have been found in non-neuronal structures, for example, mesenchymal cells 
surounding the spinal cord.
trkC
The trkC locus encodes at least eight transcripts. To date, most expression 
studies have been carried out using probes that recognize all forms. In mouse, 
transcripts are first detected at E7.5 in neuroectoderm, where the expression is low 
(Tessarollo e ta l,  1993). By E9.5, they are also detectable in developing DRG, the 
telencephalon, and the spinal cord (Tessarollo et al, 1993; Lamballe et a l, 1994). At 
E ll ,  expression is widespread throughout the central nervous system and in certain 
stnictures in the peripheral nervous system, for example, the DRG. At E13.5, it is now 
more widespread in the peripheral nervous system, noticeably in the trigeminal and otic 
ganglia (Lamballe et a l, 1994) and remains extensive at E15.5 in both the central and 
peripheral nervous systems. In the latter, expression is evident in the vestibular-
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acoustic, nodose, and geniculate cranial sensory ganglia. M C transcripts have also 
been located in structures outside the nervous system, for example, facial structures 
including vibrissae of the snout, dental papillae, and posterior tongue, and body cavity 
structures such as the submandibular gland and the walls of arteries and urinogenital 
tracts. In adult mouse, trkC transcripts can be detected in many stmctures of the central 
nervous system (Lamballe et a l, 1994).
The Roie of p75 in Neurotrophic Factor Binding and Responsiveness
The role of p75 in mediating the effects of neurotrophic factors remains unclear 
and the available evidence is conflicting. Weskamp and Reichardt (1991) have shown 
that a mutated NGF with an impaired p75 binding site is still capable of inducing 
neurite outgrowth and cell survival in PCI 2 cells and primaiy cultures of neurons. 
Also, blocking the ligand binding domain of p75 using antibodies has shown that p75 
is not necessary for NGF action. However, other studies in which p75 has a deletion 
mutation have shown that high-affinity binding is abolished unless intact p75 is co­
expressed with pl40^'^^ (Hempstead et a l, 1990; Battleman et a l, 1993).
There is an indication that the number of high-affinity bnding sites formed is 
influenced not simply by the co-expression of p75 and pl40^'^^ but by whether these 
molecules are co-expressed in the relevant ratio. p75 expression in NGF-responsive 
neurons is markedly higher than that of trkA. For example, in PC 12 cells and neonatal 
sympathetic ganglia, p75 mRNA levels aie five- to ten-fold in excess of trkA mRNA 
levels (review by Chao, 1994). Also, Hempstead and co-workers (1992) have shown 
that overexpression of trkA  in PC 12 cells increases the number of high- and low- 
affinity binding sites, indicating that neurotrophic factor binding is influenced by the 
levels of both p75 and trk components.
The nature of the p75-rt7c complex is uncertain. Hempstead and co-workers
(1991) proposed a heterodimeric model in which the cytoplasmic domain of p75 
interacts with the protein tyrosine kinase, giving rise to a high-affinity NGF binding 
site. Jing and co-workers (1992) have established that homodimerization of trkA
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receptors is necessary for NGF binding to activate them. Given that a certain ratio of 
p75 to trk may be required to determine neurotrophic factor specificity, the numbers of 
p75 and trk molecules involved in the functional receptor are likely to be complex. A 
model in which p75 first binds neurotrophic factors and then presents and transfers 
them to adjacent trk receptors has not been substantiated.
As p75 binds all neurotrophic factors, it has been suggested that it might be 
involved in the process by which the trk receptors show specificity for certain factors 
(Rodriguez-Tébar et al, 1992). For example, p75-deficient fibroblasts transfected with 
trkB will respond to BDNF, NT-3, and NT-4/5, whereas p75-expressing PC 12 cells 
transfected with trkB wiU only respond to BDNF (Ip et a l, 1993b). These results 
indicate that the trk receptors may respond to different neurotrophic factors more 
selectively when p75 is also expressed. The co-expression of p75 with p i40^^^^ can 
also result in increased sensitivity to neurotrophic factors (Scheibe and Wagner, 1992; 
Davies e t a l 1993b).
Using mice with a null mutation for p75, Lee and co-workers (1992) gained 
further insight into the role of p75 during embryonic development. These animals 
showed extensive loss of cutaneous sensory neurons along with a lack of sympathetic 
innervation in certain targets, especially the pineal gland and a subset of footpad sweat 
glands (Lee et a l, 1994a). The effect of the p75 null mutation on sensory neuron 
survival has been studied in primary cultures of trigeminal neurons from mice 
homozygous for the mutation (Davies et a l, 1993b). These neurons were less sensitive 
to NGF compared with wild-type neurons, although the survival responses to BDNF 
or NT-3 were not affected. This suggests that both p75 and trkA play an important role 
in regulating the sensitivity of these neurons to NGF during development. Neuronal 
survival may be controlled through receptor expression, with the p75 to trk ratio 
providing a means of modulating receptor specificity to neurotrophic factors.
Signal Transduction by the trk Receptor
Signal transduction is the transmission of growth factor signalling from the
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receptor to the nucleus. To date, much of the work with neurotrophic factors has 
concentrated on NGF signalling, using mostly PCI2 cells. The binding of NGF to the 
trkA. receptor initiates the tyrosine kinase activity of the receptor, leading to tyrosine 
phosphorylation of the receptor and intracellular proteins. This provides a means of 
regulating cellular protein activity and initiates gene transcription, which in turn conttols 
the growth, migration, morphology, and survival of neurons.
The binding of NGF to trkA is believed to induce the formation of trkA dimers 
or oligomers with subsequent transphosphorylation on receptor tyrosine residues (Jing 
et a l, 1992). As discussed previously, it appears that p75 may play a role in regulating 
neuronal specificity and sensitivity to neurotrophic factors. Receptor 
transphosphorylation plays a dual role. It firstly activates the receptor and, secondly, 
provides recognition sites for the binding of cellular signalling proteins. NGF induces 
phosphorylation on human trkA  on at least five tyrosine residues. Two of these 
phosphotyrosines bind at least two intracellular proteins involved in the NGF signalling 
process. These include the SHC protein group and phospholipase C-yl (PLC-yl) 
(Stephens et a l, 1994). These proteins contain in their non-catalytic regions an 
approximately 100 amino acid domain referred to as src homology 2 or SH2 (hence the 
abbreviation SHC for the former) which enables them to complex with specific 
sequences of receptors with phosphorylated tyrosine residues (Songyang eta i, 1993). 
The SHC gene encodes three proteins of similar size and sequence and these are the 
major substrates for NGF-induced tyrosine kinase activity in PC 12 cells. Other proteins 
complexing with the trkA receptor include phosphatidylinositol-3 kinase (PI-3 kinase) 
and extracellular signal-regulated kinase 1 (Erk 1) (Loeb eta l, 1992).
The receptor-protein complex is an important intermediate in growth regulatory 
signalling. The purpose of complex formation may be two-fold. It may provide a 
means of recruiting proteins from the cytoplasm to the plasma membrane (Cantley et 
a l,  1991). For example, the phosphatidylinositol phospholipid substrates of PI-3 
kinase are found in the plasma membrane and complex formation may bring enzyme 
and substrate in closer proximity. The complexing of signalling protein and receptor
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may also serve to activate the protein by inducing phosphorylation on tyrosine residues, 
as has been found for PI-3 kinase, PLC-yl, and the SHC proteins (Shoelsen et al, 
1991).
The Roles o f PLC-yl, PI-3 Kinase, SHC Proteins, and Erk 1
The activities of PLC-yl, PI-3 kinase and the SHC proteins are stimulated in 
response to NGF binding to the trkA receptor. PLC-yl catalyzes the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate to diacylglycerol (DG) and inositol trisphosphate 
(IP3), both of which are important second messengers (Rhee and Choi, 1992). DG 
activates protein kinase C and IP3 causes a transient increase in intracellular calcium 
levels. Other functions associated with PLC-yl include changes in ion fluxes and 
intracellular pH, cytoskeletal rearrangements, and stimulation of gene transcription 
(review by Kaplan and Stephens, 1994).
In PC 12 cells and fibroblasts, PI-3 kinase catalyzes the formation of 
phosphoinositides (Whitman et a l , 1987). The precise role of these second messengers 
remains uncertain. In mammalian cells, they may mediate the transport of activated 
tyrosine kinase receptors to specific intracellular sites (Kapellar et a l, 1993).
SHC proteins induce neurite outgrowth when overexpressed in PC 12 cells 
(Rozakis-Adcock et a l, 1992), They also play a part in activating the Ras protein (a 
later target of trkA activity to be discussed in the following section) (Suen et al, 1993).
Erk 1 is a serine/threonine kinase and part of the Ras signal transduction 
pathway. The trkA receptor associates with activated forms of Erk 1 which are not 
phosphorylated on tyrosine residues and so is not one of its direct substrates.
The Ras Signal Transduction Pathway
Signalling events occurring downstream of PLC-yl, the SHC proteins, and PI- 
3 kinase involve a small p21Ras G protein, activators of Ras, and serine/threonine 
kinases activated either directly or indirectly by Ras activity (Li et al, 1992). Stimulated 
trkA receptors bind to and induce tyrosine phosphorylation and activation of PLC-yl,
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PI-3 kinase, and the SHC proteins. The SHC proteins then bind to Grb2 (another 
protein bearing src homology regions) and SOS (son of sevenless). The latter is a 
protein serving as an exchange factor for the activation of p21Ras. It enhances the 
exchange of GDP against GTP on the p21Ras protein which oscillates between inactive 
GDP-bound and active (signalling) GTP-bound forms (McCormick, 1994). The 
activation of p21Ras by exchange factors or by inhibition of RasGTP-ase activating 
proteins (GAP) is also involved in raising levels of GTP-bound p21Ras during NGF 
activity in PC12 ceUs (Li et al., 1992).
In PC 12 cells, the signal transduction cascade from the cytoplasm (with 
activated p21Ras) to the nucleus is a sequence of phosphorylation events which leads to 
fibre outgrowth. This involves the serine/threonine kinase proto-oncogene Raf(c-Raf, 
b-Raf) which activates mitogen-activated protein kinase kinase (MAPKK) by serine 
phosphorylation. MAPKK then activates mitogen-activated protein kinase (MAPK) by 
phosphorylation on threonine and tyrosine residues. In PC 12 cells, MAPK comprises 
the extracellular signal-related kinases Erk 1 and Erk 2 (review by Heumann, 1994).
There is evidence for a signal transduction pathway that functions independently 
of Ras, involving SNT (fwc-associated neurotrophic factor-induced tyrosine 
phosphorylated target). This is a nuclear protein that appears to be tyrosine 
phosphorylated in NGF-treated PC12 cells and in neurotrophic factor-treated neuronal 
cultures (Rabin et a l, 1993). Studies using PC 12 cells expressing trkA mutants which 
prevent Ras signalling but not SNT tyrosine phosphorylation, suggest that SNT forms 
part of a signalling cascade that by-passes Ras (Stephens et a l, 1994).
Neurotrophic Factors and Nervous System Development
Until recently, the principal means of studying neurotrophic factors has been by 
employing blocking antibodies to neutralize their functioning. Although the information 
thus provided has proved valuable, the stmctural similarities between the factors has 
brought into question the specificity of such antibodies. Also, studies of the central 
nervous system have been ineffective since antibodies penetrate the blood-brain barrier
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poorly. More recently, gene targeting has confinned the role of neurotrophic factors in 
nervous system development through the production of mice that have a null mutation 
in genes encoding either the factors or their receptors (the so-called 'knockout' mice).
It is now clear that neurotrophic factors have a complex role in shaping the 
developing neiwous system. They not only promote the survival of developing neurons 
but regulate the proliferation and differentiation of neuron progenitor cells and 
determine other neuronal characteristics throughout life. A neuronal population may 
respond to more than one neurotrophic factor or may depend on different factors at 
different stages of development.
Proliferation and Differentiation of Neuronal Progenitors
NGF has been shown to influence in vitro proliferation of progenitor cells from 
embryonic rat striatum (Cattaneo and McKay, 1990). However, studies of striatal 
neurons from NGF 'knockout' mice (Crowley et a l, 1994) and trkA 'knockout' mice 
(Smeyne et a l, 1994) have indicated that NGF may not be involved in regulating the 
proliferation of neuronal precursors since the resultant neuronal population in the null 
mutant animals is not diminished in compared to those in wild type animals. Further 
studies of different neuronal populations from these mice should confirm any possible 
proliferative roles for NGF.
Wright et a l (1992) have shown that NT-3, and not NGF or BDNF, increases 
the number of differentiating neurons in cultures of early DRG cells. This suggests that 
NT-3 may induce proliferation and/or differentiation of sensory neuron progenitor ceUs 
from the neural crest. These progenitor trunk neural crest cells express trkC mRNA in 
vivo during migration (Tessarollo et a l, 1993) and undergo in vitro proliferation in 
response to NT-3 (Kalcheim et a l, 1992). However, it has not been ascertained 
whether NT-3 influences the proliferation of multipotent neural crest cells or neural 
crest cells that aie committed to a particular differentiation pathway. Gaese et a l (1994) 
have studied the effect of using anti-NT-3 to neutralize the function of endogenous NT- 
3 in the placode-derived nodose ganglion and in DRG during gangliogenesis. They
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found a maiked decrease in the number of neurons in these ganglia. This suggests that 
NT-3 may play a role in maintaining these neurons prior to their receiving target- 
derived influences, or it may be that NT-3 regulates neuronal proliferation during 
gangliogenesis.
Kalcheim and Gendreau (1988) have studied possible roles for NGF and 
BDNF in promoting differentiation of neuronal precursors. Using the expression of 
substance P as a maiker for sensory neurons, they found that the number of these 
neurons increased in response to BDNF and not NGF in cultures of post-migratory 
tmnk neural crest cells. This indicates that BDNF may play a pai't in the differentiation 
and/or survival of neural crest-derived sensoiy neurons. Using expression of the SSEA 
1 epitope as a marker for sensoiy neurons, studies by Sieber-Blum (1991) in the quail 
have suggested that BDNF directs pluripotent neural crest cells to differentiate along the 
primary sensoiy neuron lineage. However, it required three weeks of exposure to 
BDNF for the proportion of cells expressing SSEA 1 to increase significantly, while, in 
vivo, neuronal differentiation takes place a few days after neural crest migration. It is 
possible, therefore, that these results may not be developmentally relevant. In mice with 
a null mutation in the BDNF gene (Ernfors et a l, 1994a; Jones et a l, 1994) or the trkB 
gene (Klein e ta l,  1993), there are marked reductions in the sensory neurons, though 
these may be attributed to losses due to poor survival. To determine whether 
differentiation plays a part in reducing neuronal numbers in these mice, further detailed 
studies must be carried out to find out when the reduction takes place.
Early Neuronal Maturation
Wright et a l  (1992) have observed that early DRG neurons undergo a 
maturational change in culture; at first they have small, spindle-shaped, phase-daik cell 
bodies which become spherical and phase-bright, extending long neurites. This change 
takes place in chemically defined medium within 24 hours of the cells being placed in 
culture. Very low concentrations of BDNF and NT-3 were found to accelerate this 
maturational process, while NGF had no effect. In vivo, these neurons have not
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innervated their targets and are not in contact with target-derived neurotrophic factors, 
being independent of neurotrophic factors for survival. These early DRG neurons do, 
however, express BDNF mRNA which indicates that they may promote maturation by 
producing their own BDNF (Wright et a l, 1992). BDNF may be acting via an 
autocrine mechanism since early DRG neurons still mature when cultured in isolation 
and maturation is inhibited by antisense BDNF oligonucleotides (Wright et al, 1992).
The Onset of Neurotrophic Factor Responsiveness
Prior to innervating their targets, neurons may survive and extend axons 
without neurotrophic factor support. Evidence for this has come from studies using 
sensory ganglion explants (Davies e ta l, 1981; Davies and Lumsden, 1984). Neurites 
emerge from these explants in neurotrophic factor-free medium at the stage when the 
ganglia extend axons towards their targets in vivo. In dissociated cultures of early 
sympathetic (Emsberger et a l, 1989a) and sensory ganglia (Ernsberger and Rohrer, 
1988), in which few non-neuronal cells are present, neurons survive independently of 
neurotrophic factors, ruling out the possibility that early neurons in ganglion explants 
might obtain neurotrophic support directly from non-neuronal cells. Wright et al
(1992) have shown that early sensory neurons survive without neurotrophic factors in 
single cell cultures in defined medium and, therefore, do not obtain neurotrophic 
support from other cells or from factors in poorly defined serum supplements.
There is also a possibility that these early neurons are dependent on 
neurotrophic factors for survival but receive them via an autocrine mechanism. A 
number of studies have shown that some developing neurons do express BDNF 
mRNA and/or NT-3 mRNA (Ernfors et a l, 1992; Schecterson and Bothwell, 1992). 
To date, however, the only study showing firm evidence of an autocrine mechanism in 
developing neurons is of one promoting neuronal maturation in early DRG neurons and 
not survival (Wright e ta l, 1992). Although antisense BDNF oligonucleotides delay a 
maturational change in these neurons, they do not have any effect on survival.
The period of neurotrophic factor dependency is believed to commence when
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neuronal axons reach their targets. Evidence for this comes from studies by Davies and 
Lumsden (1984) in which trigeminal ganglion explants start showing extensive neurite 
outgrowth in response to NGF at about the stage when trigeminal neurons begin 
innervating their peripheral targets in vivo. More recent studies by Buchman and Davies
(1993) have shown that early trigeminal neurons in low-density cultures survive 
independently of neurotrophic factors at the stage when their axons are growing 
towards their targets in vivo and become neurotrophic factor dependent at the stage 
when their peripheral axons reach their targets in vivo. NGF dependency is preceded 
by a short period of dependency on BDNF, NT-3, or NT-4/5 (Buchman and Davies, 
1993; Davies eta l, 1993a).
That neurons only become neurotrophic factor dependent when their axons 
reach their targets has been further substantiated by studying other types of cranial 
sensory neurons. Extensive in vitro work has been carried out using embryonic chicken 
vestibibular, geniculate, petrosal, and nodose ganglia. These ganglia are derived from 
thickened regions of head ectoderm (the neurogenic placodes) and are bom during the 
same period in development. Their axons, however, have different distances to grow 
before reaching their central and peripheral targets and this is reflected in differences in 
their ability to survive in culture without BDNF before becoming BDNF dependent. 
Vestibular neurons have the closest targets and only survive for a short time without 
BDNF. Nodose neurons have the most distant targets and can survive the longest time 
in the absence of BDNF. Geniculate and petrosal neurons have intermediate target 
distances and survive without BDNF for intermediate times (Vogel and Davies, 1991).
Evidence fo r  the Intrinsic Timing o f Responsiveness in Neurons
If the cue for the onset of neurotrophic factor responsiveness were entirely 
dependent upon axons reaching their targets, then those axons which fail to do so 
would continue growing and not be eliminated by cell death. The above mentioned 
work of Vogel and Davies (1991) using low-density cultures of cranial sensory 
neurons has provided evidence that neurons may possess an intrinsic programme for
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timing the onset of neurotrophic factor dependency. This would presumably ensure 
that neurons do not survive if their axons fail to reach their targets. The onset of BDNF 
responsiveness in early nodose neurons can be brought forward in time by transiently 
exposing them to BDNF within 24 hours of when they would be expected to start 
responding to BDNF in vitro (Vogel and Davies, 1991). It seems likely that neurons 
innervate their targets within a 'window' of neurotrophic factor independence and 
become responsive partly under the influence of target-derived factor- the duration of 
this 'window' being controlled by an intrinsic timing programme.
Neurotrophic Factor Requirements During Early Stages of Target 
Innervation
The neurotrophic factor survival requirements of some neurons during the early 
stages of target field innervation has proved more complex than first thought. These 
have been studied extensively using cultured embryonic mouse trigeminal neurons 
(Buchman and Davies, 1993; Davies et a i, 1993a). It appears that these neurons 
respond to different neurotrophic factors at different stages during this period of 
development. When placed in low density culture in defined medium at the time when 
their axons would normally reach their peripheral targets in vivo, they require BDNF, 
NT-3, or NT-4/5 to survive but not NGF. After a few days of further development, 
they lose their responsiveness to BDNF, NT-3, and NT-4/5 and become responsive to 
NGF. Buchman and Davies (1993) have clearly demonstrated that the same neurons 
initially responsive to BDNF, NT-3, and NT-4/5 become NGF responsive. This 
observation has been further substantiated by examining the trigeminal ganglia of 
neonate mice with a null mutation in therr/:B gene. The considerable neuronal loss 
cannot be accounted for simply by the elimination of those neurons requiring BDNF for 
survival during the period of naturally occurring neuronal death as only a small 
proportion are ultimately BDNF-responsive (Klein et ai, 1993). It is possible that the 
increased cell loss results from death occurring during the earlier stage of BDNF or 
NT-4/5 responsiveness.
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There is in vitro evidence that cells of the sympathetic lineage also change 
neurotrophic factor survival requirements early in development. Many proliferating 
sympathetic neuroblasts survive in the absence of neurotrophic factors (DiCocco- 
Bloom and Black, 1988). However, NT-3 and not BDNF or NGF has been shown to 
increase the survival of these cells (DiCocco-Bloom et a l,  1993). Later in 
development, sympathetic neurons require NGF for survival, while only much higher 
concentrations of NT-3 are effective (Déchant et a l, 1993b). It has not been directly 
demonstiated whether sympathetic neuroblasts/neurons undergo a change in survival 
requirement from NT-3 early in development to NGF in later development. However, 
the fact that neonatal mice with a null mutation in the NT-3 gene possess only half the 
number of neurons in their sympathetic ganglia compared with wild type mice provides 
further evidence for this (Ernfors et a l, 1994b). NGF-responsive jugular* neurons are 
also transiently supported by BDNF and NT-3 early in their development (Buj-Bello et 
a l ,  1994). In vitro, embryonic DRG neurons are initially neurotrophic factor 
independent but subsequently respond to either NGF or BDNF before a proportion of 
the neurons lose their BDNF-responsiveness (Emsberger and Rohrer, 1988). It is not 
Icnown whether early DRG neurons ar e transiently BDNF responsive before becoming 
NGF responsive, but in vivo studies have shown that BDNF and not NGF supports 
early DRG neurons (Kalcheim et a l, 1987).
However, BDNF-responsive embryonic chicken ventrolateral trigeminal 
neurons do not respond to NGF or NT-3 in early development. Similarly, BDNF- and 
NT-3-responsive nodose neurons do not show an early response to NGF (Buj-Bello et 
a l,  1994). However, it is possible that these neurons are supported by other survival 
factors early in development.
The reason why some neurons respond to different neurotrophic factors at 
different stages of development is not known for certain. For mouse trigeminal neurons 
in vivo, it appear s that the supply of BDNF, NT-3, and NT-4/5 is not limiting for early 
survival so the purpose of the period of responsiveness to these factors could be to 
maintain survival prior to the NGF-responsive stage, during which neuronal numbers
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are regulated by naturally occuning cell death. The initial period of responsiveness to 
BDNF, NT-3, and NT-4/5 may be to delay neuronal death until most of the axons have 
reached their targets so that a maximum number of neurons can compete for NGF 
simultaneously, giving a greater selection,
N eurotrophic Factor Requirements During Neuronal Death
The availability of neurotrophic factors to developing neurons during naturally 
occuning cell death determines the final size of a neuronal population. Neurotrophic 
factor requirements of neurons during this period have been studied in culture and in 
vivo by the use of blocking antibodies to factors and gene tar geting to 'knockout' either 
the factors or their receptors. These give further insight into the role of neurotrophic 
factors in controlling neuronal survival.
NG F Responsive Neurons
For sympathetic ganglia, the period of neuronal death occurs a few days after­
birth as their time course of development is delayed compared to that for sensory 
neurons, which undergo cell death before birth. The first demonstration that 
sympathetic neurons require NGF for sirrvival came from the work of Levi-Montalcini 
(1987) in which anti-NGF antiserum was injected into neonatal rodents, destroying the 
paravertebral sympathetic chain. This observation has been confirmed by studies using 
mice with null mutations in the NGF (Crowley et a l, 1994) and trkA genes (Smeyne et 
a l, 1994). In these mice, the sympathetic chain has been almost completely eliminated 
by 10 to 14 days after birth.
A subset of DRG neurons and some cranial sensory ganglion neurons (e.g., 
trigeminal neurons in the mouse, dorsomedial trigeminal neurons in the chicken, and 
jugular neurons) require NGF for survival. These are believed to be the small-diameter 
neurons thought to mediate pain (nociceptive) and thermal receptive functions. NGF 
requirement of DRG neurons has been studied by exposing foetuses to anti-NGF in 
utero (Johnson et a l, 1990; Ruit et a l, 1992). After birth, the pups were unresponsive
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to painful stimuli and showed selective loss of small-diameter DRG neurons. The study 
by Davies and Lindsay (1985) has shown that only small-diameter cutaneous cranial 
sensory neurons respond to NGF in vitro.
The observation that NGF is necessary for the survival of nociceptive and 
thermal receptive neurons is borne out by the phenotype of mice with null mutations in 
the NGF and trkA genes (Crowley et a l, 1994; Smeyne et al, 1994). After birth, these 
mice are insensitive to painful and thermal stimuli and show selective loss in small- 
diameter DRG neurons. Conversely, transgenic mice overexpressing NGF exhibit 
extreme hyperalgesia to noxious mechanical stimulation (Davis eta l, 1993). Mice with 
a null mutation in the p75 gene have an impaired ability to detect thermal stimuli, 
indicating a loss in nociceptive and thermal receptive neurons (Lee et al, 1992). This 
strengthens the idea that p75 acts to modulate the functions of trkA, possibly increasing 
neuronal responsiveness to NGF during critical periods in development.
There are several studies which suggest that basal forebrain cholinergic neurons 
require NGF for survival. It has been shown that NGF infusion rescues these neurons 
from death after axotomy (Hefti, 1986; Montero and Hefti, 1988) and that NGF 
promotes their suivival in low density culture (Hartikka and Hefti, 1988a,b). However, 
these observations do not agree with the findings of studies using mice with null 
mutations in the NGF and trkA genes (Crowley et a l, 1994; Smeyne et a l, 1994). 
These mice appear to have suffered no reduction in the number of these neurons. 
Instead, basal forebrain cholinergic neurons from mice with a null mutation in the NGF 
gene stain more lightly for the transmitter enzyme choline acetyltransferase (ChAT) than 
those of wild type mice (Crowley et a l, 1994). This is in agreement with previous 
studies showing that NGF increases (Hartikka and Hefti, 1988a) and anti-NGF 
decreases (Vantini et a l, 1989) ChAT expression in these neurons. Mice with a null 
mutation in the trkA gene show a considerable reduction in axonal acetylcholinesterase 
activity in the hippocampal and cortical target fields of the basal forebrain cholinergic 
neurons (Smeyne et a l, 1994). It appears, therefore, that these neurons need NGF not 
for survival but for regulating the synthesis of transmitter enzymes.
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BDNF Responsive Neurons
BDNF supports the survival of proprioceptive neurons from the trigeminal 
mesencephalic nucleus (TMN) and proprioceptive neurons in DRG, which relay 
information about joint movement and position (Davies et a l 1986a,b; review by 
Davies, 1992). Neurons from the vestibular, geniculate, petrosal ganglia, from the 
ventrolateral region of the trigeminal ganglion in the chicken, and a sub-population of 
nodose ganglion neurons are also BDNF-responsive (review by Davies, 1992). BDNF 
has been shown to promote the survival of motoneurons innervating skeletal muscle. 
BDNF applied to chicken embryos in ova at the time of naturally occurring death 
rescues approximately one third of the motoneurons that normally die during this phase 
(Oppenheim, 1992). Tliis is not observed with NGF. Axotomized motoneurons in 
neonatal rats can be partially rescued from death by the local application of BDNF, but 
not NGF, to the cut nerve (KoHatsos et a i, 1993). In vitro studies have indicated that 
several populations of neurons in the central nervous system are responsive to BDNF, 
including dopaminergic neurons in the midbrain and granule cells in the cerebellum 
(review by Korsching, 1993). The high levels of BDNF expression in hippocampal 
and cortical neurons suggest that BDNF might play a role in their development (Ernfors 
etal., 1990a; Phillips etal., 1990).
Studies using mice with null mutations in the BDNF (Jones et al, 1994) and 
trkB (Klein et a l, 1993) genes have provided more detailed information about the role 
of BDNF in the development of these neurons. trkB 'knockout' mice die soon after 
birth. Presumably, because trkB is the receptor for both BDNF and NT-4/5, the 
mutation is more deleterious to nervous system development. BDNF 'knockout' mice 
exhibit behaviour consistent of an abnormally functioning inner ear related to balance. 
The vestibular ganglia innervating this region is very depleted of neurons, confirming 
the importance of BDNF in their survival. In both BDNF and trkB 'knockout' mice, 
there are significant though not massive neuronal losses in the trigeminal ganglia, 
consistent with these neurons being transiently responsive to BDNF before becoming 
NGF dependent (Buchman and Davies, 1993). There is significant depletion in
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proprioceptive TMN neurons in BDNF 'knockout' mice and also some loss of DRG 
neurons with both 'knockouts’, in agreement with the observation that BDNF supports 
a proprioceptive sub-population of these (review by Davies, 1992). This deficit in 
proprioceptive neurons might contribute to some of the movement abnormalities 
observed in BDNF 'knockout' mice. There is a significant reduction in the number of 
nodose ganglion neurons. The other BDNF-responsive cranial sensory neurons have 
not been studied in these mice.
Surprisingly, motoneurons in BDNF 'knockout' mice aie not affected (Jones et 
a l, 1994), although previously mentioned studies have shown that this factor promotes 
their survival (Oppenheim, 1992). trkB 'knockout' mice, however, exhibit a significant 
loss in motoneurons (Klein et al., 1993). This is consistent with the study of 
Henderson el al. (1993) which shows thatNT-4/5 promotes motoneuron survival. This 
suggests that NT-4/5 may be more important for motoneuron survival in vivo than 
BDNF.
The neuronal populations in the central neiwous system thought to be BDNF 
responsive (midbrain dopaminergic neurons, cerebellar granule cells, and hippocampal 
and cortical neurons) are present in normal numbers in both BDNF and trkB 
'knockout' mice (Jones et al., 1994; Klein et al., 1993). All cortical layers are 
developed but thinner than in wild type animals and the overall moiphology of the 
hippocampus appears normal. There is, however, evidence to suggest that BDNF may 
play a role in regulating neuronal functioning in the central nervous system (Jones et 
a i,  1994). Cortical intemeurons that use the neurotransmitter y-aminobutyric acid 
(GABA) express neui'opeptide Y (NPY) which is a member of the neui'opeptide family 
of neuroendocrine hormones. In BDNF 'knockout' mice, NPY expression in these 
neurons is reduced while the number of neurons positive for GABA appeal's normal. 
This suggests that BDNF may regulate peptide expression in the central nervous system 
and not neuronal survival, a function it may have in common with NGF. However, 
BDNF 'knockout' mice only live for a few weeks so it cannot be ruled out that NPY 
expression might have increased at a later stage of postnatal central nervous system
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development, or perhaps the role of BDNF is not one of regulating expression but of 
directing development along certain cell lineages (Snider, 1994). The levels of the 
calcium binding proteins pai valbumin and calbindin are also reduced in the cortical and 
hippocampal regions of BDNF 'knockout' mice and so BDNF may regulate these 
(Snider, 1994). Calcium binding proteins buffer increased intracellular calcium levels 
caused by neuronal activity (Baimbridge e ta l, 1992).
NT-3 Responsive Neurons
In vitro studies have shown that NT-3, in addition to BDNF, promotes the 
survival of proprioceptive neurons in the TMN and a proprioceptive neuronal sub­
population in DRG (Hohn et a l, 1990; Hory-Lee e ta l, 1993). Studies using mice with 
null mutations in the NT-3 (Ernfors e ta l,  1994b) and trkC (Klein et a l, 1994) genes 
have confirmed these in vitro observations. For both null mutations, the animals show 
a phenotype of abnormal postures and movements, indicative of deficits in 
proprioception. Dil labelling techiques have shown that the trkC 'knockout' mice have 
no DRG axon collaterals (group la  afferents) projecting to the spinal cord (Klein et a l, 
1994), while the NT-3 'knockout' animals have only a few (Ernfors et a l, 1994b). 
DRG in NT-3 'knockout' mice have reduced staining for carbonic anhydrase and 
parvalbumin, which are markers for proprioceptive DRG neurons (Ernfors et a l, 
1994b). Also, muscle spindles (sensoiy end organs involved in proprioception) fail to 
develop in these animals (Ernfors et a l, 1994b). Animals heterozygous for the NT-3 
mutation show a 50% reduction in the number of muscle spindles which further 
illustrates that neurotrophic factors are present in limiting quantities during 
development. NT-3 'knockout' mice also have a significant reduction in proprioceptive 
TMN neurons (Ernfors e ta l,  1994b).
NT-3, like NGF, promotes the survival of post-mitotic foetal and neonatal 
sympathetic neurons in vitro, but higher concentrations are required compared to NGF 
(Davies et a l, 1993b; Déchant et a l, 1993b; Lee et a l, 1994b). The number of 
sympathetic neurons present in NT-3 'knockout' mice is approximately half that of wild
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type animals (Ernfors et a l, 1994b). It has not been verified whether this reduction is 
due to the increased death of post-mitotic sympathetic neurons. Kalcheim et al. (1992) 
have shown that NT-3 is a mitogen for neural crest cells in vitro and so the loss in 
sympathetic neurons in NT-3 'knockout* mice could be due to the reduced development 
of sympathetic neuronal precursors. Also, a proportion of proliferating sympathetic 
neuronal precursors are supported by low concentrations of NT-3 in vitro (Birren et al., 
1993; Déchant et a t,  1993b; DiCicco-Bloom et al., 1993) and so the loss of 
sympathetic neurons could be due to the poor survival of these precursors.
Henderson et al. (1993) have shown that NT-3 promotes the survival of 
embryonic rat motoneurons in vitro. NT-3 'knockout' mice have apparently normal 
numbers of facial nucleus motoneurons (Ernfors et a l, 1994b), while the spinal nerve 
roots of trkC 'knockout' mice show a significant loss of motoneurons (Klein et a l, 
1994), as determined by myelinated axon counts. This may be indicative of the 
different neurotrophic factor requirements of cranial and spinal motoneurons. 
However, there is a possibility that any reduction in motoneuron number might be due 
to the lack of group la  afferents in NT-3 and trkC 'knockout' mice as these fibres aie 
thought to play a part in promoting motoneuron suiwivial (Okado and Oppenheim,
1984).
NT-4/5 Responsive Neurons
Davies et a l . (1993a) have shown that human recombinant NT-4/5 is a survival 
factor for distinct populations of mammalian sensory neurons during both the early 
stages of target field inneiwation and the period of naturally occurring cell death. NT- 
4/5 transiently promotes the survival of mouse trigeminal and jugular neurons during 
the early stage of target field innervation prior to naturally occurring cell death. At this 
time, these neurons are known to be transiently dependent on BDNF. NT-4/5 also 
supports the survival of BDNF-responsive mouse nodose neurons during the phase of 
cell death. In the mouse, NT-4/5 appears to be just as effective as BDNF at promoting 
the survival of these neurons, but is a much less effective survival factor,for
48
homologous populations of chick embiyo neurons. This suggests that the structure of 
NT-4/5 is not well conserved between mammals and birds or that NT-4/5 is a 
mammalian-specific neurotrophic factor. trkB 'knockout' mice show significant though 
not great losses in trigeminal ganglion neurons and massive neuronal loss in the nodose 
ganglion (Klein et al., 1993), consistent with the in vitro and in vivo BDNF and NT- 
4/5 survival requirements of these neurons (review by Davies, 1992: Davies et al., 
1993a).
NT-4/5 also promotes the survival of embryonic rat motoneurons in vitro 
(Henderson et al., 1993). trlcB 'knockout' mice exhibit significant motoneuron loss, 
especially in the facial nucleus (Klein et a l, 1993), while BDNF 'knockout' animals 
show no change in motoneuron number (Ernfors et al., 1994a; Jones et a i, 1994). 
Although previous studies have shown that BDNF promotes motoneuron survival 
(Oppenheim, 1992; Koliatsos e ta l,  1993; Henderson etal., 1993), it appears that NT- 
4/5 may play a more significant role.
N T-6 Responsive Neurons
As the most recently isolated member of the NGF family of neurotrophic 
factors, NT-6 is the least well characterized. Recombinant fish NT-6 from a rabbit 
kidney cell line was found to promote the survival of embryonic chicken sensory DRG 
and sympathetic ganglion neurons in vitro but not NGF-independent ciliary and 
nodose neurons (Gotz et a l, 1994). Its survival-promoting actions aie similar to those 
of NGF but less potent.
Neurotrophic Factors Not Related To NGF
There are a number of other factors that have been shown to influence neuronal 
growth and survival. Important examples of these are described briefly in the following 
sections.
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Ciliary Neurotrophic Factor (CNTF)
CNTF was first identified in and partially purified from chick eyes (Adler et al, 
1979) and was shown to support the survival of parasympathetic chick ciliary neurons 
in vitro. It has since been demonstrated to promote the suiwival of sympathetic, 
sensory, and spinal motoneurons in culture (Arakawa et a l, 1990; B ait in et a/., 1984; 
Manthorpe et a l, 1986). More recently, a study using mice with a null mutation in the 
CNTF gene (Masu et a l, 1993) has shown that, in vivo, CNTF promotes the survival 
of motoneurons in late postnatal mice and is not important in determining motoneuron 
numbers during embiyonic development. The cloning of CNTF has shown that it is not 
related to the NGF family of neurotrophic factors (Stockli et a l, 1989; Lin et al, 1990; 
Masiakowski et a l,  1990) but is instead a member of a family of distantly related 
cytokines that includes interleukin-6 (IL-6) and leukaemia inhibitory factor (LIF). 
Unlike NGF-related factors, it is a cytosolic protein that lacks a signal sequence for 
secretion (Stockli et a l,  1989). Emsberger et a l (1989b) have shown that CNTF 
blocks the division of chick sympathetic precursor cells. It also reduces tyrosine 
hydroxylase (TH) activity in cultures of neonatal rat sympathetic neurons while 
simultaneously incieasing ChAT activity (Sadaat eta l, 1989).
CNTF binds to a multi-component receptor. The receptor complex is believed to 
have two sub-units in common with the receptor complex for IL-6 and one in common 
with the LIF receptor (Davis and Yancopoulos, 1993). The IL-6 sub-units are a 
glycosyl-phosphatidylinositol and a 130 kDa glycoprotein (gpl30); the LIF receptor 
sub-unit is homologous to gpl30. A third receptor component, CNTFRa, has been 
identified as being essential for receptor functioning (Ip et a l,  1993a). In CNTF- 
responsive cells, the binding of CNTF to its receptor induces tyrosine phosphorylation 
of gpl30 and its homologue. The cellular mechanisms subsequent to this have yet to be 
elucidated.
F ib rob last G row th F actor (FGF)
The founder members of this growth factor family are basic and acidic
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fibroblast growth factors (bFGF and aFGF respectively). They are cytosolic proteins of 
approximately 16 IcDa, sharing about 55% amino acid sequence homology (Esch et a l,
1985). They are both found in the embryonic brain, in adult nervous tissues, and were 
initially identified as mitogens for fibroblasts and myoblasts (review by Gospodai'owicz 
et a l, 1987). They were then shown to induce the division of endothelial cells and 
stimulate the differentiation and migration of these cells, indicating that FGFs may play 
a role in the formation of blood vessels (Folkman and IGagsbrun, 1987).
A number of studies have also demonstrated that FGF (mostly basic and acidic) 
can promote the survival of embryonic neurons in vitro. These include neurons from 
the hippocampus (Walicke etal., 1986), the cerebral cortex, E l8 rat striatum, septum, 
and thalamus (Walicke, 1988), and the chick ciliaiy ganglion and spinal cord (Unsicker 
et al., 1987). Basic and acidic FGF have been shown to induce fibre outgrowth from 
several cell types, including PC12 cells (Neufeld eta l, 1987), newborn rat chromaffin 
cells (Claude e ta l, 1988), and postnatal rat retinal ganglion cells (Lipton e ta l, 1988).
The exact role of basic and acidic FGFs in the developing nervous system 
remains unclear. More lecently, however, studies have been carried out using another 
member of the FGF family, FGF-5 (Hughes et a l, 1993). This was originally found to 
be a product of a human oncogene (Zhan et a l, 1987) and later identified as a member 
of the FGF family (Zhan et a l, 1988). Unlike bFGF and aFGF, it is thought to be a 
secretory protein (Zhan et a l,  1988). Hughes et a l  (1993) have shown that 
recombinant human FGF-5 promotes the survival of chick embryonic spinal 
motoneurons in vitro and that both FGF-5 mRNA and protein can be detected in 
embryonic rat skeletal muscle during the period of naturally occurring motoneuron 
death as well as in adult muscle. This indicates that FGF-5 is potentially a survival 
factor for motoneurons during embryonic development and may play a role in 
maintaining them in the adult.
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
GDNF was purified and cloned by Lin and co-workers (1993) from the rat B49
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glial cell line and was identified as a distantly related member of the transforming 
growth factor-P (TGF-P) family (review by Massagué et a l, 1994). It comprises a 
glycosylated, disulphide-bonded homodimer. Human and rat GDNF genes have also 
been cloned (Lin et a l, 1993).
Lin et a l (1993) have studied the effect of GDNF on dopaminergic neurons in 
dissociated cultures of embryonic rat midbrain. They used high-affinity dopamine 
uptake and expression of TH as markers for dopaminergic neuron survival and 
differentiation. GDNF promotes the survival of TH+ dopaminergic neurons, enhances 
their dopamine uptalce, and is expressed in the striatum, their target field. More 
recently, studies have shown that GDNF protects adult dopaminergic neurons from 
axotomy-induced degeneration in vivo (Tomac et al, 1995; Beck et a l, 1995).
Henderson et a l  (1994) have studied the effects of GDNF on motoneuron 
survival in vitro and in vivo. They found that GDNF promotes the survival of 
embryonic motoneurons in vitro, being more potent than BDNF, NT-3, NT-4/5, and 
CNTF. In vivo, it rescues facial motoneurons from axotomy-induced cell death. 
Henderson and co-workers (1994) have also detected GDNF mRNA in the vicinity of 
motoneurons during the period of naturally occurring cell death. More recently, similar 
studies by Y m  et a l  (1995), using neonatal and adult facial motoneurons, and by 
Oppenheim et a l (1995), using developing facial motoneurons, have verified the 
importance of GDNF in the survival of these neurons. This is strong evidence that 
GDNF is a physiological survival factor for motoneurons.
Aims of Project
Much of the evidence for the neurotrophic hypothesis has come from work on 
NGF. The main aim of the research project was to explore the generality of the 
neurotrophic hypothesis but focusing on the second member of the neurotrophin 
family.
In the initial study, I have attempted to clarify whether the low-affinity p75 
receptor is important in the functioning of one particular neurotrophin. p75 mRNA
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levels were measured in purified populations of embiyonic chicken neurons that require 
different neurotrophic factors for survival to establish whether these levels were 
significantly higher in NGF- or BDNF-responsive neurons. I have also studied the 
effects of various factors, for example, NGF, CNTF, and membrane depolarization, on 
neuronal p75 mRNA expression in vitro.
BDNF mRNA is expressed in a proportion of embryonic DRG neurons which 
raises the possibility that BDNF acts by an autocrine loop in these neurons. The aim of 
the second study was to investigate the role of BDNF expression in developing sensory 
neurons, paiticulaidy during the phase of naturally occumng death when the neurons 
aie dependent on target-derived neurotrophins for survival. I have compared the levels 
of BDNF mRNA in purified populations of embiyonic chicken cranial sensoiy neurons 
that depend on either NGF or BDNF for survival. A co-culture technique was then 
used to show whether a paracrine survival mechanism, involving the production and 
release of BDNF, might exist between NGF- and BDNF-dependent neurons.
The first detailed studies of the timing and regulation of trkB and BDNF mRNA 
expression have been canied out using two populations of sensory neurons that 
innervate their targets at different stages of development. In the chicken, neurons of the 
vestibular and nodose ganglia are born during the same stage of development and start 
extending axons to their taigets at about the same time, but the distance their axons have 
to grow to reach their targets differs greatly. In the final study, I have related the timing 
of P'kB mRNA expression in these neurons to the timing of taiget field innervation and 
have studied the expression of BDNF mRNA in these targets at stages before their 
innervation. I have also studied the effect of BDNF on the regulation of trkB mRNA 
expression in BDNF-independent early nodose neurons in vitro. The timing and 
regulation of expression of BDNF and trkB mRNAs shows a number of similarities 




The normal expression and in vitro regulation of expression of p75, BDNF, 
and trkB mRNAs were determined for a variety of embryonic chicken sensory and 
autonomic neurons using a highly sensitive reverse transcription-polymerase chain 
reaction (RT-PCR) assay. This technique was chosen in favour of Northern blotting as 
it allowed for quantitation of these rare mRNAs from relatively few neurons (50-80 
neui’ons in the case of BDNF mRNA). Where neuronal number could not be accurately 
obtained, the p75, BDNF and trkB mRNA levels were standardized with respect to the 
level of mRNA encoding the ubiquitous and constitutively expressed ribosomal protein 
L27. The L27 mRNA level was measured in a separate PCR. A range of molecular 
biology techniques was also used to subclone p75, BDNF, trkB, and L27 cDNA 
fragments and so prepare the plasmid conshucts from which cRNA standards added to 
the RT-PCR assays were synthesized. Both these and the RT-PCR assay are described 
below, along with details of how the vaiious embiyonic neurons were obtained through 
dissection, separated from non-neuronal cells, and, in certain cases, set up in culture. 
Unless otherwise stated, the reagents used were purchased from BDH or Sigma. 
Oligonucleotide primers were either purchased from British Biotech or synthesized 
using an Applied Biosystems PCR Mate.
Molecular Biology Techniques 
Subcloning of cDNA Fragments 
Plasm id Vectors
p75, BDNF, trkB, and L27 cDNA fragments were more easily manipulated by 
inserting them into circulai* plasmid or vector DNA, producing a recombinant plasmid. 
The vectors used in this study were pGem-3Z and -4Z, supplied by Promega. They 
contain identical multiple cloning regions bearing a versatile selection of sites
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recognised by restriction endonucleases, into which DNA fragments can be inserted. 
Once in the vector, the cDNA fragment can be amplified in the appropriate host bacterial 
strain and, after plasmid isolation, sequenced and modified as desired. The vectors are 
differentiated by the orientation of their multiple cloning regions. SP6 and T7 RNA 
polymerase promoter sites also flank the multiple cloning regions such that RNA can be 
transcribed from either strand of the plasmids, although, for the purpose of this study, 
only the sense transcript was required. Other properties of the pGem vectors are 
discussed in more detail in later sections.
Digestion of DNA by Restriction Endonucleases
The subcloning procedure involved the initial digestion of cDNA and vector 
with appropriate restriction endonucleases to generate compatible ends for ligation. In 
this study, the production of constructs for the cRNA RT-PCR controls involved the 
excision of the desired cDNA fragment from a larger piece of DNA in a vector or the 
digestion of a PCR product, prior to insertion into the appropriate vector (individual 
cases will be discussed in more detail in the section on RT-PCR).
5-10 jig of DNA were digested in a 50 jil reaction containing 5 p.1 lOx 
restriction endonuclease buffer (usually supplied with the enzyme), the restriction 
endonuclease itself, and sufficient sterile, deionized water to give the desired volume.
1-5 jag of DNA were digested in a 20 |il reaction. The reactions were carried out at the 
recommended optimum temperature for each endonuclease (usually 37®C).
In general, restriction endonucleases were purchased from Gibco BRL and 
supplied in concentrations ranging from 5-50 units/p.1, where 1 unit represents the 
amount of enzyme required to digest 1 jig of substrate DNA in 60 minutes under the 
recommended assay conditions. The reactions were cairied out with a five- to ten- fold 
excess of endonuclease for 1-2 hours. Longer incubations were avoided as 
contaminating exonucleases in the endonuclease preparation may digest away the 
cleaved endonuclease recognition sites and so affect subsequent ligation procedures.
Digestion of DNA with two restriction endonucleases was carried out
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simultaneously when both enzymes required the same optimal conditions. However, 
when the enzymes' optimal conditions were not compatible, the DNA was first 
incubated with the enzyme æquiring the buffer with the lowest salt concentration. The 
reaction mixture was adjusted to meet the buffering requirements of the second enzyme 
which was then added and the incubation allowed to proceed. The efficiency of the 
digests was determined using electrophoresis by visualizing 0.5 |ig on a 1% 
agaiose/Tris-acetate-EDTA (TAE) gel. This procedure is described after this section.
If the vector was digested with a single restriction enzyme, it was treated with 
calf intestinal alkaline phosphatase (CIAP) to remove 5’ phosphate groups and so 
prevent the vector from re-circularizing without insert during the ligation reaction. For 
CIAP treatment, the following were added to 50 jil of the vector digest (containing 5 jig 
DNA): lOx CIAP buffer (500 mM Tris-HCl, pH 9.0, 10 mM MgCl2, 1 mM ZnCl2, 10 
mM spermidine), 1 jil CIAP, and sterile, deionized water to a final volume of 100 jil. 
The reaction was incubated at 37°C for 1 hour.
The CIAP was removed by addition of one volume of tris-buffered phenol (pH 
8.0) and, after mixing, an equal volume of chloroform/isoamyl alcohol (24:1). After a 
further mixing and centrifugation (2 minutes at 13,000 rpm), the upper aqueous phase 
was removed to a fresh Eppendoif tube. The DNA was precipitated by addition of l/9th 
volume of 5 M sodium acetate, pH 5.0, and 2.5 volumes of absolute ethanol, and 
pelleted by centrifugation (13,000 rpm) for 1 minute. The supernatant was removed 
and the pellet washed free of salts with 1 ml 70% ethanol. After a further brief 
centrifugation, the supernatant was removed and the pellet air-dried and resuspended in 
50 jil of sterile, deionized water. The quantity of DNA recovered was estimated by 
visualizing 5 jil of the resuspended DNA on a 1% agarose/TAE gel.
Purification of Digested Insert and Vector Fragments
Prior to ligation of vector and insert, the relevant DNA fragments were first 
isolated and purified from the digests. Digested vector and insert fragments were 
separated by agarose/TAE gel electrophoresis. The Geneclean H Idt (BIO 101, Stratech)
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was used to purify the fragments from the gel. The desired DNA bands were excised 
from the gel and cut into small pieces. 3 ml of Nal (from the kit) were added per gram 
of agarose and the Nal/agarose mixture placed at 55°C until the agarose was completely 
melted. 5-10 |.il of Geneclean Glassmilk were then added to the mixture and this left, 
with intermittent mixing, at room temperature for 10 minutes to allow the the DNA to 
bind.
The Glassmilk and bound DNA were pelleted by brief centrifugation at 13 ,000 
rpm and the supernatant removed. The Glassmilk was washed by the addition of 1 ml 
of the supplied New Wash solution, followed by resuspension and re-pelleting by brief 
centrifugation (at 13,000 rpm). The supernatant was removed and the washing 
procedure repeated one further time. After the final centrifugation, as much of the New 
Wash as possible was removed using a pipette with a fine-bore tip and the DNA eluted 
at 55®C into 10-20 |il of sterile, deionized water for 10-30 minutes. The Glassmilk was 
pelleted by centrifugation (at 13,000 rpm) for 1 minute and the solution of eluted DNA 
removed to a fresh Eppendorf tube. The purified fragments were visualized by loading
2-5 jil on a 1% agarose/TAE gel. The approximate amount of each fragment was 
estimated from the gel.
Ligation of DNA Fragment and Vector
Insertion of a DNA fragment into the vector was achieved by means of the 
ligation reaction. This utilized the enzyme bacteriophage T4 DNA ligase (a single 
polypeptide of Mp = 68,000) which catalyzes the formation of a phosphodiester bond 
between adjacent 3'-OH and 5'-P termini of double-stranded DNA.
Prior to setting up the ligation, it was necessary to optimize the ratio of vector to 
insert with respect to molecule number. Where the ligation was directional, with both 
vector and insert having two different termini, this ratio was 1:1. When the insert DNA 
was ligated into a single restriction site in the (CIAP-treated) vector, the optimum 
vector:insert ratio was 1:3. This ratio was estimated by visualizing equal volumes of 
vector and insert on an agarose/TAE gel and comparing the intensity of ethidium
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bromide staining with that of a DNA sample of known concentration. Once the amounts 
of vector and insert were determined, it was then necessary to take into account their 
size differences so that the vectoriinsert ratio was based on the relative number of 
molecules. Between 100-200 ng of vector DNA were added to the ligation and the 
amount of insert DNA added was determined in accordance with this.
The appropriate volumes of vector and DNA insert were added to a ligation 
reaction containing 1 jil T4 DNA ligase (Northumbria Biologicals), 1 jil lOx ligation 
buffer (supplied with the enzyme), and sterile, deionized water to 10 jil. The reaction 
was then incubated at 15°C for at least 4 hours. This procedure was suitable for the 
ligation of DNA fragments with cohesive termini. Where the termini were blunt-ended, 
however, it was found that the addition of 1 mM hexamminecobalt (IB) chloride to the 
reaction mixture increased the efficiency of ligation. This complex ion increases the 
effective concentiation of insert and vector DNA. Control ligation reactions were also 
set up containing vector only.
At this stage, the amount of ligated vector plus insert (or recombinant plasmid) 
obtained was insufficient for subsequent procedures. The usual way of increasing the 
quantity of plasmid DNA is to facilitate its uptake by host bacteria in which it is then 
replicated as the bacteria propagate. This procedure (refeired to as transformation) is 
described in the following sections.
B acterial H ost S tra in
The Escherichia coli (E. coli) host strain of XLl Blue was used in the 
amplification of all plasmid constructs from which the RT-PCR cRNA controls were 
prepared. The pGem vectors used bear the (3 lactamase gene which confers ampicillin 
resistance to the host cells. This allows for the selection of transformed cells in culture 
and when plated out. XLl Blue has the genotype supE44 hsdRll recAl endAl gyrAAb 
thi relA l lac~ VlproAE"^ lac^ lacZ AM15 TnlO (te/)]. endAl is an endonuclease 
mutation and improves the quality of plasmid DNA isolations. The lacZ mutation is a 
partial deletion of the (3-D-galactosidase gene. This gene is activated by the pGem
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vector a-complementation sequence in nonrecombinant plasmids. In recombinant. - 
plasmids, this sequence is interrupted by the presence of insert DNA and a -  
compleraentation is not possible. This feature allows for colour selection between 
bacterial colonies bearing nonrecombinant and recombinant plasmids, when the cells 
are plated out on agar supplemented with the substrate for P-D-galactosidase (i.e., X- 
gal and IPTG).
Preparation of Competent Host Cells and Transformation
The following method for preparing competent cells gave a transformation 
frequency of 10  ^transformant colonies/pg of supercoiled DNA, which was sufficient 
for the cDNA subcloning carried out in this study.
As far as possible, all manual procedures were carried out in a laminar flow 
cabinet to maintain sterility. Stocks of XLl Blue cells were kept at -70^C in Luria broth 
(L broth)/15% glycerol. XLl Blue cells were scraped from the surface of a frozen stock 
aliquot and streaked across Luria agar (L agar) using a flamed inoculating loop, so as to 
produce single colonies after an incubation of 12-16 hours at 37°C. The dish was 
incubated in an inverted position. L agar and L broth powders were purchased from 
Gibco BRL.
A culture was prepared by using a flamed loop to inoculate 25ml of sterile L 
broth from a single colony from the petri dish, and this was incubated overnight at 
37°C in a rotary incubator. The 25 ml overnight culture was then diluted in 250 ml of 
sterile L broth to give an optical density at 550 nm (OD550) of at least 0.0015. The 
diluted culture was then grown at 37^C in a rotary incubator until the OD550 was 0.48, 
or just below. It was then chilled on ice for 5 minutes and the bacterial cells pelleted by 
centrifuging in sterile, ice-cold tubes at 6,000 rpm (10 minutes, 4°C). From this point 
onwards, it was essential to keep the cells as cold as possible by placing them on ice 
whenever possible. The supernatant broth was discarded and the cells were gently 
resuspended in 100 ml of filter-sterilized, ice-cold buffer I (30 mM potassium acetate, 
100 mM rubidium chloride, 10 mM calcium chloride, 50 mM manganese chloride, and
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15% glycerol, pH 5.8). The cells were left on ice in buffer I for 5 minutes and pelleted 
at 6,000 rpm (5 minutes at 4®C). The supernatant was discarded and the cells 
resuspended in 10 ml of filter-sterilized, ice-cold buffer II (10 mM MOPS, 75 mM 
calcium chloride, 10 mM rubidium chloride, and 15% glycerol, pH 6.5). The cells 
were left on ice in buffer H for 15 minutes. They were then aliquoted in 200 |ul volumes 
into sterile Eppendoif tubes placed in a mixture of dry ice and IMS to 'snap' freeze 
them, and stored at -70®C.
The competent cells were transformed with plasmid of known concentration to 
test their efficiency using the following procedure. This transformation was usually 
carried out using 1-2 ng of DNA which should give a transformed cell number in the 
range of 10 .^ One Eppendorf tube of competent cells was first removed from storage at 
-7Q0C and placed directly on ice to defrost. It was essential that the cells were not left at 
room temperature as they would lose their competency. The plasmid DNA was also 
pre-cooled on ice. Once defrosted, the cells were gently mixed and 100 jil were 
removed to a fresh Eppendorf tube. 1-2 ng of DNA were then added to one 100 jtl 
aliquot of cells (the volume of DNA added should not exceed 10 jtl) and this was left 
on ice for 30 minutes. The other 100 jtl aliquot of cells was left on ice without any 
added DNA and would be put through the transformation procedure to check whether 
the cells had been contaminated with DNA during preparation. The cells were then heat 
shocked at 42^C for 2 minutes and returned directly to ice. 500 jtl of sterile L broth 
(without antibiotic) were added to each tube and the cells were incubated at 37^C in a 
rotary incubator for 30 minutes, to allow the transformed cells to start expressing the 
plasmid-bome antibiotic resistance gene. The cells were then plated onto L agar 
containing the antibiotic selecting for transfoimed cells. In the case of the pGem 
vectors, it was ampicillin. The ampicillin was prepared as a lOOOx stock solution of 
100 mg/ml in deionized water. It was added to molten agar cooled to 55°C so that it 
was not deactivated. 200 jil of undiluted transformed cells were plated out using a 
sterile glass spreader first immersed in alcohol and then flamed. 200 jil of a 1 in 10 and 
a 1 in 100 dilution (in L broth) of the transformed cells were also plated in case the
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number of colonies from the undiluted transformation mixture was too numerous to be 
counted. 200 jtl of the control cells (with no DNA added) were also plated out. The 
surfaces of the petri dishes were left to dry and the dishes then incubated inverted for 
12-16 hours at 37°C.
The transformation procedure using ligation and control (vector only) ligation 
mixtures was essentially the same [100 jil of competent cells were transformed with aU 
10 jtl of the ligation mixture (containing nanogram levels of ligated plasmid DNA) and 
this treated as described above]. 50, 100, and 200 jil of the transformed cells were 
plated out on L agar with 100 jig/ml ampicillin to select for transformants. X-gal and 
IPTG may also be added to the agar to allow for colour selection of recombinant from 
nonrecombinant plasmids. The plates were incubated inverted at 37°C for 12-16 hours.
It was then necessary to determine whether the transformed colonies obtained 
bore the desired recombinant plasmid. A crude, small-scale plasmid isolation procedure 
was adequate for this purpose. Single colonies were used to inoculate several 5 ml 
aliquots of sterile L broth (plus 100 jig/ml ampicillin) and these placed in a rotary 
incubator at 37®C for 12-16 hours. Plasmid DNA isolation was then carried out as 
described below.
Small-Scale Isolation of Plasmid DNA by Alkaline Lysis
The plasmid 'mini-prep' procedure used in this study allowed for the quick and 
convenient isolation of plasmid DNA without column purification or banding in 
caesium chloride gradients by ultracentrifugation. It made use of the rapid alkaline 
dénaturation of plasmid and chromosomal DNA and the selective renaturation of 
plasmid DNA after neutralization of the solution. The resultant plasmid DNA was 
suitable for restriction enzyme analysis. The procedure could be scaled-up and modified 
to include additional ammonium acetate and polyethylene glycol purificaton steps, 
giving a greater quantity of DNA suitable for restriction enzyme digestion and 
subcloning, sequencing, and in vitro transcription. This protocol is described in a later 
section.
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1 ml samples of the overnight cultures prepared from transformed colonies were 
centrifuged (at 13,000 rpm) in Eppendorf tubes to pellet the bacterial cells. The pGem 
plasmids are high copy number plasmids, with approximately 300-400 copies/cell; 1 ml 
of culture yielded 1-4 |ig of DNA.
The supernatant was discarded and the bacterial pellet resuspended in 100 jil of 
Solution I (50 mM glucose, 25 mM Tris at pH 8.0, 10 mM EDTA). The tubes were 
placed on ice, 200 jil of denaturing Solution H (0.2 M sodium hydroxide, 1% SDS) 
added, and this gently mixed. 150 jil of Solution III (per 100 ml: 60 ml of 5 M 
potassium acetate, 11.5 ml of glacial acetic acid, 28.5 ml of water-pH 4.8) were then 
added immediately to neutralize Solution H.
Cell debris and chromosomal DNA were pelleted by centrifugation at 13,000 
rpm for 1 minute. The supernatant was transferred to a fresh Eppendorf tube and the 
plasmid DNA precipitated by the addition of 1 ml of absolute ethanol. After mixing, the 
plasmid DNA was pelleted by centrifugation at 13,000 rpm for 1 minute, the 
supernatant removed, and the pellet air-dried. The DNA was resuspended in 50 jil of 
sterile, deionized water.
RNA in the DNA preparation was degraded by treatment with 1 jil of 10 mg/ml 
bovine pancreatic ribonuclease (RNase) from Pharmacia. This was added at room 
temperature and the DNA solution thoroughly mixed; no incubation time was 
necessary. The DNA solution was deproteinated by phenol-chloroform extraction. 50 
jil of tris-equilibrated phenol were added to denature the protein and the solution was 
mixed well. 50 jil chloroform/isoamyl alcohol (24:1) were then added and the solution 
mixed again to extract the phenol plus denatured protein in the chloroform. The mixture 
was centrifuged at 13,000 rpm for 3 minutes to separate aqueous and non-aqueous 
phases. The upper aqueous phase containing the DNA was transferred to a fresh 
Eppendorf tube. The DNA was precipitated by the addition of l/9th volume of 3 M 
sodium acetate, pH 5.2 and 2.5 volumes of absolute ethanol. After mixing and 
centrifugation at 13,000 rpm for 1 minute, the supernatant was removed and the DNA 
pellet washed free of salts with 1 ml of 70% ethanol. The ethanol wash solution was
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removed, and the DNA pellet air-dried and resuspended in 50 jtl of sterile, deionized 
water, 10 jtl of the 'mini-prep' could then be visualized on an agarose/TAE gel and 
analyzed using restriction enzymes. 'Mini-prep' DNA is best stored at -20°C or lower 
as it is prone to degradation by contaminating nucleases.
Once it has been ascertained that the isolated plasmid DNA is the desired one, a 
few aliquots of the original overnight culture were mixed with 15% glycerol and stored 
at -70®C. A purer, larger-scale plasmid DNA preparation was then carried out for 
future procedures.
Isolation of Plasmid DNA by Alkaline Lysis-Polyethylene Glycol
For the purpose of this study, isolation of plasmid DNA by alkaline lysis with 
subsequent purification using polyethylene glycol (PEG) was adequate. The DNA 
obtained could be used for sequencing, subcloning procedures, and in vitro 
transcription. The technique was also flexible in that it could be easily scaled-up 
depending on the yield of plasmid DNA required. The yield given by a method 
employing a caesium chloride gradient would have far exceeded the requirements of 
this study, not to mention the extra expense and time it would require. The PEG 
method utilizes the same Solutions I, II, and III as the small-scale DNA isolation 
procedure.
The appropriate 'mini-prep' overnight culture was streaked onto L agar with 
100 jig/ml ampicillin. The plate was incubated at 37®C so as to produce single 
colonies. A single colony was used to inoculate 10 ml L broth with 100 jig/ml 
ampicillin. The culture was then grown up at 37°C in a rotary incubator for 12-16 
hours.
The bacterial cells were pelleted by centrifugation at 6,000 rpm for 10 minutes 
at 2°C. The supernatant was discarded and the pellet resuspended in 400 jil of Solution 
I. If desired, a 'pinch' of lysozyme could be added at this point and the mixtiire left for 
a few minutes. 800 jil of Solution II were then added to denature the DNA and this 
mixed gently. 600 jil of Solution III were then added immediately to neutralize the
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mixture.
Cell debris and chromosomal DNA were then pelleted by centrifugation at 
11,500 rpm for 20 minutes at O^C. The supernatant was then removed to two 
Eppendorf tubes (approximately 900 jil/tube). 500 jtl of isopropanol were added to 
each tube to precipitate the DNA, and this mixed and left at -20®C for 15 minutes. The 
DNA was pelleted in a refrigerated centrifuge at 13,000 rpm for 5 minutes. The pellets 
were washed in 1 ml of 70% ethanol, air-dried, and each resuspended in 50 jtl of 
sterile, deionized water.
RNA and denatured plasmid DNA were precipitated by addition of 100 jtl of
7.5 M ammonium acetate to each tube. This was mixed and left at -20®C for 15 
minutes. The RNA and denatured plasmid DNA were pelleted in a refrigerated 
centrifuge at 13,000 rpm for 5 minutes. The supernatants from each tube were removed 
and pooled in a fresh Eppendorf tube, and the DNA precipitated by the addition of 0.6 
volume of isopropanol. The DNA was pelleted in a refrigerated centrifuge at 13,000 
rpm for 5 minutes. The pellet was washed with 1 ml of 70% ethanol, air dried, and 
resuspended in 500 jil of sterile, deionized water.
The DNA was then further purified with polyethylene glycol. 500 jil of a 
solution containing 11.2% (w/v) PEG 6000/8000 and 0.7 M sodium chloride were 
added to the resuspended DNA, this mixed and left on ice for 30 minutes. RNA and 
denatured DNA not precipitated by the ammonium acetate were then pelleted in a 
refrigerated centrifuge at 13,000 rpm for 5 minutes. The supernatant was then 
transferred to a fresh Eppendorf tube and a further 500 jil of the PEG/NaCl solution 
added. This was mixed and left on ice for 30 minutes. Increasing the concentration of 
PEG precipitated the plasmid DNA and this was pelleted in a refrigerated centrifuge at
13,000 rpm for 5 minutes. The pellet was washed three times in 1 ml 70% ethanol to 
ensure that all the PEG was removed. It was then air dried and resuspended in 50 jtl of 
sterile, deionized water.
The yield of plasmid DNA obtained from this procedure was usually in the 
range of 0.5-1.0 mg/ml. The concentration of DNA in the sample was determined by
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ultraviolet (UV) spectroscopy. This method is reliable providing the sample is pure 
(that is, free from significant amounts of UV-absorbing protein or RNA). OD readings 
were taken at 260 nm and 280 nm. The OD260 reading was used to calculate the DNA 
concentration; an OD260 of 1 represents approximately 50 jig/ml for double-stranded 
DNA. The ratio of OD260 to OD280 (OD26(/f^f^28o) gives an indication of the purity of 
the DNA sample. A good DNA preparation would give an OD260/OD280 of between 
1.75-1.85, although, ideally, it should be as close to 1.8 as possible. Values greater 
than 1.8 indicate that the sample is contaminated with RNA, whüe lower values indicate 
protein. As it was difficult to determine the effect of contamination on the OD readings, 
the concentration was also determined by estimating the intensity of fluorescence 
emitted by the ethidium bromide-stained DNA after running 1 jtl of the sample on an 
agarose gel, alongside a standard DNA sample of known concentration, (Sambrook et 
a l,  1989).
Once again the plasmid DNA is best stored at temperatures of -20°C or lower, 
although short-term storage at 4®C would not be detrimental as nuclease contamination 
is negligible in this case.
Agarose Gel Electrophoresis of DNA
DNA fragments were separated by electrophoresis through agarose gels. This 
relies on the principle that DNA, which is negatively-charged at neutral pH, will 
migrate from cathode to anode when a potential difference is applied across the gel. The 
rate of migration of linear, duplex DNA molecules is inversely proportional to the logio 
of their molecular weights. It is also affected by the agarose concentration of the gel, 
the DNA confonnation (i.e., whether it is linear, circular, or supercoiled), the voltage 
applied across the gel, and the composition and ionic strength of the electrophoresis 
buffer. 1-2% agarose gels were sufficient to separate fragments 0.1-5 kb in size.
Tris-acetate (TAE) electrophoresis buffer was used for agarose gel 
electrophoresis. It was prepaied as a 50x stock solution comprising 242 g Tris base, 
57.1 ml glacial acetic acid 100 ml 0.5 M EDTA (pH 8.0), and deionized water to 1 litre.
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For a Pharmacia Minigel, the TAE stock solution was diluted to give 500 ml of Ix 
TAE, of which 50 ml were used for gel preparation. The desired amount of ultra pure 
nuclease-free agarose (Gibco BRL) was completely melted in the TAE and the 
intercalating dye ethidium bromide added to a final concentration of 0.50 jtg/ml to both 
molten gel and the remainder of the buffer. The ethidium bromide binds to the DNA 
during elechophoresis. It fluornsces in ultraviolet (UV) light, allowing DNA bands on a 
gel to be viewed effectively. Once the molten gel had cooled to 60^C, it was carefully 
poured into a gel-casting plate sealed at either end with masking tape, and the well- 
forming plastic or comb placed in position. The gel was left to set for 20-30 minutes.
The set gel was placed in the electrophoresis tank and covered with TAE buffer. 
The comb was carefully removed and more buffer added to ensure that the wells were 
covered and free from air bubbles. The DNA samples were mixed with the appropriate 
volume of 6x gel-loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol, and 
30% glycerol in deionized water) and loaded onto the gel. DNA size markers, 
containing DNA fragments of known lengths, were also loaded onto the gel to facilitate 
identification of the sample DNA.
A voltage of 1-5 V/cm (measured as the distance between the electrodes) was 
applied across the gel. At higher voltages, the migration rate of high-moleculai*-weight 
DNA increases differentially, so reducing the resolution properties of the gel. The 
duration of electrophoresis depended on DNA fragment size and the degree of 
separation required. The progress of fragment migration could be monitored by 
occasional viewing on a UV transilluminator. If desired, a permanent record of the gel 
could be made by photographing it on the tiansilluminator after electrophoresis was 
complete.
Sequencing of Double-Stranded DNA
DNA sequencing was used to check the identity of trkB and L27 cDNA 
obtained through reverse transcription and polymerase chain reaction, after subcloning 
into pGem-3Z, and to check modifications made to p75, BDNF, trkB, and L27 cDNAs
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during preparation of the PCR conti'ol templates.
The method of sequencing used was that of dideoxy chain termination (Sanger 
et a i, 1977). This involves a DNA polymerase elongating a DNA strand from a 
specific primer annealed to a single-stranded DNA template. Also included in the 
reaction are a mixture of the four nucleotides (dNTPs), (or ^^P) labelled dATP, 
and, subsequently, one of four modified nucleotides. These modified bases are 2’,3'- 
dideoxynucleoside ^'-triphosphates (ddNTPs) which terminate DNA elongation; they 
lack the deoxyribose 3' hydroxyl group necessary for the formation of a 
phosphodiester bond with a succeeding nucleotide. In this sequencing reaction, there 
are both elongation and, less frequently, specific termination of the DNA strand. The 
reaction products are a series of oligonucleotides, the lengths of which aie determined 
by the distance between primer and termination sites. The four different ddNTPs are 
added to four sepaiate reactions and populations of oligonucleotides are synthesized 
that terminate at positions occupied by every A, C, G, or T in the template stiand. The 
reaction products are separated on a polyacrylamide gel, which is then dried down and 
placed in contact with X-ray film. The resultant autoradiograph bears a ladder of bands 
representing DNA strands of different lengths, for each of the four synthesis reactions. 
Taking all four reactions into consideration, the order of the bands, from bottom to top 
of the autoradiograph, gives the sequence of the template.
In this case, the sequencing primers used were synthetic 17mers complementary 
to sequences in the pGem vectors just upstream (3') from the T7 RNA polymerase 
promoter (T7 primer) and just downstream (5') from the SP6 RNA polymerase 
promoter (SP6 primer).
The quality of double-stranded DNA templates is of great importance. They 
should be purified and RNA-free. Purification using PEG precipitation (as described 
previously) was found to be effective. The choice of DNA polymerase used is also 
critical. Sequenase Version 2.0 (United States Biochemical) was found to very reliable. 
This enzyme is a genetically modified variant of bacteriophage T7 DNA polymerase, in 
which the 3-5' exonuclease activity of the wild-type T7 DNA polymerase has been
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removed. The enzyme is both stable and efficient.
The double-stranded DNA was first alkaline denatured as follows. To 8 jig of 
PEG purified DNA, 1/lOth volume of 3 M sodium acetate (pH 5.2) and 2 volumes of 
absolute ethanol were added to precipitate the DNA. After brief centrifugation (13,000 
rpm), the resultant DNA pellet was washed in 70% ethanol, re-pelleted, and air dried. 
The pellet was resuspended in 40 jtl of 0.2 M NaOH/0.2 mM EDTA (pH 8.0) and left 
to denature at room temperature for 5 minutes. 4 jil of 3 M sodium acetate (pH 5.2) 
were then added to neutialize the solution and the single-stranded DNA precipitated by 
the addition of 2 volumes of absolute ethanol. The precipitated DNA could be left 
overnight at -20®C if desired, but this was not essential. The DNA was pelleted by 
centrifugation at 13,000 ipm for 3 minutes, washed in 70% ethanol, re-pelleted, and air 
dried. The pellet was then resuspended in 14 jtl of sterile, deionized water.
7 jil of the resuspended single-stranded DNA were used for each sequencing 
primer. The next step in sequencing involved the annealing of primer to template. To 7 
jil of the single-stranded DNA were added 1 jil of primer (approximately 50 ng) and 2 
jil of Sequenase Reaction Buffer (from the Sequenase Version 2.0 Sequencing Kit). 
This was incubated at 37®C for 15 minutes, to allow the primer to anneal to the 
template DNA.
The Sequenase protocol then divided the sequencing procedure into two stages. 
An initial synthesis at low temperature utilising low dNTP concentrations (i.e., the 
labelling reaction) allowed for sufficient incoiporation of ^^S labelled dATP. The 
labelling reaction was then divided into four termination reactions, each containing 
higher concentrations of the conventional dNTPs and one of the four ddNTPs.
The components of the labelling reaction were added on ice directly to the 10 jil 
annealing reaction. These included the dGTP Labelling Mix and Sequenase enzyme. 
The dGTP Labelling Mix (from the Sequenase Version 2.0 Idt), comprising a mixture 
of all four dNTPs, was diluted 1 in 5 with sterile, deionized water, or 1 in 10 if 
sequences close to the primer were desired. The Sequenase enzyme itself was also 
diluted 1 in 8 before use with cold Enzyme Dilution Buffer (from the kit) and was
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stored on ice for not more than 1 hour. Thus, the following components of the labelling 
reaction were added to the 10 jil annealing reaction: 1 jil DTT (from the kit), 2 jtl dilute 
Labelling Mix, 0.5 jil 10 jiCi/jil labelled dATP, and 2 jil diluted Sequenase 
enzyme. The reactants were mixed caiefully to avoid air bubbles and incubated at room 
temperature for 5-10 minutes, depending on how close to the primer sequences needed 
to be read. If sequences close to the primer were desired, this incubation step was 
omitted.
0.5 ml Eppendorf tubes containing 2.5 jtl ddOTP, ddCTP, ddATP, and ddTTP 
were prepared and pre-warmed to 37°C 1 minute before use. 3.5 jtl of the labelling 
reaction were added to each Eppendorf tube at 37®C. After caieful mixing in the pipette 
tip, the termination reactions were allowed to proceed at 37°C for 5 minutes. The 
termination reactions were stopped by the addition of 4 jtl Stop Solution (from the kit). 
The reactions were stored on ice or at -20°C until electrophoresis.
Polyacrylam ide Gel E lectrophoresis of Sequencing Products
Sequencing products were separated using denaturing gels containing 7 M urea 
and 6% polyacrylamide. The gel apparatus used was purchased from Flowgen and 
comprised 21 x 50 cm glass plates with 0.4 mm spacers and comb. The apparatus was 
assembled according to the manufacturer's instructions. Prior to assembly, it was 
ensured that one plate was washed thoroughly and cleansed free of grease with 70% 
IMS, while the other plate was washed and siliconized. This enabled the plates to be 
sepaiated after electrophoresis such that the gel was attached to the non-siliconized 
plate.
The sequencing gel solution contained 7 M uiea, 6% acrylamide/bis (19:1), and 
Ix TBE (5x TBE comprises 54 g Tris base, 27.5 g boric acid, 20 ml 0.5 M EDTA at 
pH 8.0, and deionized water to 1 litre) and was prepared as required. The 
acrylamide/bis solution was stored at 4^C as a 30% stock. During preparation of the gel 
solution, the acrylamide and dissolved urea were deionized using Amberlite MB-1 
Mixed Bed Resin (BDH). The gel was cast as follows. 135 jil of TEMED and 800 jil
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of freshly-made 10% ammonium persulphate were added to 90 ml of gel solution. This 
was mixed and taken up into a 60 ml syringe. With the assembled gel plates held at 
angle of approximately 30° to the horizontal, the gel solution was caiefully introduced 
into the space between the plates, taking care to avoid aii* bubbles. Once this space was 
completely filled, a comb was inserted at the top of the gel, which was left to 
polymerize for at least 30-45 minutes.
The polymerized gel was placed in the gel apparatus, the buffer reservoirs of 
which were then filled with Ix TBE. The comb was carefully removed from the gel and 
unpolymerized acrylamide flushed from the wells with buffer using a pasteur pipette. 
The gel apparatus was connected to a high-voltage supply and the gel pre-run without 
loaded samples at 1,300-1,500 volts until the temperature of the gel reached 
approximately 50^C (as shown by a temperature indicator placed on the front of the gel 
plate).
Once the temperature of the gel had reached 50°C, the power supply was 
disconnected and the wells flushed out as before to remove any urea that had leached 
out of the gel. Prior to loading, the sequencing samples were denatured by heating to 
75-80°C for 2 minutes and then placed directly on ice. 2-3 jil of each sample were 
loaded into the wells using a fine-bore pipette and ’duck-billed' tips. To ensure good 
resolution, the samples were loaded as quickly as possible. Hence, in situations where 
a large number of samples were being ran, the loading procedure was staggered.
Once the samples were loaded, the power supply was reconnected and adjusted 
to 1,500 volts. During electrophoresis, the voltage was adjusted periodically so that the 
temperature of the gel was kept at approximately 50°C for optimum resolution of the 
samples. At temperatures higher than 55^C, aciylamide/urea gels may hydrolyze, 
resulting in loss of resolution. The duration of electrophoresis was dependent on the 
length of sequence required.
After completion of electrophoresis, the power supply was disconnected and the 
glass plate/gel assembly was removed from the apparatus. The glass plates were 
carefully sepaiated, leaving the gel attached to the non-siliconized plate. The plate with
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gel attached was immersed in a solution of 10% acetic acid/12% methanol for 30 
minutes to remove urea from the gel as this dampens down emissions. The gel was 
talcen up onto a piece of Whatman 3MM Paper, covered with Saran Wrap, and vacuum 
dried on a slab gel drier at 80^C. The Saian Wrap was removed from the gel, which 
was then placed in a light-proof cassette in contact with X-ray film. In general, an 
overnight exposure was sufficient to visualize the sequencing reaction products.
Reverse Transcription-Polymerase Chain Reaction Assay
The reverse transcription-polymerase chain (RT-PCR) assay used in this study 
was designed to measure very low mRNA levels. It involved the initial reverse 
transcription of extracted total RNA and the subsequent PCR amplification of the 
resultant cDNA using specific primers. As the efficiency of individual PCRs was 
affected by factors such as the composition of the reaction mix, differences in 
temperature across the heating block, etc., it was necessary to include an internal PCR 
conti'ol template of known concentration which amplified with the same primers and to 
which the level of native template could be directly related. Also, the use of ’master 
mixes' when setting up batches of PCRs was found to provide some unifonnity in 
reaction conditions.
The controls were prepaied from p75, BDNF, and L27 cDNAs so as to be 4 bp 
larger than the native template and from tj'kB cDNA so as to be 8 bp larger. This 
allowed for electrophoretic sepaiation of the two PCR species. Primer sites were 
chosen to give small amplified products (for the native templates, 88 bp (p75), 100 bp 
(BDNF), 98 bp (trkB), and 127 bp (L27)). For this size range of amplified product, a
4-8 bp difference between native and conti'ol templates was sufficient for separating the 
two species on a 7% polyacrylamide gel. It was important that the size difference be 
kept to a minimum to ensure that control and native templates were almost identical and 
so amplified with near equal efficiency. The efficiency of PCR amplification of a cDNA 
species is dependent on the kinetics of primer-template annealing, the length of template 
being amplified, and the sequence and secondary stmcture of the template. Therefore,
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reaction conditions may not equally favour the amplification of structurally unrelated 
templates.
Controls were added as cRNA to the reverse transcription so minimizing any 
discrepancies at this stage. The amount of target mRNA in the sample was estimated 
from the PCR product by calculating its ratio to cRNA control of known concentration. 
More accurate values could be determined by titrating the RNA sample against different 
concentrations of conti'ol template. The ratio between control template and taiget mRNA 
is only quantitative while the PCR is in the logarithmic phase. At this stage, the PCR 
products were not sufficient to be visualized by ethidium bromide staining. 
Radiolabelling the product was a more sensitive means of detection. This was achieved 
by labelling the PCR primers to a high specific activity on their 5' ends with ^^P ATP 
using T4 polynucleotide kinase. This enabled small amounts of target cDNA (0.5-1 fg) 
in the reaction to be visualized, after autoradiographic exposure times of a few hours, 
using only a few rounds of amplification.
A small PCR product was advantageous in that more of it could be amplified 
under given conditions, so increasing the sensitivity of the assay. It ensured that more 
of the products were full-length after each cycle, and allowed for shorter synthesis 
times and lower denaturing temperatures. This meant that the amount of Taq 
polymerase used in the reaction could be reduced. However, smaller PCR products had 
a tendency to form heteroduplexes comprising one strand of native cDNA and one 
strand of conti'ol cDNA. These formed in later cycles of the PCR when primers became 
depleted and product concentration was high, favouring re-annealing of denatured 
product rather than primer annealing and extension. Heteroduplex foimation depleted 
equal numbers of molecules from each PCR product. A PCR where this occuned was 
only quantifiable when the PCR products were present in equal amounts. If one 
product was in excess, the number of molecules removed from each would be 
disproportionate and the product ratio no longer accurate. As heteroduplexes tended to 
form in the latter stage of the logarithmic phase, they could be guarded against by 
reducing the number of cycles to keep the reaction well in this phase. The resultant loss
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in sensitivity could be counteracted by ensuring that the specific activity of the primers 
was high or simply by adding more primers to the reaction.
Precau tions A gainst C ontam ination of PCRs
A major problem encountered when setting up PCRs was contamination with 
target DNA. This could be present in the reagents, in the environment, or in the 
extracted RNA samples as genomic DNA. Amplification of such DNA could lead to 
falsely elevated levels for target DNA. The degree to which contamination was 
problematical depended on the sensitivity of PCR required. If the assay was set up to 
measure picogram amounts of target DNA, the presence of 1 fg of contaminant target 
would not be detectable. However, if the assay was measuring femtogram levels, 
contamination with even one or two copies of illegitimate target would have a 
significant effect on results.
Background contamination was monitored by setting up controls with each 
batch of PCRs. The presence of genomic DNA in RNA samples was checked by means 
of 'no-reverse transcriptase' controls. These contained all RNA samples included in the 
assay and received the same treatment as the regular assay samples except that no 
reverse transcriptase was added prior to the reverse transcription step. These controls 
also showed whether any of the reagents used were contaminated with DNA. 
Contamination of reagents with target RNA could be checked by setting up a 'no-RNA' 
control, comprising all the constituents of the régulai' assay sample but with no RNA 
added. As RNA is so susceptible to enzymatic degradation, this source of 
contamination was never encountered. Therefore, 'no-RNA' controls were only set up 
occasionally as an added precaution. A set of assay results were only valid if the 
negative controls were completely blank after autoradiographic exposure for the same 
length of time as the régulai' PCR samples.
To minimize the risk of contamination, RT-PCR was caiiied out in a specially 
designated laboratory, away from aieas where control cDNAs were handled and PCR 
products analyzed. DNA samples and reagents, equipment or labcoats from other
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laboratories were baiTed from this room and completed PCRs were never opened there. 
All necessary stocks of reagents and consumables for PCR were kept in this room.
The enzymes used in the RT-PCR assay were purchased with their reaction 
buffers and so eliminated the problem of DNA contamination through 'on-site' buffer 
preparation. For this reason, manufactured kits were used for the final stages of RNA 
extraction ('RNaid' from BIO 101, Stratech) and for purifying PCR primers after ^^P 
end-labelling ('Mermaid' from BIO 101, Stratech).
No solutions or consumable equipment used in the setting up of RT-PCR 
assays were autoclaved. Since DNA can withstand autoclave temperatures, this is a 
potential source of contamination. Bottled sterile water from Gibco was used to prepare 
other solutions or to dilute reagents. Disposable Eppendorf tubes were found to be 
essentially DNase- and RNase-free and used directly from the supplier's pack. To 
prevent RNA or cDNA carry-over between reactions, pre-packed and sterilized, 
aerosol-resistant pipette tips were used to set up assays. All RT-PCR reagents were 
aliquoted in small volumes and each aliquot discarded after single use.
P recautions in H andling RNA
If RNA is to be used effectively in any procedure, it is important that it is 
isolated in an intact and pure form. RNA is degraded at high temperatures and in 
solutions of high pH. All procedures involving RNA were carried out as quickly as 
possible and, where possible, on ice. Also, when appropriate, buffers of neutral or 
slightly acid pH were used.
If any work involving RNA is to be successful, ribonucleases (RNases) must 
be deactivated. RNases rapidly degrade RNA and are very stable. They are heat- 
resistant (autoclaving will not destroy them), retain activity over a wide pH range, and 
can renature after treatment with denaturing agents. RNases are released from disrupted 
tissues or cells during the extraction procedure, although human skin is also a source.
Gloves were worn for all work involving RNA. The glassware used was 
purchased new, washed as usual, and then baked at 250°C for 4 hours. All chemicals
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used were purchased new and kept separate from other chemicals. They were only 
handled with gloved hands and, where necessary, with baked spatulas.
All solutions used in tiie initial stages of RNA extraction were prepared with 
diethyl pyrocarbonate (DEPC) water and then re-treated with DEPC. DEPC is a non­
specific RNase inhibitor, but also reacts with adenine residues in RNA and so has to be 
removed from treated solutions before they can be used. Solutions were treated by 
adding 0.2% (v/v) DEPC in a small volume of ethanol as it is not directly miscible in 
aqueous solution. The solution was shaken vigorously and left at room temperature for 
at least 10 minutes. DEPC was removed from the solutions by autoclaving, during 
which it breaks down into CO2 and ethanol. However, DEPC cannot be used to treat 
solutions with Tris as it reacts with primary amines. These solutions were prepared 
using autoclaved DEPC water and then re-autoclaved. Individually-wrapped, sterile 
disposable pipettes, Pasteur pipettes, syringes, etc. were also used where appropriate. 
As for RT-PCR procedures, Eppendorf tubes were used directly from the supplier's 
container, while pipette tips were DEPC treated and autoclaved before use.
The RNA extraction procedure and reactions involving RNA utilized RNase 
inhibitors. The most successful extraction procedures include deproteinizing agents 
such as phenol and chloroform, denaturing agents such as SDS and sarcosyl, and 
chaotropic agents like guanidinium thiocyanate (used in conjunction with P- 
mercaptoethanol). A specific RNase inhibitor used in the extraction process was 
vanadyl-ribonucleoside complexes (VRCs, from Pharmacia). These are transition state 
analogues of the activated 2 ',3'-cyclic phosphates believed to be formed during 
catalysis of RNA breakdown by RNases. Unlike other RNA inhibitors, they 
completely block RNase activity at a concentration of 10 mM. In this study, they were 
used during DNase treatment of RNA. Placental RNase inhibitor (RNAguard from 
Pharmacia) was used during in vitro transcription reactions for PCR control preparation 
and in the reverse transcription step of the RT-PCR assay. It is a protein and requires 1 
mM DTT to be effective. It forms complexes with RNases and is rendered ineffective 
by exposure to agents that denature protein.
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PC R  P rim er Choice
The choice of primers used can greatly affect the efficiency of a PCR assay. 
Ideal primers should meet the following criteria. They should be 18-25 bases long, 
with a GC content of 50%. Their melting temperatures should be similai* and repeats of 
purines, pyrimidines, or any one base should be avoided. There should be no sequence 
complementarity between the primers, pai'ticulaiiy at their 3' ends, as this could lead to 
primer dimer formation. Primer dimers compete with the time PCR products for primers 
and enzyme and so reduce the sensitivity of the assay. Primers with excessive 
secondaiy stmcture (e.g., hairpin loops, etc.) should be avoided as these may anneal to 
the template poorly.
In this study, the choice of primers had to encompass the following constraints. 
The p75, BDNF, and L27 control templates were prepaied from cDNAs by digesting at 
a unique restriction enzyme site, filling in the overhangs to form blunt ends, and then 
re-ligating to give a cDNA 4 bp lai'ger. The trkB control template was prepared by 
pai'tially digesting the cDNA with an enzyme that has two recognition sites so that only 
the appropriate one was cut and inserting an 8 bp linker into this site. (PCR control 
template preparation is described in more detail later.) Therefore, the primers chosen 
had to bind either side of the site containing the additional 4 or 8 bp piece of cDNA. 
Also, to ensure that amplified control and native templates could be separated by 
polyacrylamide gel electrophoresis, there was a limitation on the size of the PCR 
product (the size increase in the PCR control template should be at least 3% of the total 
length).




These hybridized 88 bp apait in the chicken p75 sequence (Large et al., 1989) and 92 





These hybridized 83 bp apart in the pro-sequence sequence of chicken BDNF (Wright 
and Davies, unpublished data) and 87 bp apait in the PCR control template. For the 




These hybridized 98 bp apart in the 3' region of the sequence adjacent to that encoding 
the tyrosine Idnase domain and unique to the full-length trkB isoform (Déchant et a i, 




These hybridized 127 bp apart in the chicken L27 sequence (Lebeau et a l, 1991) and 
131 bp apart in the PCR contiol template.
P ractical Aspects of the Assay
Initially, in vivo levels of p75 mRNA and BDNF mRNA expression were 
determined in purified chicken sensory, sympathetic and parasympathetic neurons at 
valions stages of embryonic development. In order to compaie p75 mRNA or BDNF 
mRNA levels in these neurons, it was also necessaiy to measure the level of mRNA 
encoding the ubiquitous, constitutively expressed ribosomal protein L27. The level of 
p75 mRNA or BDNF mRNA could then be expressed relative to the level of L27 
mRNA. This was found to be a more accurate than relating it to the number of neurons 
in the cell pellet as deteimined by haemocytometry. Once p75, BDNF, and L27 mRNA 
levels had been ascertained in separate RT-PCR assays, it was possible to reverse 
transcribe controls for all three with the RNA sample. The volumes of the reaction 
components were adjusted accordingly. A third of the reverse transcription was then
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used to assay p75 mRNA, a third to assay BDNF mRNA, and a third to assay L27 
mRNA. The different levels of the three mRNAs and the number of PCR products 
obtained made it impractical to assay all of them in the same PCR. To find amplification 
conditions that would suit them all and then attempt to separate all the products on a gel 
would have been impossible. Also, trkB and p75 mRNA levels were determined for 
embryonic chicken vestibular* and nodose ganglia, while BDNF mRNA levels were 
determined for target fields innei*vated by axons from these ganglia. Differences in the 
size and number of these ganglia and tissues were taken into account by expressing the 
mRNA levels relative to those for L27 mRNA.
In vitro regulation of p75 mRNA expression was then determined using 
neuronal cultures. These experiments were carried out using cultures of embryonic 
chicken sympathetic chain and DRG neurons and took two forms. Firstly, that of a 
dose response in which cultures were set up containing different concentrations of a 
trophic factor. Secondly, cultures were set up containing, for example, a particular 
trophic factor or combination of factors at fixed concentrations. At least two cultures 
were set up for each condition. The number of neurons in each culture was counted at 
either 36 or 48 hours, the neuronal RNA then extracted, and the p75 mRNA levels 
assayed. p75 mRNA levels were expressed as fg/neuron.
The effect of BDNF on in vitro regulation of trkB mRNA was studied in stage 
19 chicken nodose neurons. Cultures were set up in duplicate with and without added 
BDNF. The number of neurons in two dishes with and two dishes without BDNF was 
counted at 24, 36, 48, 60, and 72 hours, the neuronal RNA extracted, and trkB mRNA 
levels determined. t?'kB mRNA levels were expressed as fg/neuron.
In order to determine how much control template to use, a fixed amount of 
RNA sample was assayed with different amounts of control template. After 
autoradiographic exposure, the reaction where the signals of both control and sample 
products were of equal or near equal intensity was taken as being the most accurate. 
This reflected the fact that there were similai* amounts of each species in the reaction and 
so reduced amplification bias of one of them. It also meant that the autoradiographic
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exposure time required to visualize each signal was similar, making it easier to ensure 
that the response of the X-ray film remained in its linear range. The ratio of the 
autoradiographic signals could then be determined and the level of target mRNA in the 
RNA sample calculated.
Routinely, 1 |il of each RNA sample was used. Once PCR control levels had 
been determined, batches of samples were assayed such that the same amount of 
control template could be added to each RT-PCR. In some cases, RNA samples had to 
be diluted or more than 1 pi added to allow all the RNA samples from one experiment 
to be assayed using the same amount of cRNA control.
Preparation of RT-PCR Control Templates
The chicken p75 cDNA, from which the p75 PCR control was prepared, was a 
gift from Thomas Large (Department of Physiology and the Howard Hughes Medical 
Institute, University of California). It comprised 1.8 kb of chicken p75 cDNA 
subcloned into the EcoR 1 site of the pGem-3Z vector. The PCR control was 
constructed by, firstly, digesting the plasmid at a unique Eag 1 restriction site located in 
the p75 insert, generating cohesive ends with 5' overhangs 4 bases in length. The 
overhangs were then filled in using the Klenow fragment of DNA polymerase 1 and the 
resultant blunt ends religated (Maniatis et al, 1989). This inserted 4 bp into the 
sequence. In order to produce a smaller template for in vitro transcription, the p75 
cDNA was then cleaved at Ava 1 sites on either side of the filled in Eag 1 site. This 
produced a fragment of cDNA approximately 700 bp in length. The Ava 1 sites of the 
fragment were filled in and the fragment blunt-end ligated into the filled in Aval sites of 
the pGem-3Z vector (the cohesive ends of insert and vector were not compatible after 
Ava 1 cleavage). The fragment of p75 cDNA subcloned corresponds to bases 483- 
1,177 of the published sequence (Large et a l, 1989). The p75 cDNA insert was in the 
sense orientation with respect to the SP6 RNA polymerase promoter site of the vector.
The chicken BDNF control template was prepared from cDNA subcloned into 
the EcoR 1 site of the pGem-4Z vector, in the sense orientation with respect to the
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vector SP6 RNA polymerase promoter site. The PCR control was constructed by 
cleaving the cDNA at a unique Xho 1 site, filling in the 5' overhangs and re-ligating the 
resultant blunt ends.
463 bp of full-length trkB cDNA were obtained by reverse transcription of total 
RNA from El 1 chicken DRG and subsequent PCR amplification using primers based 




They were designed with restriction sites (shown underlined) at their 5' ends to 
facilitate subcloning and with 3 bp of the trkB sequence prior to these to prevent the 
ends of the DNA from 'breathing' during digestion with these enzymes. The 5' primer 
bore an EcoR 1 site and the 3' primer bore a BamH 1 site. These primers isolated a 
fragment of cDNA corresponding to bases 2,214 to 2,677 of the published sequence, 
spanning parts of the tyrosine kinase domain and 3' untranslated region. The trkB 
cDNA was subcloned into the EcoR 1 and BamH 1 sites of the pGem-4Z vector. The 
trkB cDNA insert was in the sense orientation with respect to the pGem-4Z SP6 RNA 
polymerase promoter site. The first stage in the preparation of the PCR control 
constmct was the partial digestion of the rr^B/pGem-4Z DNA using Xmn 1 which 
cleaves to produce blunt ends. The rrAB/pGem-4Z construct contained two Xmn 1 
sites: one in the ampicillin resistance gene of the pGem-4Z vector and one in the 3’ 
untranslated region of the trkB insert. The construct was modified at the latter 
restriction site to produce the PCR control template using the following procedure. 
Partial digestion gave a mixture of linearized rr/:B/pGem-4Z fragments that had been cut 
at either one Xmn 1 site or the other. The digest was then run on an agarose/TAE gel to 
isolate the partially digested DNA fraction from any DNA that had been cleaved at both 
Xmn 1 sites. The bands of partially digested DNA were then excised from the gel, 
purified using the Geneclean kit, and CIAP treated as described previously. 8 bp 
phosphorylated Cla 1 linkers (Biolabs) were blunt-end ligated into the cleaved Xmn 1
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sites of the partially digested DNA. The ligation mixture was used to transform 
competent XLl Blue {E. coU) bacterial cells. The cells were plated on L agar with 
ampicillin. This eliminated all cells bearing constructs with a Cla 1 linker inserted in the 
ampicillin resistence gene of the pGem-4Z vector. A constmct with a Cla 1 linker in the 
trkB fragment was then identified and used to prepare the PCR cRNA contr ol template.
359 bp of L27 cDNA were obtained by reverse transcription of total RNA from 
E l l  chicken DRG and subsequent PCR amplification using primers based on the 




As for the trkB primers, they were designed with restriction sites (shown underlined) at 
their 5’ ends for subcloning purposes and with 3 bp of the L27 sequence prior to these 
to assist enzymatic digestion. The 5' primer bore a Sal 1 site and the 3’ primer bore a 
BamH 1 site. These primers isolated a fragment of cDNA corresponding to bases 51 to 
410 of the published sequence. The L27 cDNA was subcloned into the Sal 1 and 
BamH 1 sites of the pGem-3Z vector. The PCR control construct was prepared by 
cleaving the L27 cDNA at a unique Sty 1 restriction site, filling in the 5' overhangs, 
and re-ligating the blunt ends. The L27 cDNA insert was in the sense orientation with 
respect to the pGem-3Z SP6 RNA polymerase promoter site.
Synthesis o f  Control cRNA
All experiments within this study used the same batch of PCR cRNA control 
templates that were transcribed, purified, and quantified in one procedure. It was hoped 
that this would provide some degree of uniformity with respect to the controls.
The cDNA constructs prepared were first linearized with a suitable restriction 
enzyme such that 'run-off transcripts could be synthesized using SP6 RNA 
polymerase. The enzyme chosen must produce either cohesive termini with 5' 
overhangs or blunt-ended termini as cohesive termini with 3' overhangs tend to give
81
erroneous transcripts. The linearized template was phenol-chloroform extracted twice 
and ethanol precipitated. After pelleting, the DNA was washed in 70% ethanol and 
resuspended in DEPC-treated water so that the DNA concentration was approximately 1 
|lg/|Xl.
Control RNA transcripts were synthesized in a 200 )Lll reaction comprising: 40 
jj,l 5x transcription buffer (supplied with SP6 RNA polymerase from Gibco BRL), 8 jil 
each of 10 mM ATP, 10 mM CTP, 10 mM GTP, and 10 mM UTP, 8 |_l1 of 100 mM 
DTT, 5 \Ll of RNAguard (40 units/p-l), 5 jal of linearized DNA template (5 jig), 107 \il 
of DEPC-treated water, and 3 jil of SP6 RNA polymerase (16 units/jil). Following 
incubation at 37°C for one hour, a further 3 |il of SP6 RNA polymerase were added 
and the reaction allowed to continue at 37°C for another hour.
The reaction was then made 10 mM with respect to VRCs and 50 units of 
FPLC-pure RNase-free DNase 1 (Pharmacia) were added to digest the DNA template. 
The following purification steps were carried out in the PCR room. The DNase 1 
reaction was stopped by the addition of 600 jil of high salt binding solution (3 M 
NaClOg, supplied with the BIO 101 RNaid kit from Stratech). 50 p-l of RNaid matrix 
were then added, mixed thoroughly, and this left at room temperature for 10 minutes to 
allow the RNA to bind to the matrix. The matrix with bound RNA was sedimented by 
brief centrifugation at 13,000 rpm and the supernatant discar ded. It was then washed 
twice with 1 ml of ice-cold RNaid wash solution. The RNA was eluted from the matrix 
by adding 500 |il of sterile water (Gibco BRL) and incubating at 60^C for 5 minutes. 
Following brief centrifugation to sediment the matrix, the RNA solution was removed 
to a fresh Eppendorf tube.
A small amount of the RNA solution was used to determine the RNA 
concentration spectrophotometrically (for RNA, an OD260 of 1 was taken as 40 |ig/ml). 
This synthesis procedure usually produced 200-300 fig/ml of cRNA. The remainder of 
the cRNA was diluted and precipitated by the addition of 0.1 volume of 3 M sodium 
acetate (pH 5.2), 3 volumes of absolute ethanol, and E. coli tRNA, such that the final 
ethanolic mixture was 1 ng/|il with respect to the transcript RNA and 100 ng/|il with
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respect to E. coli tRNA. 50 |al aliquots (50 ng of tr anscripts) of the ethanol-precipitated 
RNA were then stored at -20®C untü required.
E xtrac tion  of Total RNA for PCR
This method is based on the acid guanidinium thiocyanate-phenol-chlorofor*m 
extraction procedure (Chomczynski and Sacchi, 1987) and has been adapted for use 
with PCR. It is suitable for extraction of total RNA from cells on a 35 mM tissue 
culture dish or from 10-50 ganglia.
The cells were first lysed by the addition of 500 \il of solution D (4 M 
guanidinium thiocyanate, 25 mM sodium citrate at pH 7.0, 0.5% L-laurylsarcosine, 
and 0.1 M P-mercaptoethanol). For neuronal cultures, once the F14 culture medium 
had been removed, solution D was applied directly to the culture surface, swirled 
aroumd the culture dish for 30 seconds, and transfened to an Eppendorf tube. For 
purified neurons and ganglia, solution D was added to the Eppendorf tube in which 
they had been stored frozen. The lysates were placed on ice and the following ice-cold 
solutions added to them in the order given: 1 jj.1 of 1 mg/ml E. coli tRNA; 50 jJ.1 of 2 M 
sodium acetate, pH 4.0; 500 fxl of water-saturated phenol; and 120 |il of 24:1 
chloroform/isoamyl alcohol. After each of the first three additions, the tube contents 
were mixed by inversion; after the final addition, they were mixed by vigorous shaking 
for 10 seconds. The mixture was then cooled on ice for 15 minutes and centrifuged at
14,000 rpm for 15 minutes at 4®C. The upper aqueous phase was removed to a fresh 
Eppendorf and RNA was precipitated by the addition of 2 volumes of absolute ethanol. 
Precipitation was allowed to take place at -20°C for at least one hour but usually 
overnight.
The precipitated RNA was pelleted by centrifuging at 14,000 rpm for 30 
minutes, washed thoroughly with 70% ethanol, and air dried (vacuum drying tends to 
over-dry the pellets, making the RNA difficult to resuspend). The RNA pellet was 
resuspended in 20-50 |il of a solution containing 10 mM Tris (pH 7.5), 10 mM MgCl2, 
and 50 mM VRCs, and then incubated with 20-30 units of RNase-free DNase 1
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(Pharmacia) at 37*^0 for 1-2 hours.
The following procedures were then caiiied out in the PCR room and entailed a 
further purification of the RNA using the BIO 101 RNAid kit (Stratech). Three 
volumes of high salt binding solution (3 M NaClOg, from the kit) were added to the 
RNA and VRC mixture, followed by 5-25 |il of the RNaid binding matrix. The actual 
volume of binding matrix added is dependent on the amount of cells from which the 
RNA is extracted, e.g., 5 \il of matrix for approximately 1,000 E7 chicken sympathetic 
neurons. After thorough mixing, the RNA and matrix were left at room temperature for
5-10 minutes to allow for the binding of the RNA to the matrix. The mixture was 
centrifuged briefly at 13,000 rpm to sediment the matrix with bound RNA. The pellet 
was washed twice with 500 jj,l and then 750 |xl of ice-cold RNaid wash solution. After 
a final centrifugation at 13,000 ipm, as much of the wash solution as possible was 
removed and the matrix resuspended in 10-50 |il of sterile distilled water (Gibco BRL). 
The RNA was eluted from the resuspended matrix by incubating at bO^C for 5 minutes. 
The matrix was pelleted by centrifugation at 13,000 rpm for one minute, the RNA 
solution was removed to a fresh Eppendorf tube and stored at -70^C.
P rep ara tio n  of Labelled Prim ers
The primers were labelled at their 5‘ ends in a 40 |il reaction containing 4 pi lOx 
T4 polynucleotide kinase buffer (0.5 M Tris at pH 7.6, 100 mM MgCl2, 1 mM 
speimidine, 50 mM DTT, 1 mM EDTA at pH 8.0), approximately 2 pg of each primer, 
30 pi of yATP (3,000 Ci/mmol, 10 mCi/ml), and 4.5 pi of NBL T4 polynucleotide 
kinase (10 units/pl). The reaction was mixed thoroughly and incubated at 31^C for 45 
minutes, after which a further 5 pi of T4 polynucleotide kinase were added, followed 
by a second 45-minute incubation at 37®C.
The labelled primers were recovered from the rection mixture using the BIO 101 
Mermaid oligonucleotide purfication kit (Stratech). Three volumes of Mermaid high salt 
binding solution were added to the reaction followed by 50 pi of Mermaid glass matrix. 
This was mixed thoroughly and left for 15 minutes at room temperature to permit the
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primers to bind to the glass matrix. The mixture was centrifuged briefly at 13,000 rpm 
to sediment the glass matrix plus bound primers. The pellet was washed twice with 500 
pi of the Mermaid wash solution, and, after removal of as much of the wash solution as 
possible, the primers were resuspended in 250 pi of sterile distilled water (Gibco 
BRL). They were eluted from the glass matrix by incubation at 60°C for 10 minutes. 
The glass matrix was sedimented by centiifugation at 13,000 rpm, and the primer 
solution transfeiTed to a fresh Eppendorf tube and stored at -20®C until required.
R everse T ranscrip tion
Total RNA was reverse transcribed in a 10 pi reaction using Gibco BRL 
Superscript reverse transcriptase in the supplied buffer plus 0.5 mM dNTPs (Ultrapure, 
from Pharmacia), 10 mM DTT (also supplied with the enzyme), 10 M random 
hexanucleotides (Pharmacia), 10 units of RNAguard (Pharmacia), and the appropriate 
amount of control template. The reaction was incubated for 45 minutes at 31^C.
A ’master mix' was prepared of the components that were common to both 
regular and negative control reactions. Using the same mix for one batch of 
experiments provided some degree of uniformity. The volume of 'master mix' used in 
each reaction was 8.5 pi, and so the total volume (v) for n number of reactions was
V (pi) = (n+1) X 8.5
The 'master mix' was prepared for (n+1) reactions to allow for inaccuracies in pipetting 
when aliquoting it into individual reaction tubes.
The 'master mix' was prepared as follows:
85
2 X (n+1) pi 5x supplied reaction buffer 
lx (n + l)p l0 .1 M  DTT 
1 X (n+1) pi 5mM dNTPs 
1 X (n+1) pi lOOM random hexanucleotides 
0.25 X (n+1) pi RNAguard
+ appropriate concentration of cRNA control in (n+1) pi 
+ sterile distilled water (Gibco BRL) to volume v
8.5 pi of the 'master mix' was dispensed into individual 0.5 ml Eppendorf tubes and 
the RNA samples (usually 1 pi) were then added. In cases where one RNA sample was 
being amplified with different amounts of control template, the total RNA was added to 
the 'master mix' prior to its being dispensed and the control template dilutions added to 
the individual tubes. If desired, 'no RNA' controls could be set up by preparing the 
'master mix' with all its components except the cRNA control, dispensing 7.5 pi, and 
making up the volume to 9.5 pi with 2 pi of sterile distilled water (Gibco BRL). The 
appropriate amount of cRNA control could then be added to the remainder of the 
'master mix'. The tubes were placed in a water bath at 37^C and equilibrated for one 
minute. 0.5 pi (100 units) of Superscript reverse transcriptase (Gibco BRL) was added 
and the reactants mixed in the pipette tip. Superscript was not added to the 'no-reverse 
transcriptase’ control reactions. The tubes were centrifuged briefly, returned to the 
37°C water bath, and incubated for 45 minutes.
When reverse transcribing more than one cRNA contiol in the same reaction, 
the reactant volumes and amount of total RNA added were adjusted accordingly, e.g., 
for the reverse transcription of p75, BDNF, and L27 cRNA controls in the same 
reaction, the total reactant volume would be 30 pi and 3 pi of total RNA would be 
added.
PC R
After reverse transcription, the reactions were centrifuged briefly to return the
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contents to the bottom of the tube. The RNA template was then destroyed by heating 
the reactions at 98°C for 5 minutes in the heating block of a thennal cycler. The 
reactions were then quenched on ice and briefly centrifuged once more.
The components for PCR were then added to the reverse transcriptions. These 
were prepared as a 'master mix'. The additional volume of PCR mix added to each 
reverse transcription was 40 pi and so the total volume (v) of the 'master mix' for n 
number of PCRs was (n+1) x 40 pi. The composition of the 'master mix’ was as 
follows and was adequate for the amplification of 0.5 fg-10 pg of initial target cDNA:
4 X (n+1) pi lOx supplied NH4 reaction buffer 
1 X (n+1) pi 5 mM dNTPs (Ultrapure, from Pharmacia)
X X (n)+l) pi labelled primer mix
Y X (n+1) pi 50 mM MgCl2 (supplied with Bioline Taq polymerase) 
0.5 X (n+1) pi Biotaq (5 units/pl, from Bioline)
+ sterile distilled water to volume v
The lOx NH4 PCR buffer contained no MgCl2- Volumes 'X' and 'Y' were specific for 
each target template and needed to be optimized.
Some variation was found in the efficiency to which individual primer pairs 
labelled with ^^P. An insufficient volume of labelled primers decreased the sensitivity 
of the assay, while a great excess of primers generated background signals from 
mispriming. It was, therefore, necessary to find the optimum volume required for each 
pair. This was as follows: for the p75 and trkB mRNA assays, 6 pi of purified labelled 
primers were used, while for the BDNF and L27 mRNA assays, 5 pi were used.
The concentration of free Mg^ "*" ions in the PCR was found to influence the 
efficiency and fidelity of the Taq polymerase. Since dNTPs and primers bind Mg^ "^  and 
the extent of binding is dependent on the concentration of these species, the 
concentration of MgCl2 required in the PCR had to be optimized for each template and 
primer pair. The concentrations of additional MgCl2 required by each assay were as
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follows: for the p75 mRNA assay, 1.85 mM MgCl2 were added, for the BDNF 
mRNA assay, 1 mM was added, and for the trkB and L27 mRNA assays, 1.5 mM 
were added.
After 40 pi of the PCR 'master mix' were added to each reverse transcription, 
the two solutions were mixed and overlaid with 40 pi of mineral oil. The tubes were 
then placed in a thermal cycler for amplification by rounds of denaturing, primer 
annealing, and DNA synthesis. Where, for example, p75, BDNF, and L27 cRNA 
controls were reverse transcribed together in a 30 pi reaction, 10 pi aliquots were 
dispensed for each PCR assay.
The optimum conditions for amplification were determined for each assay and 
were found to be template and primer specific, and also influenced by the initial amount 
of target cDNA. In general, the amplification conditions utilized a few 'high stiingency' 
cycles followed a larger number of 'low stringency' cycles. The 'high stringency' 
cycles comprised a high-temperature denaturing step to facilitate the separation of lai'ger 
cDNA species in the initial stages of amplification. They also comprised a high- 
temperature annealing step with a short annealing time to reduce non-specific 
amplification through mispriming and a short synthesis step to encourage the synthesis 
of a small PCR product. The 'low stringency' cycles were designed for rapid 
amplification once a good level of target cDNA had been synthesized by the high 
stringency parameters. These comprised a lower denaturing temperature to favour the 
strand separation of a short PCR product, a lower annealing temperature with a longer 
annealing time to improve primer annealing, and a longer synthesis time for greater 
product yields.
The number of amplification cycles used depended on the initial amount of 
target cDNA; the lower the concentration of target template, the more cycles were 
necessary. Whatever the number of cycles used, it was important to ensure that the 
PCR remained in the logarithmic phase and did not plateau so that the ratio between 
tai'get and control templates was accurate.
Chicken p75 tai'get cDNA was amplified by 8 cycles of 94^C for 60 seconds,
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54®C for 90 seconds, and 72^C for 45 seconds followed by 13-19 cycles of 91^C for 
60 seconds, 52^0 for 120 seconds, and 72°C for 120 seconds. There was a final 72^0 
incubation for 10 minutes. These conditions were optimal for the amplification of 2-100 
fg of both target and control templates.
Chicken BDNF target cDNA was amplified by 8 cycles of 94^C for 60 
seconds, 540C for 60 seconds, and 72°C for 60 seconds followed by 12-17 cycles of 
910C for 60 seconds, 52°C for 75 seconds, and 72^C for 90 seconds. There was a 
final 720C incubation for 10 minutes. These conditions were optimal for the 
amplification of 0.5-5 fg of both target and control templates.
Chicken trkB target cDNA was amplified by 8 cycles of 94^C for 60 seconds, 
56°C for 45 seconds, and 72^C for 45 seconds followed by 14-21 cycles of 91^C for 
60 seconds, 54®C for 60 seconds, and 72°C for 60 seconds. There was a final 72®C 
incubation for 10 minutes. These conditions were optimal for the amplification of 0.5- 
10 fg of both target and control templates.
Chicken L27 target cDNA was amplified by 8 cycles of 94^C for 60 seconds, 
60°C for 45 seconds, and 72^C for 45 seconds followed by 11-15 cycles of 910C for 
60 seconds, 58°C for 90 seconds, and 12^C for 180 seconds. There was a final 10- 
minute incubation at 72^C. These conditions were optimal for the amplification of 500 
fg-10 pg of both tai'get and contr ol templates.
E lectrophoresis of PC R  Products
The RT-PCR products were separated by electrophoresis on non-denaturing 
polyacrylamide gels. The minimum concentration of polyacrylamide found to 
completely separate two species with a size difference of around 4% was 1% of 19:1 
acrylamide/bis.
The Gibco BRL V-15.17 vertical gel apparatus was used. The gel dimensions 
were 20 x 25 cm with a thickness of 0.8 mm. The comb chosen could hold 20 10 jil 
samples. The gel plates were thoroughly cleaned and one siliconized. The apparatus 
was then assembled according to the manufacturer's instructions.
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The gel solution, comprising 7% acrylamide/bis and Ix TBE, was prepared in a 
total volume of 250 ml and stored at 4^C for up to one month. 30 ml of gel solution 
were first de-gassed under vacuum. 60 jJLl of freshly-prepared 20% ammonium 
persulphate and 45 jil of TEMED were then added and the solution mixed and 
introduced between the glass plates of the assembled gel apparatus using a 25 ml 
disposable syringe. The gel was then left to polymerize for 30 minutes at room 
temperature.
After polymerization, the comb was carefully removed from the gel and the 
wells flushed free of unpolymerized acrylamide using Ix TBE in a 25 ml syringe with a 
19 gauge needle. The gel was placed in the apparatus, the buffer reservoirs filled with 
Ix TBE, and the wells flushed again to remove air bubbles.
Prior to loading, 10 pi of 6x loading buffer (0.25% bromophenol blue, 0.25% 
xylene cyanol, and 30% glycerol) were added to the 50 pi reactions. For the p75, trkB, 
and L27 mRNA assays, 10 pl/PCR were loaded onto the gel. The smaller PCR 
products of the BDNF mRNA assay tended to run more diffusely and so 5 pl/PCR 
were loaded to give 'tighter' bands.
After running the products as near to the bottom of the gel as possible to give 
maximum resolution, the gel was removed from the apparatus and the plates carefully 
separated so that the gel remained attached to the non-siliconized plate. The gel was 
then taken up onto Whatman 3MM paper, covered with Sai'an Wrap, and dried down 
on a slab gel drier for 30 minutes at 60°C.
The dried gel was then autoradiographed. The relative intensities of the 
autoradiographic signals for control cRNA and mRNA products were then determined 
using a Moleculai' Dynamics laser densitometer with ImageQuant softwaie.
Dissection and Cell Culture Techniques 
Dissection Techniques
Embryos were obtained from Fertile White Leghorn chicken eggs incubated at 
38®C in a forced-draft incubator. For the studies using purified neurons, the sensoiy
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ganglia were dissected after 10, 12, and 14 days of incubation; the sympathetic chain 
ganglia after 10,12, 14, and 16 days; and the parasympathetic ciliary ganglia after 10, 
12, and 16 days. For the studies using cultured neurons, sympathetic chain ganglia 
were dissected after 7 and 14 days of incubation, dorsal root ganglia (DRG) after 14 
days, and dorsomedial trigeminal ganglia (DMTG) and trigeminal mesencephalic nuclei 
(TMN) after 10 days. For the study of trkB and BDNF mRNA expression, nodose and 
vestibular ganglia, heart, otic vesicle, and hindbrain were dissected from staged 
(Hamburger and Hamilton, 1951) chicken embryos early in development. Further 
details of the tissue dissection and cell culture techniques involved in this work are 
given in Chapter 5.
A detailed description of tissue dissecton is given in Davies (1988b) but a brief 
outline is shown below. All procedures were carried out using standard sterile 
technique in a laminar flow hood. Embryos were removed from the eggs by first 
holding the egg with the blunt end uppermost (where the airspace is located). The shell 
was wiped with 70% ethanol and allowed to dry, then cracked in a line around the 
airspace with forceps and the portion of shell removed along with the membrane lining 
the airspace. Embryos were removed using curved forceps placed beneath the neck, 
decapitated, and collected in a large petri dish.
The dissections were carried out in HEPES-buffered (20 mM) Hanks' balanced 
salt solution (Hanks, from Gibco BRL) under a stereomicroscope at x20 magnification. 
A fibre optic light source was used to avoid overheating the specimens. Electrolytically- 
sharpened tungsten needles were used to complete the dissections.
Sympathetic Ganglia and Dorsal Root Ganglia (DRG)
Abdominal and thoracic viscera were removed using watchmaker’s forceps and 
the posterior abdominal and thoracic walls washed with Hanks from a Pasteur pipette. 
Blunt forceps were used to slit the connective tissue sheath lying around the spinal 
column and the sheath carefully tom back. The sympathetic chain was carefully teased 
away from the spine using forceps, taking care not to separate the chain from the
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underlying DRG. The chain was removed from mid-thoracic to sacral regions and 
separated from the connective tissue using sharpened tungsten needles. DRG (shown in 
figure 1, part A) were removed from the lumbosacral region by passing the pointed 
ends of forceps between the ganglia and spinal cord, so cutting the spinal roots. Each 
ganglion was removed using watchmaker's forceps, holding the nerve distal to the 
ganglion. The ganglia were collected in a petri dish of Hanks and associated nerves 
removed using tungsten needles. Between 20-30 of each ganglia were collected.
Cranial Sensory Ganglia
The locations of these ganglia in the chicken are shown in figure 1, part B. 
Nodose ganglia are located at the base of the neck, on either side of midline 
tissues in front of the vertebral column. They are glistening white and spindle-shaped in 
appearance with the attached vagus nerve passing rostrally. The ganglia were removed 
by taking hold of the vagus nerve with watchmaker's forceps. Associated nerve fibres 
were removed with tungsten needles.
The jugular, trigeminal, and vestibulo-acoustic (vestibular) ganglia were 
dissected from the cranial base after removal of the brain. A no. 15 scalpel blade was 
used to dissect the cranial base as shown in Davies (1988b). Tungsten needles were 
then used to complete the dissection of ganglia from the resultant tissue blocks, each 
ganglion being identified by its characteristic shape (see figure 1, part B). The 
trigeminal ganglion was then subdissected using tungsten needles into the regions 
containing dorsomedial neurons and ventrolateral neurons as described in Davies 
(1988b). 20-30 ganglia of each type were dissected out.
Trigeminal Mesencephalic Nucleus (TMN)
This was dissected from the midbrain. The cranial vault was removed with 
watchmaker's forceps and the brain removed by passing a small spatula between it and 
the cranial base. 20-40 brains were collected in Hanks and these were transferred to a 
fresh petri dish of Hanks. The dissection was completed using tungsten needles as
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B ^ TMN
Figure 1 (A) Camera lucida drawing of the ventral aspect of the lumbosacral region 
of an ElO chick embryo after evisceration showing the location of the dorsal root 
ganglia. (From Davies, 1988b.) (B) Schematic illustration of an ElO chick embryo 
showing the locations of the cranial sensory ganglia. TMN, trigeminal mesencephalic 
nucleus; T, trigeminal ganglion; G, geniculate ganglion; VA, vestibulo-acoustic 
(vestibular) ganglion; J, jugular ganglion; P, petrosal ganglion. (From Davies and 
Lindsay, 1985.)
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described in Davies (1988b). Briefly, the midbrain was isolated by two coronal 
incisions and the pia mater peeled off, initially from the ventral aspect. The TMN is 
located in the cerebral aqueduct. The roof of the cerebral aqueduct was then dissected 
from the midbrain and the median part of the TMN subdissected.
Ciliary Ganglia
The parasympathetic neurons of the ciliary ganglion were removed from 
embryos by simply scoring around the edge of the eye-ball with blunt forceps and then 
removing the eye from the socket. Care was taken to not damage the eye and the 
underlying tissues in the eye socket. The ciliary ganglia, situated near the stalk of the 
optic nerve, were then removed from the posterior part of the eye using blunt forceps. 
The ganglia were then cleaned from connective tissue using tungsten needles.
Tissue Dissociation
Ganglia used to prepare samples of purified neurons and for cell culture were 
first dissociated into a single cell suspension. The dissected ganglia were transferred to 
a 10 ml conical tube containing 1-2 ml of calcium- and magnesium-free, phosphate- 
buffered isotonic saline (CMF-PBS, from Gibco BRL). This was agitated briefly to 
wash the tissue and the CMF-PBS removed with a pipette. 1.8 ml of fresh CMF-PBS 
were added plus 200 |xl of 1% trypsin (Worthington) in CMF-PBS (stored in 200 pi 
aliquots at -20®C).The tube was partially immersed in a water bath at 37°C for 15-20 
minutes and agitated at intervals. The exact time of incubation needed to be optimized 
for different batches of trypsin or ages of ganglia. This was to minimize neuronal 
damage caused by over-trypsinization or by the vigorous trituration required to 
dissociate under-trypsinized tissue.
After trypsinization, most of the liquid was removed with a pipette and the 
tissue washed with 2 x 10 ml of Hanks plus 10% heat-inactivated horse serum (HIHS, 
Gibco BRL) to remove and inactivate any remaining trypsin. This was followed by 
washing in 5 ml of CMF-PBS. Centrifugation at 2,000 x g for 1-2 minutes facilitated
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removal of the liquid between washes.
The tissue was then dissociated into a single cell suspension by trituration. This 
was carried out using a siliconized Pasteur pipette, the tip of which had been heated in a 
bunsen burner to produce a fine bore. The tissue was drawn up into the pipette in about 
1 ml of CMF-PBS, The tip of the pipette was then placed near the bottom of the tube 
and the contents of the pipette slowly expelled with firm pressure. This was repeated 
two or three times until the tissue was fully dissociated. The progress of dissociation 
was checked by examining a drop of the dissociate on a slide under an inverted phase 
microscope.
Separation of Neurons from Non-Neuronal Cells
Where possible, it was important to purify neuronal cells from other cells found 
in the ganglia. These non-neuronal cells may not only synthesize and release 
neurotrophic factors in culture, but may also express the mRNAs being quantified in 
neurons.
Neurons were purified free from non-neuronal cells by differential 
sedimentation (Davies, 1988b). This made use of the fact that larger neuronal cells 
sediment more quickly in liquid medium than smaller non-neuronal cells. It is, 
therefore, ineffective at early stages of development when neuronal and non-neuronal 
cells are similar in size.
The sedimentation procedure was carried out in a 100 ml cylindrical glass 
dropping funnel with a ground glass outlet tap. Prior to use, the funnel and tap were 
autoclaved separately with pieces of aluminium foil on the top, spout, and tap regions. 
The funnel apparatus was assembled and filled to a height of about 10 cm with Ham's 
F I4 plus 10% HIHS. It was then clamped vertically in a stand and this left on a 
vibration-free surface at 2±0.5®C overnight. The Ham's F14 was purchased from 
Gibco BRL as a powder and prepared using sterile, bottled water also from Gibco 
BRL, For 500 ml, 1 g of NaHCOg (F14 is CO2 buffered), 30 mg of penicillin, and 50 
mg of streptomycin were added, and the pH adjusted to 7.4. The medium was sterilized
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through a 0.22 jim filter and stored at 4°C for up to one month. After addition of 
HIHS, the medium was re-filtered.
The dissociated cell suspension was made up to a volume of about 2 ml in 
CMF-PBS. The dropping funnel was removed from the cool incubator and the cell 
suspension carefully layered by running down the inside of the funnel. The foil was 
replaced on the top of the funnel and this returned to the cool incubator for a further 
hour. The funnel was then caiefully talcen out of the incubator, the foil removed from 
the spout, and 5 ml aliquots run off into sterile tubes. To deteimine which fractions 
contained only neurons, 500 jal samples of these aliquots were placed in a 24-weU plate 
(16 mm wells) and examined under a phase contrast microscope.
For studies using purified neurons not placed in culture, the neuronal fractions 
were pooled and aliquots containing approximately equal numbers of neurons were 
centrifuged at 2,000 x g for 2 minutes and the supernatant removed prior to rapid 
freezing in liquid nitrogen. The neurons were stored at -70®C until required. For the 
studies using purified, cultured neurons, the neuronal fractions were again pooled and 
the neurons placed in culture as follows.
Cell Culture
For most of these studies, neuronal cultures were set up in 35 mm diameter 
plastic tissue culture dishes from Nunc (other details are given as appropriate). Neurons 
do not attach well to tissue culture plastic itself, which means that they aie unable to 
extend neurites and survive in culture. It was, therefore, necessary to coat the dishes 
with laminin, an extiacellular mau*ix protein, before placing the neurons in cultuie. The 
dishes were first coated with poly-DL-ornithine (P-ORN) which facilitates the 
adsorption of the laminin.
A 0.5 mg/ml P-ORN solution was prepaied by dissolving powdered P-ORN 
(Gibco BRL) in 0.15 M borate buffer (0.15 M boric acid adjusted to pH 8.4 with 
NaOH). The P-ORN was sterilized by passing through a 0.22 jim filter and was stored 
at 4^C for up to one week. To coat the dishes, 1.2 ml of P-ORN were added to each
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dish and this left overnight at room temperature. The P-ORN was removed using a 
Pasteur pipette attached to a suction line and the dishes washed three times with sterile 
water. 1-2 ml of sterile water were added to each dish, swirled around, and removed 
with the suction line. The dishes were left in the laminar flow hood to air dry for about 
15 minutes. The lids were then replaced and the dishes could be used immediately or 
stored for several days if desired.
1 mg/ml laminin (Gibco BRL) was stored in 20 |il aliquots at -70°C. The 
laminin was first thawed at 4^C and diluted to 20 pg/ml with sterile F14 without serum 
or CMF-PBS. 150 pi of diluted laminin were placed in the centre of each P-ORN- 
coated dish and spread across most of the base with a sterile pipette tip. The dishes 
were then placed in a humidified incubator at 37®C for a minimum of 4 hours or 
overnight.
It was necessary to wash excess laminin off the dishes immediately before use 
with 2 X 2 ml F12 medium plus 10% HIHS. As for F14, F12 was purchased in 
powdered form from Gibco BRL and was made up using autoclaved double-distilled 
water. For one litre, 100 mg of streptomycin and 60 mg of penicillin were added and 
the pH adjusted to 7.4. The medium was then sterilized by passing through a 0.22 pm 
filter. After the addition of 2 ml F 12 to each dish, the medium was swirled and 
removed using the suction line. As it was important that the dishes did not dry out in 
between washes, F12 was removed from only 4 dishes at a time and the second 2 ml of 
medium added. After the second wash, the F12 plus 10% HIHS was replaced by 1 ml 
of F14 plus 10% HIHS, measured accurately using a micropipette.
The appropriate growth factors were added to at least duplicate dishes for each 
treatment and/or time point at double the required final concentration. For dose 
response experiments, the desired trophic factor dilutions were prepared in culture 
medium at double the required concentration. Medium was removed from the washed 
dishes and 1 ml of each dilution added to at least duplicate dishes. In both cases, the 
dissociated neurons were placed in a suitable volume of F 14 plus 10% HIHS in a 
screw-top tube, evenly distributed in the medium by a gentle movement, and added to
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each dish in two 500 pi aliquots using a micropipette. The neurons were usually plated 
at a density of 800-1,000 neurons/dish. The cells were evenly distributed in the dishes 
by a gentle movement backwards and forwards and from side to side. The cultures 
were then incubated for the desired times at 31^C in 3.5% CO2 in a humidified 
incubator.
The neurons were quantified as follows. Each dish was centrally positioned 
over a 12 X 12 mm graticule comprising 2 mm squares and the number of neurons 
located in the grid counted under an inverted phase microscope at x200 magnification. 
From this, the number of neurons in each dish as a whole could be estimated for 
mRNA quantitation by RT-PCR. For neuronal sumval studies, the number of neurons 
in the grid that were attached to the P-ORN/laminin substratum was first determined for 
a few dishes at 6 to 12 hours after plating. The number of smwiving, process-beaiing 
neurons was then determined for all the dishes at 48 hours after plating. This was 
expressed as a percentage of the initial 6 to 12-hour count.
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3In Vivo p75 Expression in Sensory, Sympathetic, and Parasympathetic 
Neurons and In Vitro Regulation of p75 Expression in 
Sympathetic and Dorsal Root Ganglion Neurons 
Introduction
At the time of this study, the role of the common low-affinity p75 receptor in 
mediating the effects of neurotrophic factors was unclear and the available evidence 
conflicting. It had been shown that p75-deficient NIH 3T3 fibroblasts transfected with 
each of the trk receptors can suivive (Glass et a l, 1991) and proliferate (Cordon-Cardo 
et a l, 1991; Lamballe et a l, 1991; Glass et a l, 1991; Kaplan et a l, 1991b; Klein et 
a l,  1991a) in response to the appropriate neurotrophin, indicating that p75 may be 
unnecessary for neurotrophic factor signalling. In contrast, other evidence suggested 
that p75 may be required for certain responses to neurotrophic factors. Transfection 
experiments using PC 12 cells indicated that both ti'kh and p75 are necessaiy for the 
formation of functional, high-affinity NGF receptors (Hempstead et a l, 1989,1991). 
Likewise, NGF-unresponsive medulloblastoma cells transfected with p75 cDNA 
exhibited both high- and low-affinity NGF binding and increased c-fos expression in 
response to NGF (Pleasure et a l, 1990). Also, neuroblastoma cells transfected with 
p75 cDNA extended neurites in response to NGF, indicating the importance of p75 for 
this function (Matsushima et a l, 1990). However, cells transfected with p75 cDNA 
lacking the region encoding the cytoplasmic domain showed only low-affinity binding 
with no increases in intracellular c-fos (Hempstead et a l,  1990) or tyrosine 
phosphorylation (Berg et a l, 1990) in response to NGF.
Several studies have been earned out to investigate the possible factors 
regulating p75 expression. NGF was shown to upregulate p75 mRNA levels in 
developing (Wyatt and Davies, 1993) and adult (Lindsay et a l, 1990) sensory neurons, 
central cholinergic neurons (Higgins et a l, 1989), and PC 12 cells (Doherty et a l.
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1988) in vitro. Tissue injury may affect p75 expression. Emfors and co-workers
(1989) found that axotomized motoneurons showed a dramatic increase in p75 
expression. Other regulators of p75 expression were found to include bFGF, which 
increased p75 levels in PC 12 cells (Doherty et a l, 1988) and in the MAH 
sympathoadrenal progenitor cell line (Birren et a l, 1990), and dexamethasone, which 
decreased low-affinity binding on PC 12 cells (Tocco et a l, 1988) and p75 mRNA 
expression in MAH cells (Birren et a l, 1990).
The initial part of the present study of p75 was a comparison of p75 mRNA 
expression in chicken neurons that differ in their neurotrophic factor requirements. It 
was hoped that this would provide further insight into the role of the p75 receptor in 
forming functional receptors for the various neurotrophic factors. Four types of 
sensory neuron were studied: trigeminal mesencephalic (TMN) neurons which are 
proprioceptive neurons that are BDNF-and NT-3-responsive (Davies et al, 1986a; 
Hohn et al, 1990); dorsomedial trigeminal (DMTG) neurons which are sraall-diameter, 
neural crest-derived, cutaneous sensory neurons that respond to NGF (Davies and 
Lindsay, 1985); ventrolateral trigeminal (VLTG) neurons which are large-diameter, 
placode-derived, cutaneous sensory neurons that respond to BDNF (Davies et a l , 
1986b); and Jugular neurons which are like DMTG neurons in their morphology and 
function, and respond to NGF (Davies and Lindsay, 1985). It was thought that the 
varied neurotrophic requirements of these neurons might be reflected in their relative 
expression of p75 mRNA. As a further comparison, p75 mRNA levels were also 
measured in sympathetic chain neurons which are NGF-responsive (Chun and 
Patterson, 1977) and parasympathetic ciliary neurons which are not responsive to 
NGF, BDNF, or NT-3, but are CNTF-responsive (Barbin et a l, 1984). p75 mRNA 
levels were determined for these neurons at various stages of embryonic development, 
ranging from ElO, when these neurons are dependent on neurotrophic factors for 
survival, through to E l6.
The second part of this study of p75 investigated factors that might influence 
neuronal p75 mRNA levels in vitro. Immature E7 chicken sympathetic neurons were
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used because these proliferate and survive in culture independently of neurotrophic 
factors (Ernsberger et a l, 1989a) and do not become NGF-responsive in vitro unless 
retinoic acid (RA, a derivative of retinol/vitamin A) is present in the culture medium 
(Rodriguez-Tébai* and Rohrer, 1991). These characteristics were considered useful 
when studying factors that might regulate p75 mRNA levels, as such regulation could 
be linked with the induction of NGF-responsiveness. In agreement with this, 
Rodriguez-Tébar and Rohrer (1991) showed that RA not only induced NGF- 
dependency in E7 chicken sympathetic neurons in vitro but also increased the number 
of high-affinity receptors on these neurons.
In the present study, the effects of NGF, CNTF, stem cell factor (SCF), TGF- 
p l, -p2, -p3, and RA on in vitro p75 mRNA levels were investigated in E7 chicken 
sympathetic neurons. SCF is a ligand for the c-kit tyrosine Idnase receptor which is 
widely expressed throughout the nervous system and is believed to influence migratory 
cells during development (Matsui etal., 1990; Motro etal., 1991; Keshet et a i, 1991). 
In vitro, SCF has been shown to support a proportion of NGF-responsive mouse 
(Hirata et al, 1993) and chick (Carnahan et ai, 1994) dorsal root ganglion neurons. It 
does not enhance the survival of sympathetic, parasympathetic, or placode-derived 
sensoiy neurons (Cainahan et a l, 1994). The potential roles of TGF-Ps include the 
control of embryonic development and cellular differentiation (review by Massagué et 
a l,  1994). Collins etal. (1991) found that membrane depolarization can promote 
neuronal suiwival by opening voltage-gated calcium channels. The effect of 
depolarization on p75 mRNA levels was studied by the addition of KCl to cultures. The 
effects of NGF, CNTF, and KCl on in vitro p75 mRNA levels in E14 sympathetic and 




In Vivo p75 Expression in Sensory, Sympathetic, and Parasympathetic 
neurons
The following ganglia were dissected, dissociated, and purified free of non- 
neuronal cells as described in Chapter 2: TMN, DMTG, VLTG, and jugular at ElO, 
E12, and E14; lumbosacral paravertebral sympathetic chain at ElO, E12, E14, and E16; 
and ciliary at ElO, E12, and E16. Aliquots of approximately equal numbers of cells (as 
estimated using a haemocytometer) were centrifiged at 2,000 x g for 5 minutes and the 
supernatant removed prior to rapid freezing in liquid nitrogen and storage at -70°C. As 
required, cells were defrosted on ice and total RNA was extracted. p75 mRNA levels 
were determined using quantitative RT-PCR and these levels were standardized against 
levels of mRNA encoding the L27 ribosomal protein, also determined by RT-PCR. 
These procedures are described in Chapter 2.
In Vitro Regulation of p75 Expression in Sympathetic and Dorsal Root 
Ganglion Neurons
E7 and E14 chicken lumbosacral paravertebral sympathetic chain neurons and 
E l4 chicken dorsal root ganglion neurons were dissected and placed in culture as 
described in Chapter 2. Dose responses were set up with E7 sympathetic neurons for 
SCF, NGF, and CNTF at concentrations of 0.001, 0.01, 0.1, 1, 5, 25, and 125 ng/ml 
and included control cultures with no added factors. E7 sympathetic neurons were also 
cultured with 35 mM additional KCl (FI4 medium contains 5 mM KCl) and KCl plus 5 
ng/ml CNTF. Cultures were incubated for 36 hours. A RA dose response was set up 
with E7 chicken sympathetic neurons using RA concentrations of 10”i2^  10‘iO^ iq-8, 
10*6, and 10-4 M (according to Rodriguez-Tébar and Rohrer, 1991) and included 
control cultures with no RA added. Because the RA was dissolved in DMSO, neurons 
were also cultured in 1 pi DMSO/ml F14 (no RA) to check if the DMSO itself had any 
effect on p75 mRNA levels. These cultures were incubated for 48 hours. E7 chicken 
sympathetic neurons were cultured with TGF-pi (50 ng/ml), TGF-P2 (20 ng/ml), and
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TGF-p3 (20 ng/ml) and incubated for 48 hours.
E14 chicken sympathetic and DRG neurons were cultured with the following 
combinations of factors: NGF (10 ng/ml), CNTF (10 ng/ml), NGF plus CNTF (both at 
10 ng/ml), additional KCl (35 mM), NGF plus additional KCl (10 ng/ml and 35 mM 
respectively). These cultures were incubated for 48 hours.
Treatments were set up in duplicate for both E7 and E14 neurons. Neuronal 
counts of all dishes were carried out prior to RNA extraction and RT-PCR quantitation 
of p75 mRNA levels as described in Chapter 2. Purified recombinant NGF, BDNF, 
CNTF, and TGF-fs were gifts from Genentech Inc. RA and KCl (tissue culture grade) 
were purchased from Sigma.
Results
Specificity and Reliability of Quantitation of p7S mRNA by RT-PCR
The levels of p75 mRNA in total RNA from purified neurons and neuronal 
cultures were measured using a quantitative RT-PCR technique. The p75 levels for 
purified neurons were expressed relative to mRNA levels for the ubiquitous and 
constitutively expressed L27 ribosomal protein, which were also determined by RT- 
PCR.
The target mRNAs in total RNA from neuronal samples were co-reverse 
transcribed with a slightly larger control RNA (prepared from p75 or L27 cDNAs) and 
co-amplified by PCR, as described more fully in Chapter 2. Co-reverse transcription 
and CO-amplification of target mRNA and control RNA reduced the variables that affect 
reaction efficency. To determine the reliability of the RT-PCR technique, reactions were 
carried out using known quantities of target and control RNA transcripts. During the 
log-phase of the reaction, the ratio between the reaction products was identical to the 
initial ratio of target and control RNAs, regardless of the starting quantities of these 
RNAs (data not shown).
Examples of autoradiographs showing the separated target and control RT-PCR 




Figure 2 Reliability of the RT-PCR technique. Autoradiographs showing the 
products of RT-PCRs amplified with either p75-specific primers (p75) or L27-specific 
primers (L27). (l)Reactions containing total RNA from ElO chicken DMTG neurons, 
showing the 88 bp p75 mRNA and 127 bp L27 mRNA amplification products. (2) 
Reactions containing 50 fg of p75 control RNA template or 2 pg L27 control RNA 
template, showing 92 bp and 131 bp products respectively. (3) Reactions containing 50 
fg of p75 control RNA template and 2 pg of the L27 control template plus total RNA 
from ElO DMTG neurons, showing both sets of the respective amplification products. 
(C) Control reactions showing no products; these contained the respective control RNA 
templates plus total RNA from ElO DMTG neurons but did not undergo the reverse 
transcription step.
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that was not reverse tiansciibed gave no PCR products when amplified with either p75- 
or L27-specific primers, showing that the RNA sample contained no contaminating 
DNA. As little as 0.5 fg of p75 control RNA could be detected using the RT-PCR 
assay, allowing the measurement of target RNA in less than 10 neurons. The sensitivity 
of this technique has allowed for the measurement of p75 mRNA levels in low-density 
neui'onal cultures.
In Vivo p75 Expression in Sensory, Sympathetic, and Parasym pathetic 
N eurons
Figure 3 shows the in vivo p75 mRNA levels for embiyonic chicken sensory, 
sympathetic, and parasympathetic neurons during development. For ElO sensoiy 
neurons, there was a significant difference between the p75 mRNA level of BDNF- 
responsive VLTG neurons and those of NGF-responsive DMTG and jugular neurons 
(p<0.05, t-test). However, the p75 mRNA level for BDNF- and NT-3-responsive 
TMN neurons is not significantly different from those of NGF-responsive DMTG and 
jugular neurons. This trend was observed throughout the period of development 
studied. Therefore, the data obtained show no clear-cut evidence that a relationship 
exists between p75 mRNA levels and neurotrophic factor requirement in sensory 
neurons at, or after, the time in embryonic development when they are dependent on 
neurotrophic factors for smvival.
The p75 mRNA level for NGF-dependent ElO sympathetic neurons was similar 
to that for CNTF-dependent ciliary neurons. Both these values were significantly lower 
(p<0.01, t-test) than those for NGF-dependent DMTG and jugular neurons. The 
differences in sensory neuronal and sympathetic and parasympathetic neuronal p75 
mRNA levels were maintained at E12 and also observed in the sensoiy and sympathetic 
neurons studied at E14. The overall levels of p75 expression increased slightly with 
embiyonic age for all neurons studied except those of the TMN, in which there was a 
slight decrease. It is not cleai* what significance, if any, these fluctuations have for the 
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Figure 3 p75 mRNA expression relative to L27 mRNA in puiified preparations of 
chicken sensory, sympathetic, and parasympathetic neurons at ElO, E12, E14, and 
E16. D, DMTG neurons; J, jugulai* neurons; T, TMN neurons; V, VLTG neurons; S, 
sympathetic chain neurons; C, ciliary neurons. The graphs show the means of 4 
samples for each neuronal type ± the standard error.
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neurons was equivalent to the level for ElO NGF-responsive sensory neurons. This 
could indicate that the p75 receptor is more important in the development of sensory 
neurons or could merely represent the fact that sensory and sympathetic neurons start 
developing at different stages, sensory neurons being 'born' before sympathetic 
neurons.
In Vitro R egulation of p7S Expression in  Sym pathetic and DRG neurons
Figure 4 shows a phase contrast photomicrograph of E7 chicken sympathetic 
neurons surviving on a polyornithine-laminin substratum in the absence of neurotrophic 
factor (a control culture). The number of non-neuronal cells in the cultures was 
negligible. The data for in vitro regulation of p75 expression in E7 chicken sympathetic 
neurons are shown in figure 5. Part A of this figure shows the results for NGF, 
CNTF, and SCF dose responses. Increasing concentrations of NGF (added to a 
maximum of 125 ng/ml) failed to produce any significant change in p75 mRNA levels, 
which remained similar to the control level (no added NGF) of 1.13±0.092 fg/neuron. 
CNTF had a negligible effect on p75 mRNA levels. Even up to a concentration of 125 
ng/ml, the p75 mRNA level remained similar to that of the control level (no added 
CNTF) of 1.31±0.085 fg/neuron. A similar result was obtained with the SCF dose 
response. Up to a maximum SCF concentration of 125 ng/ml, p75 mRNA levels 
remained similar to the control level of 1.29±0.205 fg/neuron. Neither CNTF nor SCF 
had an effect on neuronal survival and so did not appear to induce NGF dependency.
There was an increase in E7 sympathetic neuronal p75 mRNA level with 
increasing RA concentration in vitro (figure 5, part B). The level of p75 mRNA 
upregulation at a RA concentration of 10"  ^M was significantly greater than the control 
p75 mRNA level (p<0.02, t-test). As no effect on neuronal survival was observed, it 
appeared that RA did not induce NGF dependency. The DMSO control (no RA) 
confirmed that the DMSO in which the RA was dissolved had no effect on neuronal 
survival or p75 expression.
The addition of TGF-pl, -p2, and -p3 to cultures of E7 sympathetic neurons
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Figure 4 Phase contrast photomicrograph of E7 chicken sympathetic neurons 
surviving without neurotrophic factors on a polyornithine-laminin substratum. (A) A 





















Figure 5 Regulation of in vitro p75 mRNA levels in E7 chicken sympathetic 
neurons. (A) NGF, CNTF, and SCF dose responses. The control p75 mRNA level (no 
factor added) is the mean control for all 3 dose responses, i.e., 1.24±0.095 fg/neuron 
(n = 6). (B) RA dose response. Control p75 mRNA level (no RA added) was 
0.86±0.053 fg/neuron. p75 mRNA levels are expressed as fg/neuron. The graphs 
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Figure 5 continued Regulation of in vitro p75 mRNA levels in E7 chicken 
sympathetic neurons. (C) Effect of TGF-Ps. 1, TGF-pl (50 ng/ml); 2, TGF-P2 (20 
ng/ml); 3, TGF-p3 (50 ng/ml). (D) Effect of depolarization. KCl and/or CNTF were 
added at a concentration of 35 mM and 5 ng/ml respectively. p75 mRNA levels aie 
expressed as fg/neuron. The graphs show the mean of two samples ± the standard 
error.
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failed to significantly affect p75 mRNA levels; the level for each TGF-p remained 
similar* to the control level of 0.88+0.035 fg/neuron (figure 5, part C). The TGF-ps 
had no effect on neuronal survival and so did not appear to induce NGF dependency.
Membrane depolarization of E7 sympathetic neurons, achieved by the addition 
of KCl to the cultures, produced a significant decrease in p75 mRNA level compared to 
the control level (p<0.01, t-test) (figure 5, part D). A similar decrease in p75 mRNA 
level was observed when KCl was added in combination with CNTF (p<0.02, t-test) 
(figure 5, part D). Depolarization appeared to have no effect on neuronal survival, 
either alone or in the presence of CNTF. It is unlikely that depolarization induced NGF 
dependency in these neurons.
p75 mRNA levels in NGF-dependent E14 sympathetic neurons treated in 
culture with NGF, CNTF, CNTF plus NGF, KCl, and NGF plus KCl showed no 
significant differences from that of the control culture treated with NGF (figure 6). For 
E14 DRG neurons treated in culture with NGF, CNTF, CNTF plus NGF, KCl, and 
NGF plus KCl, p75 mRNA levels were similar to that of the untreated control culture 
(figure 6).
Discussion
No conclusions for the selective role of the p75 receptor in modulating the 
function of particular neurotrophins could be made from studying the in vivo p75 
mRNA levels of neurons with different neurotrophin requirements. There was no trend 
to suggest that p75 is more important in the functioning of any particular neurotrophin. 
More information is now available on the role of the low-affinity p75 receptor in 
modulating the effects of neurotrophins in sensory and sympathetic neurons. Perhaps 
one of the most revealing studies utilized mice with a null mutation in the p75 gene (Lee 
et a l,  1992). These mice showed reduced sensitivity to heat and painful stimuli. There 
were also some deficits in sympathetic innervation, particularly in the pineal gland and 
in a subset of the footpad sweat glands (Lee et a l, 1994a). In vitro studies using 
neurons from p75 null mutant mice have indicated that p75 modulates the effects of
111





NGF CNTF NGF-fCNTF KCl NGF+KCi 
C ultu re treatm en t
E14 chicken DRG neurons
2 “
CONTROL NGF CNTF NGF4CNTF KCl NGF+KCl
C ulture treatm en t
Figure 6 Regulation of in vitro p75 mRNA levels in E14 chicken sympathetic and 
DRG neurons. Effect of NGF (N, 10 ng/ml), CNTF (C, 10 ng/ml), additional KCl (K, 
35 mM), NGF+CNTF, and NGF+KCl; CONT, untreated control. p75 mRNA levels 
are expressed as fg/neuron. The graphs show the mean of two samples ± the standard 
eiTor.
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NGF and accounts for the phenotype of null mutant mice. The NGF dose response of 
cutaneous sensory trigeminal neurons from null mutant embryos was shifted to a higher 
concentration compared to wild type neurons, while the BDNF and NT-4/5 dose 
responses of p75-deficient embryonic enteroceptive sensory nodose neurons remained 
unchanged (Davies et a l, 1993b). Studies comparing the NGF survival response of 
sympathetic neurons from p75 null mutant mice and wild type mice have shown that 
there is no difference in response prenatally, but postnatally p75-deficient neurons are 
less sensitive to NGF, suggesting that p75 plays an important role in sympathetic 
neurons late in their development (Davies et a l, 1993b; Lee et a l, 1994a). In the 
present study, the observation that p75 expression was lower in sympathetic neurons 
compared to sensory neurons raises the possibility that the p75 receptor might be more 
important in sensory neurons during the stages of development studied. To clarify this, 
a study of posthatching p75 expression should be canied out in sympathetic neurons to 
determine if p75 expression becomes elevated later in their development. The evidence 
clearly indicates that p75 plays a role in increasing neuronal sensitivity to NGF and 
indicates that both p75 and trkh  receptors are required for maximum NGF 
responsiveness.
Interestingly, p75 mRNA was detected in parasympathetic ciliary neurons 
which do not respond to any member of the NGF family of neurotrophic factors. The 
p75 mRNA level detected in these neurons was similar to that of sympathetic neurons 
but much lower than those of the sensory neurons. Allsopp et a l (1993) have shown 
that the induced expression of trkh  in ciliary neurons microinjected with the 
pCMX/fr/:A expression construct was insufficient to confirm an NGF survival 
response, even though trkh  protein was detected on their cell bodies and neurites and 
their survival in medium containing CNTF was unaffected. In contrast, pCMX/f/tA- 
microinjected TMN neurons (normally NGF-insensitive and BDNF- and NT-3- 
responsive) were supported in culture by NGF. It may be that, although ciliary neurons 
possess p75 receptors, they do not possess the intracellular signalling mechanisms 
which are initiated by trkh  and p75 leading to survival.
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In contrast to previously cited studies that have shown that NGF can upregulate 
p75 expression both in vivo (Wyatt and Davies, 1990 ; Higgins et at., 1989; Miller et 
a i,  1991) and in vitro (Lindsay et a l, 1990; Doherty et al, 1988), NGF failed to 
upregulate in vitro p75 expression in NGF-independent E7 chicken sympathetic 
neurons. Although NGF can upregulate p75 expression in more mature sympathetic 
neurons (Miller et a l, 1991), it is a possible that another factor is present which acts in 
conjunction with NGF to upregulate receptor expression in immature chicken 
sympathetic neurons in vivo. However, a recent study by Wyatt and Davies (1995) has 
shown that NGF can upregulate p75 expression in cultured immature mouse 
sympathetic neurons.
The effect of CNTF on E7 chicken sympathetic neurons has been characterized 
in vitro in the previously cited study by Ernsberger et a l (1989b). It was found to 
inhibit the in vitro proliferation of these neurons and affect differentiation by inducing 
the expression of vasoactive intestinal peptide. In the present study, CNTF was found 
to have no effect on in vitro p i5 mRNA levels in these neurons. Hagg et a l (1992) 
have shown that, in vivo, CNTF prevents the degeneration of injured adult rat medial 
septum neurons (NGF rescues only the cholinergic neurons) and upregulates the p75 
receptor in these neurons, as determined by immunostaining. CNTF may influence 
these central nervous system neurons differently compared to E7 chicken sympathetic 
neurons. However, it is possible that, in vivo, other factors may be acting in 
conjunction with CNTF and these interactions were not recreated in vitro.
SCF is the product of the SI (Steel) locus and has been identified as the ligand 
for the c-kit tyrosine kinase receptor encoded by the W (Dominant white spotting) 
locus. Mice with mutations in both these loci develop abnormalities in three migratory 
cell lineages: neural crest-derived melanocytes, primordial germ cells, and 
haematopoietic stem cells. This results in loss of pigmentation, reduced fertility, and 
anaemia (Matsui et a l, 1990; Keshet et a l, 1991). Keshet et a l (1991) have shown 
that the developmental expression patterns of SCF and its receptor in skin and gonads 
indicate that the biological effect of SCF is to give a chemotactic signal to c-kit
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expressing migratoiy cells. They have also shown that these genes aiie expressed in the 
nervous system and may play a role in the organization of the brain and neural tube. 
The primaiy function of SCF may be to provide a guidance mechanism for migratoi^y 
cells during development. It is, therefore, not surprising that it failed to upregulate E7 
sympathetic neuronal p75 expression, which could be considered as a raaturational 
change. It has been shown that, unlike CNTF, SCF does not inhibit in vitro 
proliferation of these immature neurons (C.L. Stewart and A.M. Davies, personal 
communication).
RA is a naturally occurring metabolite of vitamin A that regulates cell growth 
and differentiation. Sidell (1982) observed that RA stimulated neurite outgrowth and 
inhibited proliferation in cultured human neuroblastoma cells (LA-N-1). Haskell et a l 
(1987) reported that RA increased the number of both high- and low-affinity NGF 
receptors in cultured human neuroblastoma cells (LA-N-1). They also reported that 
neurite outgrowth similar to that produced by NGF was obseiwed in LA-N-1 cells, 
SY5Y neuroblastoma cells, and explanted chick DRG following treatment with RA. 
Scheibe and Wagner (1992) reported that RA stimulated p75 but not trkh  expression in 
PC12 cells. Rodriguez-Tébai* and Rohrer (1991) showed that RA induces the ability of 
immature chicken sympathetic neurons to survive in the presence of NGF and increases 
the number of high-affinity NGF receptors on these neurons. In the present study, RA 
was found to upregulate p75 expression in E7 chicken sympathetic neurons but did not 
have any detrimental effect on neuronal survival, which suggests that RA alone does 
not induce NGF responsiveness in these neurons. A number of RA receptors have been 
characterized (Giguère e ta l,  1987; Brand et a l, 1988; Krast et a l, 1989; Rowe et al,
1991). Strong expression of the RA receptor RXRa has been detected in the 
developing chick peripheral neiwous system (Rowe et a l, 1991), so it is possible that 
RA may play an indirect role in inducing NGF responsiveness in immature sympathetic 
neurons.
Members of the TGF-p family have diverse roles in development, including the 
inhibition of cellular growth and differentiation and the control of hormone secretion
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and immune function (Massagué eî a l, 1994). The function of TGF-ps in the nervous 
system is not well understood. Nichols et a l (1991) have demonstrated that TGF-p 
mRNA is upregulated in the hippocampus after entorhinal lesioning and Lindholm et al
(1990) have shown that TGF-P 1 stimulates NGF expression in cultured rat astrocytes. 
In addition, Chalazonitis et a l  (1992) have reported that TGF-pl and -p2 increase 
neuronal survival and expression of the peptide neurotransmitter substance P in cultures 
of neonatal rat DRG. They found that TGF-P 1 enhanced the survival of cultured DRG 
neurons indirectly by acting on non-neuronal cells, although a direct effect on the 
neurons could not be ruled out. More recently, Buchman et a l (1994) have carried out 
in vitro studies of the effects of TGF-Ps on NGF and NT-3 mRNA expression in 
dermal and epidermal cells from the maxillary territory of the embryonic mouse 
trigeminal ganglion. They found that, in E ll  and E12 cultures, when the levels of NGF 
and NT-3 mRNAs are increasing in vivo, TGF-pl, -P2, and -P3 each increased the 
level of NGF mRNA but had no effect on the NT-3 mRNA level. In E13 cultures, 
when in vivo levels of NGF and NT-3 mRNAs reach a peak before falling dramatically 
in the case of NGF mRNA and gradually in the case of NT-3 mRNA, TGF-Ps 
promoted further increases in the NGF mRNA level but caused a decrease in the NT-3 
mRNA level. They also found that all three TGF-ps could be detected in the maxillary 
territory in vivo, before innervation by the earliest sensory axons and that their levels 
increased during the period of innervation. These observations suggest that TGF-Ps 
may play a role in regulating neurotrophin gene expression in sensory neuron target 
fields. In the present study, the addition of TGF-pl, -p2, or -p3 to cultures of E7 
chicken sympathetic neurons had no significant effect on p75 expression or neuronal 
survival.
It has been well documented that chronic depolarization increases the survival of 
many types of neuron in culture (review by Franklin and Johnson, Jr., 1992). 
Depolarization is usually achieved by elevating the level of K+ ions in the culture 
medium and probably promotes survival by mimicking electrical activity that occurs in 
vivo, resulting in activation of voltage-gated calcium channels and raised intracellular
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Ca2+. Nishi and Berg (1981) have demonstrated that the survival response to 
depolarization in cultured chicken ciliaiy ganglion neurons could be blocked by the 
non-specific calcium channel blockers verapamil and Mg^+. More specifically, CoUins 
and Lile (1989) have shown that potent inhibitors of L-type calcium channels prevent 
depolarization, rescuing trophic factor-deprived chicken ciliaiy, sympathetic and DRG 
neurons. Conversely, Laimet et a l (1992) have shown that, in vitro, reduction of 
intracellular free calcium kills early neurotrophic factor-independent chicken nodose 
neurons but has no significant effect on the survival of older, BDNF-responsive 
neurons. The role of enhanced intracellular calcium in promoting neuronal survival is 
likely to involve the binding of free calcium to membrane-bound proteins which act as 
receptors to initiate a cascade of signalling events (review by Franklin and Johnson, 
Jr., 1992). Birren et a l  (1992) have studied the effect of depolaiization on trlcA and 
p75 expression in MAH cells (an immortalized sympathoadrenal progenitor cell line). 
They found that depolarization induced expression of trk A  but not p75 mRNA which 
was sufficient for a large proportion of the cells to develop and survive as neurons in 
NGF and FGF. However, depolarization does not induce trkA  or p75 expression in 
normal mouse sympathetic neuroblasts in vitro (Wyatt and Davies, 1995). In the 
present study, depolarization was found to decrease in vitro p i5 expression in E7 
chicken sympathetic neurons. A similar decrease in p75 expression was also observed 
when these neurons were depolarized in the presence of CNTF, which has been shown 
to produce a maturational change by inhibiting neuronal proliferation and inducing 
cholinergic differentiation (Ernsberger et a l, 1989b). The significance of this 
downregulaton of p75 is unclear* but it did not adversely affect neuronal survival.
p75 expression in NGF-dependent E14 chicken sympathetic neurons was 
unaffected in vitro by NGF, CNTF, NGF plus CNTF, KCl, and NGF plus KCl. It has 
been demonstrated that p75 expression in both mouse sympathetic neuroblasts and 
more mature mouse sympathetic neurons can be upregulated by NGF in vitro, while 
KCl has no effect (Wyatt and Davies, 1995). In vitro p i5 mRNA levels in E14 DRG 
sensory neurons were also unaffected by NGF, CNTF, NGF plus CNTF, KCl, and
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NGF plus KCl. Previous studies have shown that p75 expression in adult DRG can be 
upregulated by NGF both in vivo (Verge et a l, 1992) and in vitro (Lindsay et a l,  
1990).
Conclusion
This study has shown that there are no clear-cut differences in the p75 mRNA 
levels of NGF-dependent cutaneous sensoiy DMTG and jugular neurons compared 
with BDNF- responsive TMN and VLTG neurons. Thus, although in vitro studies of 
the effect of the p75 null mutation have only revealed changes in the NGF dose 
response, not the BDNF dose response, this is not reflected in the relative levels of p75 
mRNA (and possibly p75 protein) in NGF- and BDNF-responsive neurons. Perhaps 
p75 expression in BDNF-dependent neurons seiwes some other function. Likewise, 
p75 mRNA is expressed in ciliary neurons which have no known response to 
neurotrophins. It is possible that neurotrophins may have a role in the development of 
ciliary neurons that is not connected with suiwival.
The role of p75 regulation in the induction of NGF dependency in neurons was 
not established by this study. Although RA increased p75 mRNA levels in E7 chicken 
sympathetic neurons in vitro, it appeared to have no effect on neuronal suiwival. It is 
possible that p75 upregulation is one of a number of processes required to induce NGF 
responsiveness and not all of these can be recreated in vitro.
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CHAPTER 4
Synthesis of BDNF by NGF-dependent Embryonic Sensory Neurons 
Introduction
Substantial numbers of developing vertebrate sensory neurons die shortly after 
their axons reach their peripheral and central target fields (Oppenheim et a l, 1991). 
Experimental manipulation of target field size during this phase of development has 
been shown to influence the number of surviving neurons, indicating that target fields 
may play a major role in regulating neuronal survival (Davies, 1987). Further evidence 
shows that neurotiophic factors are responsible for the suiwival-promoting effects of 
sensoiy neuron target fields and are expressed in the peripheral and central target fields 
of these neurons during development (Davies et a t, 1987; Harper and Davies, 1990; 
Schecterson and Bothwell, 1992, 1994; Buchman and Davies, 1993; Buchman et al,, 
1994; Hallbdok et aL, 1993). Neurons can be rescued from naturally occuning cell 
death by the administiation of exogenous neurotrophic factors (Levi-Montalcini and 
Angeletti, 1968; Hofer and Barde, 1988), while the use of blocking antibodies to these 
factors results in the elimination of neurons (Levi-Montalcini and Angeletti, 1968; 
Gaese et at., 1994). Targeted null mutations in neurotrophic factors (Crowley et at., 
1994; Ernfors et at., 1994a,b; Jones et al., 1994) and their receptor tyrosine Idnases 
(Klein et al., 1993, 1994; Smeyne et al., 1994) cause the loss of sensory neurons 
known to be supported by these factors in vitro (Davies, 1994a).
The expression of neurotrophic factors is not limited to the target fields of 
sensory neurons. BDNF mRNA has been detected in a proportion of embryonic dorsal 
root ganglion (DRG) neurons using in situ hybridization (Emfors et al., 1990b; Emfors 
and Persson, 1991; Schecterson and Bothwell, 1992; Zhang et al., 1994). This raises 
the possibility that BDNF could act on developing sensory neurons by an autocrine 
route. Strong evidence for an autocrine action of BDNF in sensoiy neurons has come 
from studies using antisense BDNF oligonucleotides to interfere with the production of
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BDNF in cultured DRG neurons. This was initially carried out using DRG neurons 
which had been dissected out and cultured before their axons had reached their targets. 
At this stage, the neurons survive in isolation in defined medium without added 
neurotrophic factor and undergo a maturational change from small, spindle-shaped, 
phase-dark neurons with short neurites to larger, phase-bright, spherical neurons with 
long neurites. BDNF accelerates this maturational change, while antisense BDNF 
oligonucleotides have an inhibitory effect (Wright et al, 1992), indicating that BDNF 
may promote maturation via an autocrine mechanism. The survival of early DRG 
neurons is unaffected by antisense oligonucleotides, suggesting that BDNF does not act 
by an autocrine mechanism to promote neuronal survival at this stage (Wright et al,
1992). Recent studies using antisense BDNF oligonucleotides have also shown that 
BDNF acts by an autocrine route on adult DRG neurons (Acheson et a l, 1995). Like 
early DRG neurons that have not yet innervated their targets, adult DRG neurons 
survive independently of neurotrophic factors in vitro (Lindsay, 1988), but the BDNF 
autocrine loop at this stage is required for sustaining the survival of some of these 
neurons.
Now that BDNF has been shown to act on early and adult sensory neurons by 
an autocrine mechanism during developmental stages when these neurons survive 
independently of added neurotrophic factors (Wright e ta l ,  1992; Acheson e ta l,  
1995), it is important to determine whether a BDNF autocrine loop might also operate 
during the phase of naturally occurring neuronal death. This was addressed in part by 
measuring the levels of BDNF mRNA in highly purified preparations of different 
populations of cranial sensory neurons that depend on either NGF or BDNF for 
survival. During the latter half of embryonic development, neurons of the trigeminal 
mesencephalic nucleus (TMN) are supported by BDNF (Davies et a l, 1986a,b) but not 
NGF (Davies et a l, 1987), neurons of the dorsomedial part of the trigeminal ganglion 
(DMTG neurons) and jugular ganglion are supported by NGF and contain very few 
BDNF-responsive neurons, and neurons of the ventrolateral part of the trigeminal 
ganglion (VLTG neurons) are supported by BDNF and contain few NGF-responsive
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neurons (Davies and Lindsay, 1985; Davies et al,, 1986a). In the chicken embryo, the 
number of neurons in the jugular ganglion pealcs at E8 and decreases by half over the 
next 5 days (Hiscock and Straznicky, 1986) and the number of neurons in the TMN 
peaks at E9 and decreases by 80% over the next 5 days (Rogers and Cowan, 1974). 
Although there are no published data on the timing of neuronal death in the embryonic 
chicken trigeminal ganglion, these neurons are born over the same period of 
development as jugular* and TMN neurons (between E2 and E7) (D'Amico and Noden, 
1980; D'Amico, 1982; Hiscock and Straznicky, 1986). Thus, it is probable that all four 
populations will undergo naturally occuning neuronal death over much the same period 
of development. Hence, the expression of BDNF mRNA in these neurons was studied 
from ElO to E14. During this period, NGF-dependent neurons were found to express 
the highest levels of BDNF mRNA, while BDNF-dependent neurons expressed lower 
or undetectable levels of BDNF mRNA. This finding together with the demonstration 
that NGF-dependent sensory neurons synthesize and release biologically active NGF, 
suggests that, during the period of naturally occuning neuronal death, BDNF may act 
by a paracrine and not an autociine route in certain sensoiy neurons.
Methods
Iso lation  and Purification  of Neurons
The median part of the TMN, dorsomedial and venti olateral poles of trigeminal 
ganglia, and the jugular ganglia were dissected from chicken embryos of 10 to 14 days 
incubation (ElO to E l4). The ganglia were dissociated into neurons and these purified 
free of non-neuronal cells as described in Chapter 2.
M easurem ent of BDNF mRNA in  Isolated  Neurons
A quantitative RT-PCR technique (Wyatt and Davies, 1993) was used to 
measure the very low levels of BDNF mRNA in puiified neuronal samples as described 
in Chapter 2.
To compare the relative level of BDNF mRNA in different Idnds of sensory
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neurons, the level of L27 mRNA, which codes for a ubiquitous, constitutively 
expressed ribosomal protein, was measured in RNA samples from purified neurons by 
quantitative RT-PCR. The level of BDNF mRNA in samples could then be expressed 
relative to the level of L27 mRNA in these samples. The RT-PCR protocol for 
measuring L27 mRNA levels is given in Chapter 2.
N euronal C ultures
To study the suiwival response of purified ElO TMN, DMTG, VLTG, and 
jugular neurons to BDNF and NGF, these neurons were plated in 35 mm tissue culture 
dishes (Nunc) that had been pre-coated with P-ORN (0.5 mg/ml in 0.15 M borate 
buffer, pH 8.4, overnight) and laminin (20 fXg/ml in F14 medium, 4 hours). The 
neurons were grown in 2 ml of Ham's F14 medium plus 10% heat-inactivated horse 
serum (HIHS) supplemented with either 5 ng/ml NGF or 5 ng/ml BDNF, and were 
incubated at 37°C in a humidified 4% CO2 incubator. The tissue culture procedure is 
described in more detail in Chapter 2. Six to twelve hours after plating, the number of 
attached neurons within a 12 x 12 mm square in the centie of each dish was counted. 
The number of surviving neurons in this same area was counted after 48 hours 
incubation and is expressed as a percentage of the number of attached neurons at 6 to 
12 hours. 11 ^
To determine if BDNF mRNA-expressing neurons synthesize and release 
BDNF, BDNF mRNA-expressing DMTG neurons were co-cultured with BDNF- 
dependent TMN neurons. High density cultures of purified ElO DMTG neurons were 
first established in 11 mm diameter tissue culture wells (Greiner) pre-coated with P- 
ORN and laminin. The neurons (approximately 5,000 per well) were grown in 100 ml 
of F14 medium with 10% HIHS and 5 ng/ml NGF (to promote their sumval). After 24 
hours incubation, purified ElO TMN neurons were plated at lower density (between 
300 and 500 neurons per well). To distinguish the TMN neurons from the DMTG 
neurons, the former were labelled prior to plating with Dil (1,1 '-dioctadecyl-3,3,3',3'- 
tetramethylindocarbocyanine perchlorate, from Molecular Probes) (Honig and Hume,
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1986) by incubating them in a 40 |Tg/ml solution of Dil in Ham's F14 medium 
containing 10% HIHS for 1 hour at 37®C in a bacteriology grade plastic petii dish. The 
neurons were then washed three times in F14 plus 10% HIHS; the neurons were 
pelleted by centrifugation (2,000 g for 5 minutes) to remove the medium between 
washes. The labelled neurons were visualized with an inverted fluorescent microscope 
using rhodamine filters after a further 24 hours in culture. TMN neurons were also 
cultured alone with 5 ng/ml BDNF. A TrlcB-IgG immunoadhesin (Shelton et a l,  
1995), which binds and inhibits the action of BDNF, was added to TMN/DMTG 
neuronal co-cultures at a concentration of 50 ng/ml to determine if the survival- 
promoting effect of the DMTG neurons was due to their synthesizing and secreting 
BDNF. In addition, TMN neurons were cultured with 5 ng/ml BDNF plus 50 ng/ml 
TrkB-IgG. The TrkB-IgG was a gift from Dave Shelton of Genentech Inc and the 
purified recombinant NGF and BDNF used in all these neuronal culture studies were 
gifts from Gene Burton of Genentech Inc.
Results
BDNF mRNA Expression by Different Kinds of Sensory Neurons
Quantitative RT-PCR was used to measure BDNF mRNA levels in total RNA 
extracted from >95% pure prépar ations of DMTG, jugular, TMN, and VLTG neurons 
obtained from ElO, E12 and E14 chicken embryos. An example of an autoradiograph 
showing the sepaiated RT-PCR products for the BDNF mRNA assay is given in figure 
7. The levels of BDNF mRNA in different total RNA samples were standardized 
against the levels of mRNA encoding the ubiquitous, constitutively expressed L27 
ribosomal protein, also determined using RT-PCR. The sensitivity and accuracy of the 
competitive RT-PCR technique used in these studies has been documented previously 
(Wyatt and Davies, 1993). Figure 8 shows that, at each age, BDNF mRNA levels were 
highest in DMTG and jugulai* neurons and increased approximately two-fold between 
ElO and E14. Lower levels of BDNF mRNA were expressed in VLTG neurons and 




Figure 7 Autoradiograph showing the products of RT-PCRs amplified with BDNF- 
speciflc primers. (1) Reaction containing total RNA from purified ElO chicken DMTG 
neurons showing the 83 bp amplification product. (2) Reaction containing 0.5 fg of 
control RNA template, showing the 87 bp amplification product. (3) Reaction 
containing 0.5 fg control RNA template plus total RNA from purified ElO chicken 
DMTG neurons, showing both amplification products. (C) Control reaction showing 
no products; these contained the control RNA template plus total RNA from ElO 
DMTG neurons but did not undergo the reverse transcription step.
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The survival responses of DMTG, jugular, TMN, and VLTG neurons to NGF 
and BDNF aie shown in figure 9. The majority of DMTG and jugular neurons were 
supported for 48 hours by NGF, with only a small population of between 5 and 10% 
responding to BDNF. Conversely, the majority of TMN and VLTG neurons were 
supported by BDNF. NGF did not support the survival of any TMN neurons and 
promoted the survival of about 10% of VLTG neurons. These findings are similar to 
previously reported survival responses of DMTG, VLTG, and TMN neurons to NGF 
and BDNF (Davies et a l, 1986a,b, 1987).
Thus, during the middle phase of embryonic development when naturally 
occuning neuronal death takes place in populations of cranial sensory neurons (Rogers 
and Cowan, 1974; Hiscock and Straznicky, 1986), BDNF mRNA is expressed 
predominantly in populations of NGF-dependent sensory neurons. The BDNF- 
dependent TMN neurons, which contain no NGF-responsive neurons, do not express 
BDNF mRNA, while the VLTG neurons, which contain a minor set of NGF- 
responsive neurons, express lower levels of BDNF mRNA than DMTG and jugular 
neurons.
BDNF Synthesis by N G F-D ependent Neurons
Whether or not BDNF mRNA-expressing, NGF-dependent sensoiy neurons 
synthesize and release biologically active BDNF was determined by co-culturing NGF- 
dependent DMTG neurons with BDNF-dependent TMN neurons to see if the former 
could promote the survival of the latter without BDNF in the medium. Before plating, 
the TMN neurons were labelled with Dil, a fluorescent, lipophilic, carbocyanine dye 
(Honig and Hume, 1986) so that they could be identified in the co-cultures. Figure 10 
shows how Dil labelling allowed TMN neurons to be easily identified in TMN/DMTG 
neuronal co-cultures. Since TMN neurons do not respond to NGF (Davies et a l ,
1987), the survival of DMTG neurons in co-cultures could be promoted by adding 
NGF to the culture medium without affecting the survival of TMN neurons.
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DMTG Jugular TMN VLTG
Figure 9 Bar chart showing the percent survival of ElO DMTG, jugular, TMN, and 
VLTG neurons after 48 hours in control cultures (C) and cultures supplemented with 5 
ng/ml NGF (N) and 5 ng/ml BDNF (B). The mean and standard error of the neuronal 
counts for three separate culture dishes are shown.
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Ba
Figure 10 Photomicrographs of co-cultures of TMN and DMTG neurons. (A) Phase 
contrast view showing all neurons and their processes in the field. (B) The same field 
as in (A) viewed by rhodamine epifluorescence showing Dil-labeUed TMN neuron. The 
remaining neurons (DMTG) are not fluorescent
128
after 48 hours of incubation (data not shown), whereas approximately 50% of TMN 
neurons were still surviving when co-cultured with DMTG neurons in the absence of 
added BDNF (figure 11). This was almost equivalent to the percentage of TMN 
neurons that suiwived alone in BDNF-supplemented medium (figure 11). To ascertain 
whether the survival-promoting effect of DMTG neurons on TMN neurons was due to 
the synthesis and release of BDNF, a TiicB-IgG immunoadhesin (Shelton et a l, 1995) 
was added to the culture medium to bind and inhibit the action of BDNF. In cultures of 
TMN neurons grown alone in medium containing 5 ng/ml BDNF, TrkB-IgG at a 
concentration of 50 ng/ml reduced neuronal survival from 67% to 8% (figure 11). The 
same level of TrkB-IgG did not affect the number of ElO DMTG neurons surviving in 
medium containing 5 ng/ml NGF (data not shown). TrkB-IgG reduced the survival of 
TMN neurons growing in DMTG/TMN neuronal co-cultures from 51% to 22% (figuie 
11). This is strong evidence that the sumval-promoting effect of DMTG neurons on 
TMN neurons was at least partly due to the synthesis and release of BDNF by DMTG 
neurons.
Discussion
Since BDNF is expressed in a proportion of embryonic DRG neurons (Emfors 
et al. y 1990b; Emfors and Persson, 1991; Schecterson and Both well, 1992; Zhang et 
at., 1994) and studies have shown that BDNF acts on sensory neurons via an autocrine 
mechanism at stages in their development when they are independent of target-derived 
neurotrophic factors (Wright et aL, 1992; Acheson et at., 1995), a BDNF autocrine 
mechanism might also exist during the phase of naturally occurring neuronal death. 
This would malce the process of neuronal selection more complex than first proposed 
by the classic neurotrophic theory which states that the survival of sensory neurons 
during this period is promoted by only target-derived neurotrophic factors. If BDNF 
were to promote survival via an autocrine action, it would compromise the neuronal 
selection process by target fields.







BDNF BDNF+TricB-IgG No added BDNF TrkB-IgG 
TMN neurons alone TMN+DMTG neurons
Figure 11 Bar chart showing the percent survival of ElO TMN neurons cultured 
alone or co-cultured with a ten-fold greater number of ElO DMTG neurons. All cultures 
were supplemented with 5 ng/ml NGF. In addition, TMN neurons were cultured with 
either 5 ng/ml BDNF or 5 ng/ml BDNF plus 50 ng/ml TrkB-IgG. TMN/DMTG 
neuronal co-cultures were also grown with or wthout 50 ng/ml TrkB-IgG. The mean 
and standard error of three separate experiments, each set up in duplicate, are shown.
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and jugular neurons during the period of naturally occurring neuronal death, it is 
unlikely that BDNF acts via an autocrine mechanism to promote the survival of these 
cutaneous sensory neurons during this stage of their development. Likewise, the fact 
that BDNF mRNA expression could not be detected in BDNF-dependent TMN neurons 
during the period of naturally occurring neuronal death suggests that BDNF does not 
act by an autocrine mechanism in these proprioceptive neurons during this stage. A 
lower level of BDNF mRNA expression was found for the primarily BDNF-dependent 
VLTG neurons, raising the possibility that BDNF may act by an autocrine route in 
these cutaneous sensory neurons. However, this could be ruled out by the fact that the 
amount of BDNF produced was insufficient to promote the survival of ElO VLTG 
neurons grown without BDNF. Moreover, it has been shown that, at sub-saturating 
levels of BDNF, the difference in the survival responses of ElO TMN and VLTG 
neurons are not sufficient (L. Pinon and A. M. Davies, unpublished findings) to 
account for any enhancement in VLTG neuronal survival by the autocrine action of 
BDNF.
The finding by this study that NGF-dependent embryonic sensory neurons 
synthesize sufficient BDNF to promote the survival of co-cultured BDNF-dependent 
neurons suggests a possible role for NGF-dependent sensory neurons in the 
maintenance of BDNF-responsive neurons in vivo. It is possible, for example, that 
BDNF-producing, NGF-dependent sensory neurons synapse with BDNF-dependent 
second order sensory neurons in the central nervous system. DRG comprise both 
NGF- and BDNF-responsive neurons which would make a paracrine action between 
neuronal cell bodies in the intact developing ganglion a theoretical possibility. In 
practice, however, this is unlikely to be the case because it would interfere with the 
target selection of neurons during the phase of naturally occurring neuronal death.
Conclusion
The work carried out in this study has revealed an important insight into the 
neurotrophic interactions between sensory neurons. Further studies are required to
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determine, firstly, the extent to which neurotrophic factors are transported to and 
released from specific parts of factor-producing neurons and, secondly, what 
mechanisms might regulate these processes. This information wül cleaiiy be important 




Timing and Regulation of trk^ and BDNF mRNA Expression 
in Placode-Derived Sensory Neurons and Their Targets 
Introduction
Neurons in the developing vertebrate peripheral nervous system require a 
supply of neurotrophins from the tissues they innervate in order to survive (Davies, 
1994c). When sensory and sympathetic neurons are placed in culture before they have 
innervated their targets, they survive and extend axons in the absence of added 
neurotrophins (Davies and Lumsden, 1984; Coughlin and Collins, 1985; Emsberger 
and Rohrer, 1988; Davies, 1989; Emsberger etal., 1989a) and only become dependent 
on a particular* neurotrophin for survival at the stage when their axons would normally 
encounter their targets in vivo (Davies and Lumsden, 1984; Vogel and Davies, 1991; 
Buchman and Davies, 1993).
In vitro studies of different populations of cranial sensory neurons have 
provided insight into how the timing of neurotrophin dependence is regulated (Davies, 
1987,1994b). In the chicken embryo, several populations of these nburons are derived 
from ectoder*mal placodes (D'Amico and Noden, 1983), are 'born' during the same 
period of development (D’Amico, 1982), and start extending axons to their peripheral 
and central targets at approximately the same time, but differ in the distance their axons 
have to grow to reach these targets (Davies, 1989). The two extremes are the neurons 
of the vestibular* ganglion, which lie close to the hindbrain and innervate nearby targets 
in the developing otic vesicle, and the neurons of the nodose ganglion, which are 
located some distance away from the hindbrain and inner*vate distant targets in the 
thorax and abdomen, such as the heart (Davies, 1994b). When placed in culture at the 
stage when the first axons are beginning to grow towards their central and peripheral 
targets, vestibular* neurons die rapidly in the absence of neurotrophins whereas nodose 
neurons die much more slowly. Hence, early vestibular* neurons start responding to
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BDNF with enhanced survival before nodose neurons (Vogel and Davies, 1991). 
Because these experimental results were obtained in very low density cultures, it is 
likely that early cranial sensory neurons are individually programmed to survive for a 
specific length of time before they become dependent on BDNF for survival (i.e„ these 
survival differences are intrinsic properties of the neurons).
Although the timing of BDNF dependence appears to be controlled primarily by 
an intrinsic programme, there is some evidence that the onset of dependence can be 
accelerated by BDNF itself. Early nodose neurons normally begin responding to BDNF 
with enhanced survival after about 72 hours in culture. However, if these neurons are 
transiently exposed to BDNF between 48 and 72 hours, they die more rapidly and to a 
greater extent after 72 hours following BDNF deprivation than neurons that were not 
exposed to BDNF (Vogel and Davies, 1991).
BDNF exerts its effects on neurons by binding to the trk'B receptor, a member 
of the trk family of tyrosine kinase receptors (Squinto et a l, 1990; Berkemeier et a l, 
1991; Klein et a l, 1991b, 1992; Soppet et a l, 1991; Ip et a l, 1992). In addition to 
catalytic tt'kB receptors that possess a kinase domain, alternative splicing generates tî'kB 
variants that lack the tyrosine kinase domain (Klein et a l,  1990a,b), although the 
function of these non-catalytic receptors is unclear. BDNF, like other neurotrophins, 
also binds to the common neurotrophin receptor, p75. However, the function of p75 in 
mediating or modulating the BDNF suivival response, if any, is unclear. Although p75 
null mutant mice have defective innervation of tissues by some NGF-responsive 
sensory and sympathetic neurons (Lee et a l, 1992, 1994a) and p75-deficient 
embryonic sensory and postnatal sympathetic neurons are less responsive to NGF than 
wild type neurons (Davies et a l, 1993b; Lee et a l, 1994b), the dose response of p75- 
deficient nodose neurons to BDNF is normal (Davies et a l, 1993b). Two issues have 
yet to be studied. Firstly, how differences in the timing of the BDNF survival response 
are related to the expression of catalytic trkB and, secondly, whether the effect of 
BDNF on accelerating BDNF dependence in early sensory neurons is related to 
changes in /rkB expression. In an attempt to address these issues, the timing and
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regulation of catalytic trkB mRNA expression was studied in developing sensory 
neurons. p75 mRNA expression in BDNF-dependent neurons was also studied to 
obtain potentially useful information for comparison with p75 mRNA expression in 
NGF-responsive neurons.
Another important but poorly understood issue is the extent to which BDNF 
acts on developing sensory neurons by an autocrine route (Davies and Wright, 1995). 
Many embryonic dorsal root ganglion (DRG) neurons express BDNF mRNA (Emfors 
et a l, 1990b; Emfors and Persson, 1991; Schecterson and Both well, 1992; Zhang et 
a l, 1994) and antisense BDNF oligonucleotides inhibit an early maturational change in 
many cultured early DRG neurons before they become dependent on added 
neurotrophins for survival (Wright et a l, 1992). Similar experiments on adult DRG 
neurons, which like very early sensory neurons survive independently of nemotrophins 
in culture (Lindsay, 1988), have shown that antisense BDNF oligonucleotides reduce 
the number of surviving neurons by 35% (Acheson et ah, 1995), suggesting that 
BDNF acts by an autocrine route to promote the survival of a subset of these neurons. 
The BDNF autocrine loop in early DRG neurons, however, does not seem to play a 
role in neuronal survival because antisense BDNF oligonucleotides do not affect the 
number of surviving neurons (Wright et a l, 1992). Studying when trkB is expressed 
in developing sensoiy neurons would provide additional information on when BDNF 
autocrine loops are potentially capable of influencing neuronal development.
The present study focused on the two populations of cranial sensory neurons 
that have the most extreme differences in the duration of neurotrophin independence, 
those of the vestibular and nodose ganglia. Nodose neurons with their particularly 
lengthy phase of neurotrophin independence were especially useful for studying the 
timing and regulation of trkB expression. Because only very small numbers of cranial 
sensory neurons were available from early chicken embryos for these studies a reliable, 
quantitative, competitive reverse transcription-polymerase chain reaction (RT-PCR) 
technique was used (Wyatt and Davies, 1993) to measure the level of trkB mRNA 
encoding functional r?tB receptors that possess a kinase domain. Results obtained in
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the present study show that mRNA is expressed with a different time course in 
vestibular and nodose neurons that accords with the different timing of the BDNF 
survival response in these neurons. Moreover, the results on the regulation of trkB 
mRNA expression in cultured neurons suggest that BDNF's modulation of when these 
neurons acquire neurotrophin dependence may be mediated by changes in trkB 
expression. It was also shown that a BDNF autocrine loop cannot operate in at least 
some populations of sensory neurons during the earliest stages of neurotrophin 
independent survival.
Materials and Methods 
Embryonic Tissues
Tungsten needles were used to dissect the nodose and vestibular ganglia, heart, 
otic vesicle and hindbrain from staged (Hamburger and Hamilton, 1951) chicken 
embryos. General dissection procedures are given in Chapter 2. Adherent mesenchymal 
tissue was removed from the hindbrain and otic vesicle by incubating these tissues with 
10 mg/ml dispase (Boehringer-Mannheim, grade II) in HEPES-buffered (20 mM) 
Hanks’ balanced salt solution for 5 minutes at 25^C. Tissues for RNA extraction were 
frozen and stored at -70^C.
Neuronal Cultures
Stage 19 nodose ganglia were trypsinized for 8 minutes and dissociated to give 
a single cell suspension as described in Chapter 2. The cells were plated at a density of 
1,000-1,500 neurons per dish in 60 mm plastic tissue culture dishes (Nunc) that had 
been pre-coated with P-ORN (0.5 mg/ml in 0.15 M borate buffer, overnight) and 
laminin (20 p.g/ml for 4 hours). The neurons were incubated at 37°C in a humidified 4 
% CO2 incubator in 4 ml of Ham's F14 supplemented with penicillin (60 mg/1), 
streptomycin (100 mg/1), 10% heat-inactivated horse serum (HIHS) and 5% heat- 
inactivated fetal calf serum (HIFCS, Gibco BRL). The neurons were grown with or 
without purified recombinant BDNF (gift of John Winslow and Gene Burton,
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Genentech Inc) at a concentration of 5 ng/ml. Chapter 2 gives further details of the 
neuronal culture procedure.
M easurem ent of Specific mRNA Transcripts
A quantitative, competitive, RT-PCR technique (Wyatt and Davies, 1993) was 
used to measure the levels of mRNAs encoding BDNF, catalytic trkB, p75 , and L27 
in total RNA from tissues and cultured neurons. Details of the RNA extraction 
procedure and RT-PCR assays are given in Chapter 2.
Results
Expression of trkB  mRNA in Developing Nodose and Vestibular Ganglia 
The levels of mRNA encoding full-length, catalytic trkB in the vestibular and 
nodose ganglia of chicken embiyos during the early stages of axonal outgrowth and 
target encounter were determined using RT-PCR (Wyatt and Davies, 1993). An 
example of an autoradiogram showing the separated PCR products is shown in figure 
12. Figure 13 shows the level of trkB mRNA in vestibular and nodose ganglia from 
stages 17 to 24 (Hamburger and Hamilton, 1951). To compare the relative levels of 
trkB mRNA in these ganglia, quantitative RT-PCR was used to measure the mRNA 
level of L27, a ubiquitous, constitutively expressed ribosomal protein, in RNA samples 
used for measuring trkB mRNA. At stage 17, trkB mRNA was not detected in either 
ganglion. trkB mRNA was first detected in the vestibular ganglion at stage 18 and at 
stage 21 in the nodose ganglion. The ear lier appearance of trkB mRNA in the vestibular 
ganglion accords with the shorter period of neurotrophin independence and earlier 
response of these neurons to BDNF compared with nodose neurons (Vogel and 
Davies, 1991).
Expression of p75 mRNA in Developing Nodose and Vestibular Ganglia 
Although the function of p75 in mediating or modulating the BDNF survival 
response is unclear, the level of p75 mRNA was measured in vestibular and nodose
137
^  106 bp
# #  98 bp
Figure 12 Autoradiograph showing the products of RT-PCRs amplified with 
primers specific for full-length chicken trkB. (1) Control reaction showing no 
amplification products; this contained 1 fg of the control RNA template plus total RNA 
from stage 24 nodose ganglia but did not undergo the reverse transcription step. (2) 
Reaction containing 1 fg of the control RNA template plus total RNA from stage 24 
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Figure 13 Graph of the level of full-length trkB mRNA relative to L27 mRNA (fg 
ti'kB mRNA per pg L27 mRNA) in the vestibular and nodose ganglia of chicken 
embryos at stages 17 to 24. The means and standard eiTors of measurements from 2 to 
4 separate sets of ganglia are shown.
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ganglia during the early stages of their development to see if the expression of this 
transcript closely follows that of trkB mRNA, as is the case for p75 mRNA and trk A  
mRNA expression in developing trigeminal ganglia (Wyatt and Davies, 1993). The 
level of p75 mRNA was measured in total RNA extracted from staged vestibular and 
nodose ganglia by quantitative, competitive RT-PCR and is expressed relative to L27 
mRNA (figure 14). In both vestibular and nodose ganglia, p75 mRNA was clearly 
detected before full-length trkB mRNA (as early as stage 17 in vestibular* ganglia and 
stage 20 in nodose ganglia, the earliest stages studied in each case). There were marked 
differences in the relative levels of p75 mRNA in the vestibular and nodose ganglia. 
The level of p75 mRNA remained low in the vestibular ganglion from stages 20 to 24, 
while the level of p75 mRNA increased 3-fold in the nodose ganglion between stages 
20 and 24. At stage 24, the level of p75 mRNA was 9-fold greater in the nodose 
ganglion compared to the vestibular ganglion, while at the same stage of development, 
the levels of trkB mRNA were similar in both of these ganglia (figure 13).
Expression of BDNF mRNA in the Peripheral and Central Targets of 
Vestibular and Nodose Neurons
To determine whether BDNF mRNA is expressed in the central or peripheral 
tai*gets of the vestibular and nodose ganglia and to determine the relationship between 
expression and the timing of innervation, quantitative RT-PCR was used to measure the 
level of BDNF mRNA in the hindbrain (the common central target field of the 
vestibular and nodose ganglia), otic vesicle (innei*vated by the vestibulocochlear 
neurons), and heart (one of the peripheral innervation targets of the nodose ganglion). 
Figure 15 shows the level of BDNF mRNA in these tissues relative to L27 mRNA 
from stages 16 to 24. BDNF mRNA was detected in all three tissues throughout this 
period of development. Although the level of BDNF mRNA relative to L27 mRNA was 
highest in the otic vesicle and lowest in heart, there was little change in the overall level 
of BDNF mRNA in each tissue between stages 16 to 24. This indicates that BDNF 
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Figure 14 Graph of the level of p75 mRNA relative to L27 mRNA (fg p75 mRNA 
per pg L27 mRNA) in the vestibular and nodose ganglia of chicken embryos at stages 
17 to 24. The means and standard eiTors from 2 to 4 separate sets of ganglia at each 
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Figure 15 Graph of the level of BDNF mRNA relative to L27 mRNA (fg BDNF 
mRNA per ng L27 mRNA) in the heart, hindbrain, and otic vesicle of chicken embryos 
at stages 16 to 24. The means and standard errors of measurements from 1 (stage 16 
only) to 3 separate sets of hindbrains and otic vesicles and 2 to 4 separate sets of hearts 
at each stage are shown.
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and that there is no obvious increase in BDNF mRNA concentration during the eai'ly 
stages of target field inneivation.
Regulation of trkB  mRNA Expression in Cultured Nodose Neurons
To investigate the regulation of trkB mRNA expression during the eai'ly stages 
of sensory neuron development, the levels of this transcript were measured in very low 
density cultures of nodose ganglion neurons. These neurons were placed in culture at 
stage 19 before they have innervated their targets and become dependent on BDNF for 
survival (Vogel and Davies, 1991). Figure 16 shows the level of trkB mRNA in these 
neurons grown with and without BDNF in the culture medium. trkB mRNA was not 
detectable in these cultures until after 36 hours incubation. At this time and at 48 hours 
there was no significant difference between the level of trkB mRNA in control cultures 
and BDNF-supplemented cultures. There were significantly higher levels of trkB 
mRNA in BDNF-supplemented cultures after 60 hours and by 72 hours the level of 
trkB mRNA was approximately 3-fold higher in BDNF-supplemented cultures.
Discussion
The pmsent studies of the timing and regulation of rrA:B mRNA expression have 
clarified how BDNF responsiveness is controlled in developing sensory neurons and 
provided interesting contiasts with previous developmental studies of the expression of 
trkA  mRNA which codes for the NGF tyrosine kinase receptor. trkB mRNA was 
expressed in the developing vestibular ganglion before the nodose ganglion. This 
accords with the earlier response of vestibular neurons to BDNF in vitro compared with 
nodose neurons (Vogel and Davies, 1991), suggesting that the timing of BDNF 
responsiveness is controlled by the expression of its receptor. In contrast, Wyatt and 
Davies (1993, 1995) have shown that trkA  mRNA is expressed at low levels in 
developing sensoiy and sympathetic neurons before these neurons show any obvious 
response to NGF, although there is a marked increase in the expression of trkA mRNA 
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Figure 16 Graph of the level of full-length trkB mRNA (fg per neuron) at 12 hourly 
intervals in low-density cultures of stage 19 chicken nodose neurons grown without or 
with BDNF in the culture medium for 72 hours. The means and standard errors of 
measurements from triplicate dishes of botli experimental conditions at each time point 
are shown.
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been detected in the vestibular and nodose ganglia of the rat embryo by in situ 
hybridization, the relative timing of trkB mRNA expression in these two ganglia was 
not studied (Emfors et a i, 1992).
It was shown in the present study that nodose neurons cultured early during the 
phase of neurotrophin independent survival (stage 19) start expressing mRNA 
after 36 hours in vitro. Although BDNF does not enhance the survival of these neurons 
until after 72 hours in vitro (Vogel and Davies, 1991), BDNF exposure between 48 and 
72 hours does give rise to two other effects. It induces an increase in cell body size and 
accelerates the acquisition of BDNF-dependent survival as suggested by the 
observation that neurons die more rapidly and extensively after 72 hours following 
BDNF deprivation compared with neurons that have not been exposed to BDNF in 
vitro (Vogel and Davies, 1991). Interestingly, the accelerated acquisition of BDNF 
dependence is brought about by exposure to a 12- or 24-hour pulse of BDNF only 
between 48 and 72 hours; pulses of BDNF administered prior to 48 hours in vitro do 
not accelerate BDNF dependence. In the present study, BDNF was shown to increase 
the expression of trkB mRNA between 48 and 72 hours in vitro but failed to influence 
either the onset of trkB mRNA expression or level of trkB mRNA for the first 48 hours 
in vitro. The temporal coincidence of the upregulation of trkB mRNA expression and 
acceleration of BDNF dependence by BDNF raises the possibility that the enhanced 
BDNF dependence of BDNF-exposed neurons is due to an increase in the expression 
of BDNF receptors.
The effects of BDNF on tî'kB mRNA expression observed in this study differ 
from those of NGF on trkA mRNA expression in developing sensory neurons. While 
BDNF was shown to increase the expression of trkB mRNA in cultured nodose 
ganglion neurons shortly before they become BDNF-dependent, Wyatt and Davies 
(1993) have found that NGF does not affect trkA mRNA expression in cultured mouse 
trigeminal neurons at either the equivalent stage or later stages of development. They 
have also found that trkA mRNA expression increases normally in the early trigeminal 
ganglia of mouse embryos that are homozygous for a null mutation in the NGF gene.
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indicating that trkA expression is regulated independently of NGF in developing 
sensory neurons. Likewise, trkA  mRNA is regulated independently of NGF in 
developing sympathetic neurons in vitro (Wyatt and Davies, 1995).
Studies using antisense BDNF oligonucleotides to inhibit BDNF synthesis in 
cultured embryonic chicken DRG neurons have shown that BDNF acts by an autocrine 
loop to promote an early maturational change in many of these neurons before they 
become dependent on added neurotrophins for survival (Wright et a/., 1992). Similar in 
vitro experiments on adult DRG neurons have also shown that a BDNF autocrine loop 
operates in many of these neurons to maintain survival (Acheson et al., 1995). It was 
demonstrated in the present study that nodose neurons do not express trkB mRNA 
during the first 24 hours of the phase of neurotrophin independence, clearly indicating 
that BDNF cannot act by an autocrine route via its tyrosine kinase receptor during this 
early period of development. Thus, a BDNF autocrine loop is not a characteristic of aU 
newly differentiated sensory neurons and is not required for their early survival in the 
absence of exogenous neurotrophins. The demonstration that reduction of intracellular 
free-Ca '^*' or depletion of intracellular Ca^+ stores kills early neurotrophin-independent 
nodose neurons but has negligible effect on older neurons growing in the presence of 
BDNF suggests that intracellular Ca^ "^  plays an important role in regulating neuronal 
survival during this stage of development (Larmet et al, 1992).
The developmental changes in the level of p75 mRNA expression relative to 
trkB mRNA in vestibular and nodose ganglia differ from the findings of previous 
quantitative studies of changes in the level of p75 mRNA expression relative to trkA 
mRNA in ganglia of NGF-dependent neurons. Wyatt and Davies (1993, 1995) have 
shown that in both trigeminal ganglia and superior cervical sympathetic ganglia (SCG), 
p75 and trkA mRNAs are co-expressed from the earliest stages, while in the present 
study, p75 mRNA expression was found to precede that of trkB mRNA in developing 
vestibular and nodose ganglia. The demonstration by in situ hybridization that p75 
mRNA is expressed in the epibranchial placode that gives rise to nodose neurons 
(Hallbook et a l, 1990) suggests that p75 may be expressed prior to neuronal
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differentiation by the sensory neuron progenitor cells of this ganglion. The levels of 
p75 mRNA and trkB mRNA were found to increase to a similar extent from stages 21 
to 24 in the nodose ganglion, while the level of p75 mRNA was found to be much 
lower than that of trkB mRNA in the vestibular ganglion and showed no increase over 
the equivalent period of development (compare figures 13 and 14). The relationship 
between p75 and trkB mRNA expression in the developing nodose ganglion is similar 
to the relationship between p75 and trkA  mRNA expression in the developing 
tiigeminal ganglion where the levels of these mRNAs increase in parallel (Wyatt and 
Davies, 1993). The relationship between p75 and trkB mRNA expression in the 
developing vestibulai* ganglion is similar to the relationship between p75 and trkA 
mRNA expression in the developing SCG where the level of p75 mRNA remains low 
in the eaily stages of development of this ganglion (Wyatt and Davies, 1995). In the 
present study, it was not ascertained whether the level of p75 mRNA in vestibular 
ganglia increases later in development (as it does in SCG). However, in situ 
hybridization studies of p75 mRNA expression in chicken embryos have shown that 
the grain density is much higher over the nodose ganglion compaied with the vestibular 
ganglion at stage 27 (Hallbook et at., 1990), suggesting that p75 mRNA continues to 
be expressed at a low level in the vestibulai* ganglion later in development. While the 
differing patterns of trkA and p75 expression in trigeminal and SCG neurons modulate 
the sensitivity of these neurons to NGF at different stages of development (Wyatt and 
Davies, 1993, 1995), the functional significance of the differing patterns of trkB and 
p75 expression in the BDNF-dependent vestibulai* and nodose neurons is unclear.
Intei*prelation of the relative differences in the levels of transcripts for p75 and 
ti'k tyrosine kinase receptors in whole ganglia is potentially complicated by the presence 
of both neurons and non-neuronal cells in these ganglia. Transcripts for the catalytic 
trkB receptor have been detected in various neurons and not in non-neuronal cells 
(Klein et a i,  1990b; Merlio et a/.,1992; Beck et a i, 1993; Frisen et a i , 1993; 
Funakoshi et a l, 1993; Rudge et a l, 1994; Biffo et a i, 1995), while p75 mRNA and 
p75 protein aie expressed in both neurons and a vaiiety of non-neuronal cells (Emfors
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et a l,  1988; Scaipini et a l, 1988; Yan and Johnson, 1988; Hallbook et a i, 1990; 
Wyatt et a l, 1990; von Bartheld et a l, 1991; Wheeler and Bothwell, 1992). However, 
in late embiyonic trigeminal and SCG, when neurons become cleaiiy distinguishable 
moiphologically and can be separated from the non-neuronal cells, p75 mRNA is 
detectable only in the neurons (Wyatt and Davies, 1993,1995). Thus, regaidless of the 
presence of non-neuronal cells in developing ganglia, the overall levels of transcripts 
for p75, trkA and catalytic trkB in whole ganglia are lilcely to reflect the relative levels 
of these transcripts in neurons.
In the present study, BDNF mRNA was found to be expressed in both the 
central and peripheral target fields of the vestibular and nodose ganglia from as eaiiy as 
stage 16, with very little change in the level of BDNF mRNA relative to L27 mRNA 
throughout the period most vestibular and nodose axons reach these targets. Axon 
tracing studies have shown that vestibular axons start entering the hindbrain between 
stages 16 and 17 and that the eaihest nodose axons enter the hindbrain at stage 19. The 
peripheral axons of vestibular neurons are present in the otic vesicle as eaiiy as stage 21 
and the peripheral axons of the nodose ganglion do not reach the heart until between 
stages 24 and 26 (Vogel and Davies, 1991). Thus, it is likely that BDNF synthesis 
begins in these tissues prior to the anival of the earliest sensory axons. Likewise, 
BDNF mRNA has been detected in the peripheral target field of the mouse trigeminal 
ganglion at least a day before the arrival of the earliest sensory axons (Buchman and 
Davies, 1993), whereas NGF protein and message aie first detected with the arrival of 
the earliest sensory axons (Davies et a l, 1987). Although the present study has focused 
on the timing of BDNF mRNA expression, in situ hybridization studies of the E4 
(stage 24) chicken embryo have localized BDNF mRNA to the regions of the otic 
vesicle epithelium that give rise to the vestibular appaiatus (Hallbook et a l, 1993). In 
situ hybridization has also localized BDNF mRNA to regions of the early otic vesicle of 
rat embryos that give rise to both vestibular and cochlear sensory structures (Pirvola et 
a l,  1992).
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